Gene Symbol | Gene ID | Gene Info |
---|---|---|
Foxp1
|
ENSMUSG00000030067.11 | forkhead box P1 |
Foxj2
|
ENSMUSG00000003154.9 | forkhead box J2 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr6_122826008_122826698 | Foxj2 | 322 | 0.785708 | 0.68 | 1.4e-08 | Click! |
chr6_122819893_122820044 | Foxj2 | 54 | 0.898932 | 0.57 | 4.6e-06 | Click! |
chr6_122828189_122828365 | Foxj2 | 1602 | 0.211768 | 0.45 | 6.0e-04 | Click! |
chr6_122826708_122826886 | Foxj2 | 122 | 0.923794 | 0.42 | 1.5e-03 | Click! |
chr6_122819506_122819887 | Foxj2 | 218 | 0.813220 | 0.41 | 1.8e-03 | Click! |
chr6_99014263_99014430 | Foxp1 | 10666 | 0.272091 | -0.76 | 2.7e-11 | Click! |
chr6_99202935_99203086 | Foxp1 | 39992 | 0.202420 | -0.69 | 7.8e-09 | Click! |
chr6_98947946_98948134 | Foxp1 | 12495 | 0.273105 | -0.66 | 4.8e-08 | Click! |
chr6_99175500_99175684 | Foxp1 | 12574 | 0.283182 | 0.63 | 2.0e-07 | Click! |
chr6_99201225_99201753 | Foxp1 | 38471 | 0.207208 | -0.61 | 6.2e-07 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr1_40230393_40230707 | 32.69 |
Il1r1 |
interleukin 1 receptor, type I |
5470 |
0.21 |
chr19_6300372_6300856 | 30.81 |
Ehd1 |
EH-domain containing 1 |
2700 |
0.11 |
chr2_167431166_167431353 | 30.06 |
Slc9a8 |
solute carrier family 9 (sodium/hydrogen exchanger), member 8 |
7140 |
0.18 |
chr11_69062573_69063351 | 28.52 |
9330160F10Rik |
RIKEN cDNA 9330160F10 gene |
2479 |
0.1 |
chr12_111896884_111897036 | 27.41 |
Ppp1r13b |
protein phosphatase 1, regulatory subunit 13B |
10659 |
0.12 |
chr14_41007337_41007980 | 27.31 |
Prxl2a |
peroxiredoxin like 2A |
608 |
0.7 |
chr2_173736867_173737587 | 26.50 |
Vapb |
vesicle-associated membrane protein, associated protein B and C |
284 |
0.88 |
chr8_109584965_109585123 | 26.43 |
Hp |
haptoglobin |
5872 |
0.14 |
chr9_72409226_72409810 | 26.39 |
Gm27255 |
predicted gene 27255 |
250 |
0.55 |
chr19_41495576_41495952 | 26.23 |
Lcor |
ligand dependent nuclear receptor corepressor |
12735 |
0.21 |
chr13_111397493_111397892 | 25.69 |
Gm6270 |
predicted gene 6270 |
29012 |
0.14 |
chr7_135721881_135722214 | 25.61 |
Mki67 |
antigen identified by monoclonal antibody Ki 67 |
5686 |
0.18 |
chr5_123201506_123201803 | 25.59 |
Gm43409 |
predicted gene 43409 |
10066 |
0.1 |
chr1_166002288_166003185 | 25.28 |
Pou2f1 |
POU domain, class 2, transcription factor 1 |
58 |
0.72 |
chr1_179854274_179854595 | 24.43 |
Ahctf1 |
AT hook containing transcription factor 1 |
50754 |
0.12 |
chr13_63564531_63566515 | 24.39 |
Ptch1 |
patched 1 |
212 |
0.91 |
chr13_35959790_35959969 | 24.23 |
Ppp1r3g |
protein phosphatase 1, regulatory subunit 3G |
1040 |
0.4 |
chr4_87806707_87807032 | 23.84 |
Mllt3 |
myeloid/lymphoid or mixed-lineage leukemia; translocated to, 3 |
546 |
0.86 |
chr2_6331309_6331868 | 23.67 |
AL845275.1 |
novel protein |
8508 |
0.19 |
chr2_119605771_119605947 | 23.64 |
Oip5os1 |
Opa interacting protein 5, opposite strand 1 |
11556 |
0.1 |
chr11_20916554_20916845 | 23.55 |
Gm23681 |
predicted gene, 23681 |
21002 |
0.18 |
chr9_98313593_98313876 | 23.33 |
Gm28530 |
predicted gene 28530 |
12084 |
0.2 |
chr11_57960034_57960300 | 23.26 |
Gm12245 |
predicted gene 12245 |
11082 |
0.15 |
chr6_13052400_13052710 | 22.98 |
Gm5300 |
predicted gene 5300 |
4042 |
0.25 |
chr19_47403091_47403290 | 22.98 |
Sh3pxd2a |
SH3 and PX domains 2A |
7169 |
0.23 |
chr13_46875476_46875736 | 22.71 |
Gm48250 |
predicted gene, 48250 |
5421 |
0.17 |
chr17_86313458_86313775 | 22.64 |
2010106C02Rik |
RIKEN cDNA 2010106C02 gene |
26438 |
0.23 |
chr16_90779900_90780106 | 22.61 |
Urb1 |
URB1 ribosome biogenesis 1 homolog (S. cerevisiae) |
7212 |
0.16 |
chr1_86479174_86479713 | 22.18 |
Rpl30-ps6 |
ribosomal protein L30, pseudogene 6 |
5784 |
0.15 |
chr8_77478972_77479191 | 22.16 |
0610038B21Rik |
RIKEN cDNA 0610038B21 gene |
37975 |
0.13 |
chr1_185472844_185473015 | 22.03 |
5033404E19Rik |
RIKEN cDNA 5033404E19 gene |
14365 |
0.12 |
chr6_84640633_84641008 | 21.88 |
Cyp26b1 |
cytochrome P450, family 26, subfamily b, polypeptide 1 |
46912 |
0.17 |
chr1_175607974_175608194 | 21.48 |
Fh1 |
fumarate hydratase 1 |
1437 |
0.39 |
chr4_130295074_130295364 | 21.45 |
Fabp3 |
fatty acid binding protein 3, muscle and heart |
13376 |
0.13 |
chr5_123223029_123223358 | 21.27 |
Psmd9 |
proteasome (prosome, macropain) 26S subunit, non-ATPase, 9 |
4997 |
0.12 |
chr9_64793074_64793409 | 21.21 |
Dennd4a |
DENN/MADD domain containing 4A |
18099 |
0.18 |
chr14_75837044_75838069 | 21.20 |
Gm48931 |
predicted gene, 48931 |
3930 |
0.16 |
chr4_130715764_130715925 | 21.14 |
Snord85 |
small nucleolar RNA, C/D box 85 |
33790 |
0.11 |
chr6_38343722_38344076 | 20.93 |
Zc3hav1 |
zinc finger CCCH type, antiviral 1 |
10374 |
0.13 |
chr11_76884538_76884711 | 20.91 |
Tmigd1 |
transmembrane and immunoglobulin domain containing 1 |
17535 |
0.16 |
chr3_100438275_100438426 | 20.82 |
Gm43121 |
predicted gene 43121 |
516 |
0.73 |
chr16_20424230_20424415 | 20.62 |
Abcc5 |
ATP-binding cassette, sub-family C (CFTR/MRP), member 5 |
1664 |
0.28 |
chr2_18969128_18969574 | 20.35 |
Pip4k2a |
phosphatidylinositol-5-phosphate 4-kinase, type II, alpha |
28775 |
0.18 |
chr3_36918411_36918688 | 20.33 |
4932438A13Rik |
RIKEN cDNA 4932438A13 gene |
10401 |
0.23 |
chr9_50692728_50692943 | 20.33 |
Dixdc1 |
DIX domain containing 1 |
964 |
0.45 |
chr8_91331323_91331874 | 20.29 |
Fto |
fat mass and obesity associated |
17984 |
0.13 |
chr8_23053611_23053959 | 20.19 |
Ank1 |
ankyrin 1, erythroid |
4474 |
0.2 |
chr4_150685197_150685518 | 20.15 |
Gm16079 |
predicted gene 16079 |
6565 |
0.21 |
chr12_110024246_110024718 | 20.02 |
Gm34667 |
predicted gene, 34667 |
609 |
0.65 |
chr9_71162558_71162709 | 19.96 |
Aqp9 |
aquaporin 9 |
0 |
0.96 |
chr10_41241135_41241338 | 19.92 |
Gm25526 |
predicted gene, 25526 |
25191 |
0.16 |
chr3_96555067_96555630 | 19.82 |
Gm15441 |
predicted gene 15441 |
2467 |
0.11 |
chr5_51039988_51040153 | 19.75 |
Gm40319 |
predicted gene, 40319 |
12311 |
0.29 |
chr2_163586914_163587109 | 19.72 |
Ttpal |
tocopherol (alpha) transfer protein-like |
15303 |
0.13 |
chr14_69321815_69322332 | 19.71 |
Gm16677 |
predicted gene, 16677 |
15009 |
0.09 |
chr14_69540059_69540582 | 19.70 |
Gm27174 |
predicted gene 27174 |
15012 |
0.09 |
chr10_117916427_117916622 | 19.59 |
4933411E08Rik |
RIKEN cDNA 4933411E08 gene |
8935 |
0.18 |
chr15_59047713_59048081 | 19.42 |
Mtss1 |
MTSS I-BAR domain containing 1 |
7300 |
0.23 |
chr3_108096711_108096990 | 19.39 |
Gnat2 |
guanine nucleotide binding protein, alpha transducing 2 |
393 |
0.71 |
chr6_120579566_120580923 | 19.30 |
Gm44124 |
predicted gene, 44124 |
68 |
0.96 |
chr7_75611639_75612062 | 19.17 |
Akap13 |
A kinase (PRKA) anchor protein 13 |
10 |
0.98 |
chr16_49839698_49840015 | 19.10 |
Cd47 |
CD47 antigen (Rh-related antigen, integrin-associated signal transducer) |
15510 |
0.24 |
chr13_107101149_107101349 | 19.02 |
Gm31452 |
predicted gene, 31452 |
37554 |
0.14 |
chr7_135813245_135813557 | 18.95 |
6330420H09Rik |
RIKEN cDNA 6330420H09 gene |
40281 |
0.12 |
chr13_104037534_104037876 | 18.94 |
Nln |
neurolysin (metallopeptidase M3 family) |
63 |
0.98 |
chr15_73561033_73561396 | 18.80 |
Dennd3 |
DENN/MADD domain containing 3 |
3578 |
0.23 |
chr7_14525378_14525601 | 18.69 |
Obox4-ps2 |
oocyte specific homeobox 4, pseudogene 2 |
4577 |
0.13 |
chr3_121346684_121346842 | 18.66 |
Gm5711 |
predicted gene 5711 |
33916 |
0.12 |
chr12_80114984_80115584 | 18.62 |
1300014J16Rik |
RIKEN cDNA 1300014J16 gene |
579 |
0.62 |
chr12_69367557_69367877 | 18.55 |
Gm18113 |
predicted gene, 18113 |
2306 |
0.15 |
chr2_131213938_131214219 | 18.48 |
Ap5s1 |
adaptor-related protein 5 complex, sigma 1 subunit |
3474 |
0.13 |
chr5_139734496_139734696 | 18.48 |
Micall2 |
MICAL-like 2 |
1740 |
0.28 |
chr5_139389682_139390030 | 18.22 |
Gpr146 |
G protein-coupled receptor 146 |
71 |
0.95 |
chr14_14351950_14353283 | 18.16 |
Il3ra |
interleukin 3 receptor, alpha chain |
2995 |
0.15 |
chr16_4559726_4560765 | 18.14 |
Tfap4 |
transcription factor AP4 |
391 |
0.8 |
chr6_57745228_57745390 | 18.06 |
Lancl2 |
LanC (bacterial lantibiotic synthetase component C)-like 2 |
42222 |
0.09 |
chr1_58144549_58144718 | 18.04 |
Gm24548 |
predicted gene, 24548 |
10455 |
0.19 |
chr1_174171670_174171842 | 18.03 |
Spta1 |
spectrin alpha, erythrocytic 1 |
1020 |
0.34 |
chr4_59292306_59292644 | 18.00 |
Susd1 |
sushi domain containing 1 |
23491 |
0.17 |
chr11_79069807_79070128 | 17.86 |
Ksr1 |
kinase suppressor of ras 1 |
4519 |
0.24 |
chr8_126609749_126610213 | 17.82 |
Irf2bp2 |
interferon regulatory factor 2 binding protein 2 |
15995 |
0.22 |
chr13_112043565_112043865 | 17.77 |
Gm15323 |
predicted gene 15323 |
38213 |
0.15 |
chr17_6804856_6805157 | 17.76 |
4933426B08Rik |
RIKEN cDNA 4933426B08 gene |
3503 |
0.19 |
chr17_47535748_47536285 | 17.73 |
Ccnd3 |
cyclin D3 |
30775 |
0.1 |
chr7_125478687_125478971 | 17.70 |
Nsmce1 |
NSE1 homolog, SMC5-SMC6 complex component |
270 |
0.91 |
chr4_41630119_41630576 | 17.69 |
Dnaic1 |
dynein, axonemal, intermediate chain 1 |
1297 |
0.28 |
chr7_143769581_143769748 | 17.65 |
Mrgprg |
MAS-related GPR, member G |
2671 |
0.15 |
chr8_94354109_94354553 | 17.65 |
Slc12a3 |
solute carrier family 12, member 3 |
715 |
0.52 |
chr11_95356789_95356995 | 17.41 |
Fam117a |
family with sequence similarity 117, member A |
16930 |
0.11 |
chr3_89136366_89136871 | 17.22 |
Pklr |
pyruvate kinase liver and red blood cell |
5 |
0.94 |
chr7_98048253_98048538 | 17.16 |
Myo7a |
myosin VIIA |
16807 |
0.21 |
chr16_76323171_76323322 | 17.08 |
Nrip1 |
nuclear receptor interacting protein 1 |
412 |
0.88 |
chr2_29677911_29678077 | 17.08 |
Rapgef1 |
Rap guanine nucleotide exchange factor (GEF) 1 |
24488 |
0.15 |
chr5_139796762_139798525 | 17.06 |
Mafk |
v-maf musculoaponeurotic fibrosarcoma oncogene family, protein K (avian) |
129 |
0.94 |
chr12_24889410_24890042 | 17.03 |
Mboat2 |
membrane bound O-acyltransferase domain containing 2 |
58095 |
0.09 |
chr11_5009014_5009183 | 17.00 |
Ap1b1 |
adaptor protein complex AP-1, beta 1 subunit |
376 |
0.8 |
chr18_24102564_24102822 | 16.92 |
Ino80c |
INO80 complex subunit C |
12220 |
0.18 |
chr12_111517954_111518283 | 16.90 |
Gm40578 |
predicted gene, 40578 |
17278 |
0.1 |
chr6_5156932_5157313 | 16.86 |
Pon1 |
paraoxonase 1 |
36641 |
0.14 |
chr2_132695735_132696027 | 16.86 |
Shld1 |
shieldin complex subunit 1 |
2238 |
0.17 |
chr4_150007392_150007724 | 16.86 |
H6pd |
hexose-6-phosphate dehydrogenase (glucose 1-dehydrogenase) |
1465 |
0.34 |
chr1_167802317_167803268 | 16.83 |
Lmx1a |
LIM homeobox transcription factor 1 alpha |
113235 |
0.07 |
chr7_83885959_83886110 | 16.77 |
Mesd |
mesoderm development LRP chaperone |
1568 |
0.21 |
chr8_14889769_14890087 | 16.72 |
Cln8 |
CLN8 transmembrane ER and ERGIC protein |
569 |
0.76 |
chr9_52103873_52104213 | 16.70 |
Gm27686 |
predicted gene, 27686 |
264 |
0.91 |
chr2_73023761_73024098 | 16.59 |
Sp3os |
trans-acting transcription factor 3, opposite strand |
36688 |
0.12 |
chr2_78718744_78718973 | 16.56 |
Gm14463 |
predicted gene 14463 |
61429 |
0.13 |
chr16_95855291_95855553 | 16.52 |
1600002D24Rik |
RIKEN cDNA 1600002D24 gene |
9652 |
0.19 |
chr9_58657759_58658148 | 16.47 |
Rec114 |
REC114 meiotic recombination protein |
1339 |
0.42 |
chr1_9772840_9773422 | 16.45 |
1700034P13Rik |
RIKEN cDNA 1700034P13 gene |
10647 |
0.13 |
chr10_41241676_41241839 | 16.45 |
Gm25526 |
predicted gene, 25526 |
25712 |
0.16 |
chr6_67162285_67162524 | 16.45 |
A430010J10Rik |
RIKEN cDNA A430010J10 gene |
2520 |
0.24 |
chr10_115817172_115817352 | 16.42 |
Tspan8 |
tetraspanin 8 |
9 |
0.99 |
chr9_107971568_107971739 | 16.32 |
Uba7 |
ubiquitin-like modifier activating enzyme 7 |
3852 |
0.07 |
chr9_90235030_90235570 | 16.25 |
Gm16200 |
predicted gene 16200 |
13675 |
0.16 |
chr4_130715186_130715488 | 16.24 |
Snord85 |
small nucleolar RNA, C/D box 85 |
34297 |
0.11 |
chr10_80858382_80858558 | 16.22 |
Sppl2b |
signal peptide peptidase like 2B |
1349 |
0.2 |
chr4_41387869_41388043 | 16.20 |
Ubap1 |
ubiquitin-associated protein 1 |
16231 |
0.12 |
chr8_68259367_68259714 | 16.14 |
Sh2d4a |
SH2 domain containing 4A |
17027 |
0.19 |
chr1_132373964_132374532 | 16.12 |
Tmcc2 |
transmembrane and coiled-coil domains 2 |
6361 |
0.13 |
chr14_121355790_121356113 | 16.04 |
Stk24 |
serine/threonine kinase 24 |
3917 |
0.25 |
chr11_20636524_20636686 | 15.99 |
Sertad2 |
SERTA domain containing 2 |
4626 |
0.25 |
chr3_37510762_37510917 | 15.94 |
Spata5 |
spermatogenesis associated 5 |
17651 |
0.13 |
chr9_61370339_61371660 | 15.93 |
Gm10655 |
predicted gene 10655 |
628 |
0.63 |
chr1_134426409_134426588 | 15.92 |
Platr1 |
pluripotency associated transcript 1 |
9130 |
0.1 |
chr19_29066936_29067376 | 15.92 |
Gm9895 |
predicted gene 9895 |
191 |
0.91 |
chr11_69073513_69073915 | 15.90 |
Snord118 |
small nucleolar RNA, C/D box 118 |
287 |
0.63 |
chrX_139596463_139596745 | 15.80 |
Rnf128 |
ring finger protein 128 |
14016 |
0.22 |
chr5_108674685_108675069 | 15.76 |
Slc26a1 |
solute carrier family 26 (sulfate transporter), member 1 |
92 |
0.94 |
chr2_170154042_170154240 | 15.74 |
Zfp217 |
zinc finger protein 217 |
6038 |
0.3 |
chr10_68446597_68447155 | 15.65 |
Cabcoco1 |
ciliary associated calcium binding coiled-coil 1 |
78891 |
0.09 |
chr14_32146198_32146521 | 15.63 |
Msmb |
beta-microseminoprotein |
1228 |
0.33 |
chr15_98827590_98827953 | 15.51 |
Prkag1 |
protein kinase, AMP-activated, gamma 1 non-catalytic subunit |
1643 |
0.18 |
chr15_58592269_58592967 | 15.46 |
Fer1l6 |
fer-1-like 6 (C. elegans) |
45887 |
0.16 |
chr17_70850487_70852089 | 15.42 |
Tgif1 |
TGFB-induced factor homeobox 1 |
81 |
0.94 |
chr18_82522478_82522653 | 15.40 |
Rpl21-ps8 |
ribosomal protein L21, pseudogene 8 |
1456 |
0.41 |
chr7_68129008_68129537 | 15.39 |
Igf1r |
insulin-like growth factor I receptor |
19318 |
0.23 |
chr2_130655785_130655966 | 15.39 |
Ddrgk1 |
DDRGK domain containing 1 |
1098 |
0.34 |
chr4_139433058_139433245 | 15.36 |
Ubr4 |
ubiquitin protein ligase E3 component n-recognin 4 |
1859 |
0.31 |
chr4_151773758_151773918 | 15.35 |
Camta1 |
calmodulin binding transcription activator 1 |
87812 |
0.08 |
chr6_8770042_8770195 | 15.30 |
Ica1 |
islet cell autoantigen 1 |
422 |
0.91 |
chr11_78074361_78074827 | 15.30 |
Mir451b |
microRNA 451b |
1353 |
0.16 |
chr18_62180293_62180673 | 15.27 |
Gm9949 |
predicted gene 9949 |
357 |
0.62 |
chrX_169106002_169106405 | 15.27 |
Gm15261 |
predicted gene 15261 |
333 |
0.91 |
chr11_75637667_75638005 | 15.26 |
Inpp5k |
inositol polyphosphate 5-phosphatase K |
1301 |
0.31 |
chr1_88206786_88207160 | 15.25 |
Dnajb3 |
DnaJ heat shock protein family (Hsp40) member B3 |
1191 |
0.22 |
chr11_115832202_115832361 | 15.25 |
Llgl2 |
LLGL2 scribble cell polarity complex component |
313 |
0.8 |
chr10_121488739_121488914 | 15.22 |
Gm40787 |
predicted gene, 40787 |
160 |
0.92 |
chr19_32215250_32215441 | 15.19 |
Sgms1 |
sphingomyelin synthase 1 |
4332 |
0.25 |
chr4_126990673_126990824 | 15.14 |
Gm12939 |
predicted gene 12939 |
7309 |
0.13 |
chr5_75377343_75377643 | 15.14 |
Gm22084 |
predicted gene, 22084 |
5348 |
0.21 |
chr15_16314738_16314903 | 15.10 |
Gm6479 |
predicted gene 6479 |
106867 |
0.07 |
chr6_72293058_72293242 | 15.09 |
Sftpb |
surfactant associated protein B |
11460 |
0.13 |
chr11_5499263_5499558 | 15.08 |
Gm11963 |
predicted gene 11963 |
570 |
0.67 |
chr2_131497603_131497764 | 15.07 |
Smox |
spermine oxidase |
5419 |
0.19 |
chr1_132389189_132389375 | 15.05 |
Tmcc2 |
transmembrane and coiled-coil domains 2 |
1036 |
0.42 |
chr4_139335168_139335391 | 15.05 |
AL807811.1 |
aldo-keto reductase family 7 member A2 (AKR7A2) pseudogene |
1901 |
0.15 |
chr10_84639605_84639777 | 14.96 |
Polr3b |
polymerase (RNA) III (DNA directed) polypeptide B |
595 |
0.69 |
chr8_94899227_94899584 | 14.91 |
Ccdc102a |
coiled-coil domain containing 102A |
18116 |
0.1 |
chr12_83073005_83073315 | 14.91 |
Gm29530 |
predicted gene 29530 |
25714 |
0.15 |
chr12_80083901_80084242 | 14.90 |
Gm36660 |
predicted gene, 36660 |
2637 |
0.2 |
chr5_107875021_107875182 | 14.86 |
Evi5 |
ecotropic viral integration site 5 |
6 |
0.96 |
chr9_67235542_67235843 | 14.86 |
Mir190a |
microRNA 190a |
1034 |
0.55 |
chr15_76253653_76253816 | 14.85 |
Mir6953 |
microRNA 6953 |
5543 |
0.07 |
chr11_53483383_53483573 | 14.85 |
Sowaha |
sosondowah ankyrin repeat domain family member A |
3204 |
0.1 |
chr17_86757763_86757914 | 14.83 |
Epas1 |
endothelial PAS domain protein 1 |
4138 |
0.21 |
chr11_85352595_85352790 | 14.83 |
Bcas3 |
breast carcinoma amplified sequence 3 |
475 |
0.84 |
chr7_138918949_138919944 | 14.82 |
Gm9358 |
predicted gene 9358 |
5058 |
0.13 |
chr5_134644858_134645082 | 14.81 |
Eif4h |
eukaryotic translation initiation factor 4H |
5480 |
0.13 |
chr9_57769535_57769863 | 14.78 |
Clk3 |
CDC-like kinase 3 |
3839 |
0.17 |
chr11_95800592_95800866 | 14.77 |
Phospho1 |
phosphatase, orphan 1 |
23770 |
0.1 |
chr18_84885392_84885727 | 14.77 |
Cyb5a |
cytochrome b5 type A (microsomal) |
7958 |
0.17 |
chr13_111940877_111941182 | 14.74 |
Gm15322 |
predicted gene 15322 |
50437 |
0.1 |
chr5_146307212_146307364 | 14.72 |
Cdk8 |
cyclin-dependent kinase 8 |
10923 |
0.17 |
chr8_94354649_94354841 | 14.72 |
Slc12a3 |
solute carrier family 12, member 3 |
301 |
0.82 |
chr1_133797348_133797649 | 14.67 |
Atp2b4 |
ATPase, Ca++ transporting, plasma membrane 4 |
3538 |
0.18 |
chr14_121423066_121423250 | 14.63 |
Gm33299 |
predicted gene, 33299 |
32604 |
0.14 |
chr4_154121558_154121709 | 14.62 |
Trp73 |
transformation related protein 73 |
5028 |
0.13 |
chr13_47170791_47171101 | 14.61 |
Gm48581 |
predicted gene, 48581 |
15938 |
0.14 |
chr4_118424946_118425157 | 14.60 |
Elovl1 |
elongation of very long chain fatty acids (FEN1/Elo2, SUR4/Elo3, yeast)-like 1 |
3042 |
0.14 |
chr7_4239121_4239351 | 14.57 |
Lilra5 |
leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 5 |
1482 |
0.25 |
chr8_121580437_121580812 | 14.55 |
Gm17786 |
predicted gene, 17786 |
1141 |
0.31 |
chr7_132308529_132308892 | 14.54 |
Gm44891 |
predicted gene 44891 |
5368 |
0.15 |
chr5_110836375_110836537 | 14.54 |
Hscb |
HscB iron-sulfur cluster co-chaperone |
136 |
0.93 |
chr12_88984058_88984248 | 14.53 |
Nrxn3 |
neurexin III |
30754 |
0.23 |
chr4_119189949_119190118 | 14.50 |
Ermap |
erythroblast membrane-associated protein |
22 |
0.95 |
chr7_103909517_103909932 | 14.50 |
Olfr65 |
olfactory receptor 65 |
3382 |
0.08 |
chr13_30346944_30347268 | 14.47 |
Agtr1a |
angiotensin II receptor, type 1a |
1565 |
0.41 |
chr6_72104595_72104829 | 14.46 |
Gm29438 |
predicted gene 29438 |
511 |
0.68 |
chr12_80130626_80131086 | 14.44 |
2310015A10Rik |
RIKEN cDNA 2310015A10 gene |
1740 |
0.26 |
chr14_75138507_75138871 | 14.43 |
Gm15628 |
predicted gene 15628 |
1777 |
0.27 |
chr15_6059468_6059633 | 14.41 |
Gm8047 |
predicted gene 8047 |
24589 |
0.23 |
chr14_7952438_7953164 | 14.35 |
Gm45521 |
predicted gene 45521 |
4487 |
0.21 |
chr6_14185920_14186504 | 14.34 |
Gm23760 |
predicted gene, 23760 |
72896 |
0.11 |
chr16_92234695_92234852 | 14.33 |
Gm29880 |
predicted gene, 29880 |
27285 |
0.12 |
chr4_139299064_139299339 | 14.33 |
Capzb |
capping protein (actin filament) muscle Z-line, beta |
10255 |
0.1 |
chr5_129742979_129743345 | 14.32 |
Nipsnap2 |
nipsnap homolog 2 |
9496 |
0.1 |
chr10_95779761_95779926 | 14.29 |
4732465J04Rik |
RIKEN cDNA 4732465J04 gene |
926 |
0.46 |
chr1_162891926_162892449 | 14.28 |
Fmo2 |
flavin containing monooxygenase 2 |
5672 |
0.19 |
chr2_11218145_11218468 | 14.27 |
Prkcq |
protein kinase C, theta |
8562 |
0.13 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
13.9 | 13.9 | GO:1904502 | regulation of lipophagy(GO:1904502) positive regulation of lipophagy(GO:1904504) |
10.7 | 32.0 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
9.4 | 28.3 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
8.3 | 8.3 | GO:0033668 | negative regulation by symbiont of host apoptotic process(GO:0033668) negative regulation by symbiont of host programmed cell death(GO:0052041) negative regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052490) |
8.3 | 33.1 | GO:0051919 | positive regulation of fibrinolysis(GO:0051919) |
8.0 | 40.1 | GO:0015722 | canalicular bile acid transport(GO:0015722) |
7.8 | 31.2 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
7.6 | 37.8 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
7.4 | 22.3 | GO:0060154 | cellular process regulating host cell cycle in response to virus(GO:0060154) |
7.2 | 36.0 | GO:2000561 | regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000561) |
7.2 | 21.5 | GO:0034197 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
7.0 | 21.1 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
7.0 | 21.1 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
6.9 | 20.6 | GO:0046340 | diacylglycerol catabolic process(GO:0046340) |
6.7 | 26.6 | GO:0019805 | quinolinate biosynthetic process(GO:0019805) |
6.6 | 19.7 | GO:1901078 | negative regulation of relaxation of muscle(GO:1901078) |
6.4 | 19.3 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
6.3 | 18.8 | GO:1902809 | regulation of skeletal muscle fiber differentiation(GO:1902809) |
6.1 | 6.1 | GO:0072513 | positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
5.6 | 16.8 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
5.5 | 22.1 | GO:0010510 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) |
5.4 | 16.3 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
5.3 | 21.3 | GO:0032264 | IMP salvage(GO:0032264) |
5.2 | 15.6 | GO:1904222 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) regulation of serine C-palmitoyltransferase activity(GO:1904220) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
5.2 | 15.6 | GO:1900740 | regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
5.2 | 15.6 | GO:0019676 | ammonia assimilation cycle(GO:0019676) |
5.0 | 15.1 | GO:0009804 | coumarin metabolic process(GO:0009804) |
5.0 | 15.0 | GO:0006106 | fumarate metabolic process(GO:0006106) |
4.9 | 19.7 | GO:2000659 | regulation of interleukin-1-mediated signaling pathway(GO:2000659) |
4.9 | 14.8 | GO:0048208 | vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) |
4.9 | 14.6 | GO:0008228 | opsonization(GO:0008228) |
4.8 | 14.4 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) |
4.8 | 33.5 | GO:2000096 | positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
4.8 | 14.3 | GO:0001306 | age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
4.7 | 14.0 | GO:0030397 | membrane disassembly(GO:0030397) nuclear envelope disassembly(GO:0051081) |
4.6 | 13.9 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
4.6 | 13.8 | GO:0006578 | amino-acid betaine biosynthetic process(GO:0006578) |
4.6 | 13.7 | GO:0006768 | biotin metabolic process(GO:0006768) |
4.6 | 4.6 | GO:1901421 | regulation of response to alcohol(GO:1901419) positive regulation of response to alcohol(GO:1901421) |
4.5 | 8.9 | GO:0002019 | regulation of renal output by angiotensin(GO:0002019) |
4.5 | 13.4 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
4.4 | 17.7 | GO:0015825 | L-serine transport(GO:0015825) |
4.2 | 8.4 | GO:0035672 | oligopeptide transmembrane transport(GO:0035672) |
4.2 | 16.9 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
4.1 | 12.4 | GO:0061625 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) glycolytic process through fructose-1-phosphate(GO:0061625) |
4.1 | 12.3 | GO:0048769 | sarcomerogenesis(GO:0048769) |
4.1 | 12.3 | GO:0071816 | protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
4.1 | 16.3 | GO:0048625 | myoblast fate commitment(GO:0048625) |
4.1 | 12.2 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
4.0 | 12.1 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
4.0 | 7.9 | GO:0042908 | xenobiotic transport(GO:0042908) |
4.0 | 43.7 | GO:0060213 | regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060211) positive regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060213) |
4.0 | 23.8 | GO:2001269 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |
4.0 | 11.9 | GO:2000870 | regulation of progesterone secretion(GO:2000870) |
3.9 | 11.8 | GO:1902065 | response to L-glutamate(GO:1902065) |
3.9 | 15.7 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
3.9 | 23.5 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
3.9 | 19.5 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) |
3.9 | 80.9 | GO:0006779 | porphyrin-containing compound biosynthetic process(GO:0006779) tetrapyrrole biosynthetic process(GO:0033014) |
3.8 | 7.7 | GO:1990705 | cholangiocyte proliferation(GO:1990705) |
3.8 | 7.6 | GO:0010901 | regulation of very-low-density lipoprotein particle remodeling(GO:0010901) |
3.8 | 15.1 | GO:0010991 | negative regulation of SMAD protein complex assembly(GO:0010991) |
3.8 | 11.3 | GO:0010873 | positive regulation of cholesterol esterification(GO:0010873) |
3.8 | 3.8 | GO:2000909 | regulation of cholesterol import(GO:0060620) regulation of sterol import(GO:2000909) |
3.7 | 14.8 | GO:2000504 | positive regulation of blood vessel remodeling(GO:2000504) |
3.7 | 11.1 | GO:2000467 | positive regulation of glycogen (starch) synthase activity(GO:2000467) |
3.7 | 11.0 | GO:0008050 | female courtship behavior(GO:0008050) |
3.6 | 10.9 | GO:1903599 | positive regulation of mitophagy(GO:1903599) |
3.6 | 18.2 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
3.6 | 21.7 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
3.6 | 36.0 | GO:0060896 | neural plate pattern specification(GO:0060896) |
3.6 | 7.2 | GO:0045626 | negative regulation of T-helper 1 cell differentiation(GO:0045626) |
3.6 | 3.6 | GO:1902988 | neurofibrillary tangle assembly(GO:1902988) regulation of neurofibrillary tangle assembly(GO:1902996) |
3.6 | 7.1 | GO:2000465 | regulation of glycogen (starch) synthase activity(GO:2000465) |
3.5 | 10.6 | GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
3.5 | 3.5 | GO:0055088 | lipid homeostasis(GO:0055088) |
3.5 | 7.1 | GO:0035771 | interleukin-4-mediated signaling pathway(GO:0035771) |
3.5 | 10.4 | GO:0034372 | very-low-density lipoprotein particle remodeling(GO:0034372) |
3.5 | 10.4 | GO:0002432 | granuloma formation(GO:0002432) |
3.4 | 13.8 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
3.4 | 10.3 | GO:0032782 | bile acid secretion(GO:0032782) |
3.4 | 17.0 | GO:0010746 | regulation of plasma membrane long-chain fatty acid transport(GO:0010746) |
3.4 | 17.0 | GO:0019532 | oxalate transport(GO:0019532) |
3.4 | 10.2 | GO:1903898 | negative regulation of PERK-mediated unfolded protein response(GO:1903898) |
3.4 | 10.2 | GO:0006393 | termination of mitochondrial transcription(GO:0006393) |
3.4 | 16.9 | GO:0009642 | response to light intensity(GO:0009642) |
3.4 | 13.4 | GO:0044789 | modulation by host of viral release from host cell(GO:0044789) positive regulation by host of viral release from host cell(GO:0044791) |
3.3 | 10.0 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
3.3 | 9.9 | GO:0015886 | heme transport(GO:0015886) |
3.3 | 9.8 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
3.2 | 13.0 | GO:2000741 | positive regulation of mesenchymal stem cell differentiation(GO:2000741) |
3.2 | 9.7 | GO:2001245 | regulation of phosphatidylcholine biosynthetic process(GO:2001245) |
3.2 | 16.2 | GO:0006548 | histidine catabolic process(GO:0006548) imidazole-containing compound catabolic process(GO:0052805) |
3.2 | 19.3 | GO:0019856 | 'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) pyrimidine nucleobase biosynthetic process(GO:0019856) |
3.2 | 6.4 | GO:0010751 | negative regulation of nitric oxide mediated signal transduction(GO:0010751) |
3.2 | 34.9 | GO:0042730 | fibrinolysis(GO:0042730) |
3.1 | 12.5 | GO:0010891 | negative regulation of sequestering of triglyceride(GO:0010891) |
3.1 | 6.3 | GO:0071699 | olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
3.1 | 12.5 | GO:0070836 | caveola assembly(GO:0070836) |
3.1 | 18.7 | GO:0003176 | aortic valve development(GO:0003176) aortic valve morphogenesis(GO:0003180) |
3.1 | 9.3 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
3.1 | 9.2 | GO:0072531 | pyrimidine-containing compound transmembrane transport(GO:0072531) |
3.1 | 24.6 | GO:0045792 | negative regulation of cell size(GO:0045792) |
3.1 | 6.1 | GO:0018992 | germ-line sex determination(GO:0018992) |
3.0 | 12.2 | GO:0010727 | negative regulation of hydrogen peroxide metabolic process(GO:0010727) |
3.0 | 24.2 | GO:0090209 | negative regulation of triglyceride metabolic process(GO:0090209) |
3.0 | 6.0 | GO:0003062 | regulation of heart rate by chemical signal(GO:0003062) |
3.0 | 24.0 | GO:0016226 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
3.0 | 12.0 | GO:0035519 | protein K29-linked ubiquitination(GO:0035519) |
3.0 | 9.0 | GO:0021699 | cerebellar cortex maturation(GO:0021699) |
3.0 | 44.5 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
3.0 | 3.0 | GO:0051409 | response to nitrosative stress(GO:0051409) |
3.0 | 14.8 | GO:0061727 | methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
3.0 | 8.9 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
2.9 | 11.7 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
2.9 | 8.7 | GO:0060931 | sinoatrial node cell development(GO:0060931) |
2.9 | 14.6 | GO:0032049 | phosphatidylglycerol biosynthetic process(GO:0006655) cardiolipin biosynthetic process(GO:0032049) |
2.9 | 17.4 | GO:0006477 | protein sulfation(GO:0006477) |
2.9 | 11.6 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
2.9 | 8.7 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
2.9 | 23.0 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
2.9 | 8.6 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
2.9 | 2.9 | GO:1902237 | positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902237) |
2.9 | 8.6 | GO:1990928 | response to amino acid starvation(GO:1990928) |
2.9 | 22.8 | GO:0070257 | positive regulation of mucus secretion(GO:0070257) |
2.8 | 14.2 | GO:0019087 | transformation of host cell by virus(GO:0019087) |
2.8 | 11.3 | GO:1901300 | positive regulation of hydrogen peroxide-mediated programmed cell death(GO:1901300) positive regulation of hydrogen peroxide-induced cell death(GO:1905206) |
2.8 | 8.4 | GO:0017187 | peptidyl-glutamic acid carboxylation(GO:0017187) |
2.8 | 8.4 | GO:0071288 | cellular response to mercury ion(GO:0071288) |
2.8 | 22.3 | GO:0060586 | multicellular organismal iron ion homeostasis(GO:0060586) |
2.8 | 11.1 | GO:0050747 | positive regulation of lipoprotein metabolic process(GO:0050747) |
2.8 | 5.6 | GO:0010989 | negative regulation of low-density lipoprotein particle clearance(GO:0010989) |
2.8 | 5.5 | GO:0071926 | cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) |
2.8 | 11.0 | GO:0060681 | branch elongation involved in ureteric bud branching(GO:0060681) |
2.8 | 5.5 | GO:0001907 | killing by symbiont of host cells(GO:0001907) disruption by symbiont of host cell(GO:0044004) |
2.8 | 5.5 | GO:0035461 | vitamin transmembrane transport(GO:0035461) |
2.7 | 2.7 | GO:0034204 | lipid translocation(GO:0034204) |
2.7 | 8.2 | GO:0034727 | lysosomal microautophagy(GO:0016237) piecemeal microautophagy of nucleus(GO:0034727) late nucleophagy(GO:0044805) |
2.7 | 54.9 | GO:0032878 | regulation of establishment or maintenance of cell polarity(GO:0032878) |
2.7 | 16.3 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
2.7 | 8.2 | GO:2000705 | regulation of dense core granule biogenesis(GO:2000705) |
2.7 | 8.1 | GO:0097167 | circadian regulation of translation(GO:0097167) |
2.7 | 10.8 | GO:0070627 | ferrous iron import(GO:0070627) ferrous iron import into cell(GO:0097460) |
2.7 | 16.2 | GO:0006559 | L-phenylalanine catabolic process(GO:0006559) erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process(GO:1902222) |
2.7 | 2.7 | GO:0046838 | phosphorylated carbohydrate dephosphorylation(GO:0046838) |
2.7 | 2.7 | GO:0010878 | cholesterol storage(GO:0010878) |
2.7 | 13.3 | GO:0010886 | positive regulation of cholesterol storage(GO:0010886) |
2.7 | 8.0 | GO:0018197 | peptidyl-aspartic acid modification(GO:0018197) |
2.6 | 10.6 | GO:0090148 | membrane fission(GO:0090148) |
2.6 | 7.9 | GO:0006068 | ethanol catabolic process(GO:0006068) |
2.6 | 7.9 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
2.6 | 7.8 | GO:1902775 | mitochondrial large ribosomal subunit assembly(GO:1902775) |
2.6 | 7.7 | GO:0032485 | regulation of Ral protein signal transduction(GO:0032485) |
2.6 | 10.3 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
2.6 | 56.3 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
2.5 | 10.2 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
2.5 | 12.7 | GO:2001275 | positive regulation of glucose import in response to insulin stimulus(GO:2001275) |
2.5 | 7.6 | GO:0061428 | negative regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061428) |
2.5 | 15.2 | GO:0071499 | response to laminar fluid shear stress(GO:0034616) cellular response to laminar fluid shear stress(GO:0071499) |
2.5 | 5.0 | GO:0006901 | vesicle coating(GO:0006901) |
2.5 | 10.0 | GO:0043097 | pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) |
2.5 | 10.0 | GO:2000188 | regulation of cholesterol homeostasis(GO:2000188) |
2.5 | 20.0 | GO:0016540 | protein autoprocessing(GO:0016540) |
2.5 | 10.0 | GO:0072386 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
2.5 | 5.0 | GO:0043096 | purine nucleobase salvage(GO:0043096) |
2.5 | 12.4 | GO:0090527 | actin filament reorganization(GO:0090527) |
2.5 | 12.4 | GO:1904707 | positive regulation of vascular smooth muscle cell proliferation(GO:1904707) |
2.5 | 12.3 | GO:0034383 | low-density lipoprotein particle clearance(GO:0034383) |
2.5 | 7.4 | GO:0019853 | L-ascorbic acid biosynthetic process(GO:0019853) |
2.5 | 14.8 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
2.5 | 12.3 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
2.5 | 9.8 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
2.4 | 7.3 | GO:0050904 | diapedesis(GO:0050904) |
2.4 | 12.2 | GO:0043456 | regulation of pentose-phosphate shunt(GO:0043456) |
2.4 | 36.5 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
2.4 | 2.4 | GO:0070587 | negative regulation of heterotypic cell-cell adhesion(GO:0034115) regulation of cell-cell adhesion involved in gastrulation(GO:0070587) |
2.4 | 9.7 | GO:0072656 | maintenance of protein location in mitochondrion(GO:0072656) |
2.4 | 14.5 | GO:0034770 | histone H4-K20 methylation(GO:0034770) |
2.4 | 4.8 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
2.4 | 23.9 | GO:0060390 | regulation of SMAD protein import into nucleus(GO:0060390) |
2.4 | 7.1 | GO:0009177 | deoxyribonucleoside monophosphate biosynthetic process(GO:0009157) pyrimidine deoxyribonucleoside monophosphate biosynthetic process(GO:0009177) |
2.4 | 16.6 | GO:0032933 | response to sterol depletion(GO:0006991) SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
2.4 | 9.5 | GO:2000774 | positive regulation of cellular senescence(GO:2000774) |
2.4 | 7.1 | GO:1901856 | negative regulation of cellular respiration(GO:1901856) |
2.4 | 9.4 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
2.4 | 11.8 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
2.3 | 9.4 | GO:0001712 | ectodermal cell fate commitment(GO:0001712) |
2.3 | 2.3 | GO:0044860 | protein localization to plasma membrane raft(GO:0044860) |
2.3 | 13.9 | GO:0034154 | toll-like receptor 7 signaling pathway(GO:0034154) |
2.3 | 6.9 | GO:0051661 | maintenance of centrosome location(GO:0051661) |
2.3 | 9.2 | GO:1905097 | regulation of guanyl-nucleotide exchange factor activity(GO:1905097) |
2.3 | 20.6 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
2.3 | 6.8 | GO:0015817 | histidine transport(GO:0015817) |
2.3 | 6.8 | GO:1990168 | protein K29-linked deubiquitination(GO:0035523) protein K33-linked deubiquitination(GO:1990168) |
2.3 | 40.7 | GO:0019432 | triglyceride biosynthetic process(GO:0019432) |
2.2 | 22.5 | GO:0010226 | response to lithium ion(GO:0010226) |
2.2 | 4.5 | GO:0006481 | C-terminal protein methylation(GO:0006481) |
2.2 | 8.9 | GO:0061418 | regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061418) |
2.2 | 6.6 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
2.2 | 8.8 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
2.2 | 6.6 | GO:1903964 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
2.2 | 15.3 | GO:1900246 | positive regulation of RIG-I signaling pathway(GO:1900246) |
2.2 | 6.6 | GO:0000087 | mitotic M phase(GO:0000087) |
2.2 | 17.4 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
2.2 | 19.5 | GO:0030953 | astral microtubule organization(GO:0030953) |
2.2 | 6.5 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
2.1 | 12.9 | GO:2000258 | negative regulation of complement activation(GO:0045916) negative regulation of protein activation cascade(GO:2000258) |
2.1 | 46.6 | GO:0006301 | postreplication repair(GO:0006301) |
2.1 | 2.1 | GO:0006084 | acetyl-CoA metabolic process(GO:0006084) |
2.1 | 6.3 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
2.1 | 4.2 | GO:0072718 | response to cisplatin(GO:0072718) |
2.1 | 10.5 | GO:2000052 | positive regulation of non-canonical Wnt signaling pathway(GO:2000052) |
2.1 | 4.2 | GO:0070947 | neutrophil mediated killing of fungus(GO:0070947) |
2.1 | 16.6 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
2.1 | 6.2 | GO:0015772 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
2.1 | 12.4 | GO:0034242 | negative regulation of syncytium formation by plasma membrane fusion(GO:0034242) |
2.1 | 6.2 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) |
2.1 | 2.1 | GO:1901977 | negative regulation of cell cycle checkpoint(GO:1901977) |
2.0 | 8.2 | GO:0061622 | glycolytic process through glucose-1-phosphate(GO:0061622) |
2.0 | 2.0 | GO:0032898 | neurotrophin production(GO:0032898) |
2.0 | 12.2 | GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
2.0 | 6.1 | GO:0032439 | endosome localization(GO:0032439) |
2.0 | 4.0 | GO:0050779 | RNA destabilization(GO:0050779) |
2.0 | 6.1 | GO:0035553 | oxidative RNA demethylation(GO:0035513) oxidative single-stranded RNA demethylation(GO:0035553) |
2.0 | 2.0 | GO:0060331 | negative regulation of response to interferon-gamma(GO:0060331) negative regulation of interferon-gamma-mediated signaling pathway(GO:0060336) |
2.0 | 14.1 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
2.0 | 4.0 | GO:0046061 | dATP catabolic process(GO:0046061) |
2.0 | 2.0 | GO:0044314 | protein K27-linked ubiquitination(GO:0044314) |
2.0 | 16.1 | GO:0031507 | heterochromatin assembly(GO:0031507) |
2.0 | 6.0 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
2.0 | 4.0 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
2.0 | 9.9 | GO:0009992 | cellular water homeostasis(GO:0009992) |
2.0 | 9.9 | GO:0045053 | protein retention in Golgi apparatus(GO:0045053) |
2.0 | 5.9 | GO:1902683 | regulation of receptor localization to synapse(GO:1902683) |
2.0 | 7.9 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
2.0 | 7.9 | GO:0060978 | angiogenesis involved in coronary vascular morphogenesis(GO:0060978) |
2.0 | 5.9 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
1.9 | 13.6 | GO:0070561 | vitamin D receptor signaling pathway(GO:0070561) |
1.9 | 7.8 | GO:1902255 | positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902255) |
1.9 | 5.8 | GO:0040031 | snRNA modification(GO:0040031) |
1.9 | 1.9 | GO:0098763 | mitotic cell cycle phase(GO:0098763) |
1.9 | 7.8 | GO:0019346 | homoserine metabolic process(GO:0009092) transsulfuration(GO:0019346) |
1.9 | 3.9 | GO:0010957 | negative regulation of vitamin D biosynthetic process(GO:0010957) |
1.9 | 13.6 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
1.9 | 5.8 | GO:1900095 | regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
1.9 | 1.9 | GO:0003289 | atrial septum primum morphogenesis(GO:0003289) |
1.9 | 5.8 | GO:0015888 | thiamine transport(GO:0015888) |
1.9 | 11.5 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
1.9 | 1.9 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
1.9 | 1.9 | GO:0060018 | astrocyte fate commitment(GO:0060018) |
1.9 | 21.0 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
1.9 | 13.3 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
1.9 | 9.5 | GO:0060087 | relaxation of vascular smooth muscle(GO:0060087) |
1.9 | 1.9 | GO:0010872 | regulation of cholesterol esterification(GO:0010872) |
1.9 | 1.9 | GO:1900037 | regulation of cellular response to hypoxia(GO:1900037) |
1.9 | 5.7 | GO:0006083 | acetate metabolic process(GO:0006083) |
1.9 | 7.6 | GO:0006007 | glucose catabolic process(GO:0006007) |
1.9 | 5.7 | GO:0034380 | high-density lipoprotein particle assembly(GO:0034380) |
1.9 | 5.7 | GO:0003383 | apical constriction(GO:0003383) |
1.9 | 34.0 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
1.9 | 5.7 | GO:2000667 | positive regulation of interleukin-5 secretion(GO:2000664) positive regulation of interleukin-13 secretion(GO:2000667) |
1.9 | 7.5 | GO:0006041 | glucosamine metabolic process(GO:0006041) |
1.9 | 7.5 | GO:1900153 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900151) positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900153) |
1.9 | 9.4 | GO:0070475 | rRNA base methylation(GO:0070475) |
1.9 | 1.9 | GO:1903795 | regulation of inorganic anion transmembrane transport(GO:1903795) positive regulation of inorganic anion transmembrane transport(GO:1903797) |
1.9 | 11.2 | GO:0045409 | negative regulation of interleukin-6 biosynthetic process(GO:0045409) |
1.9 | 1.9 | GO:0036215 | response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) |
1.9 | 3.7 | GO:0043974 | histone H3-K27 acetylation(GO:0043974) regulation of histone H3-K27 acetylation(GO:1901674) |
1.9 | 5.6 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
1.8 | 20.3 | GO:0048268 | clathrin coat assembly(GO:0048268) |
1.8 | 9.2 | GO:0015871 | choline transport(GO:0015871) |
1.8 | 5.5 | GO:0036302 | atrioventricular canal development(GO:0036302) |
1.8 | 12.9 | GO:0097067 | cellular response to thyroid hormone stimulus(GO:0097067) |
1.8 | 1.8 | GO:0055070 | copper ion homeostasis(GO:0055070) |
1.8 | 1.8 | GO:0090283 | regulation of protein glycosylation in Golgi(GO:0090283) |
1.8 | 27.5 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
1.8 | 7.3 | GO:0042023 | DNA endoreduplication(GO:0042023) |
1.8 | 16.5 | GO:0006662 | glycerol ether metabolic process(GO:0006662) |
1.8 | 5.5 | GO:0060298 | positive regulation of sarcomere organization(GO:0060298) |
1.8 | 1.8 | GO:0014873 | response to muscle activity involved in regulation of muscle adaptation(GO:0014873) |
1.8 | 1.8 | GO:0033122 | negative regulation of purine nucleotide catabolic process(GO:0033122) |
1.8 | 7.3 | GO:0046499 | S-adenosylmethioninamine metabolic process(GO:0046499) |
1.8 | 1.8 | GO:0002424 | T cell mediated immune response to tumor cell(GO:0002424) regulation of T cell mediated immune response to tumor cell(GO:0002840) |
1.8 | 3.6 | GO:1901475 | pyruvate transport(GO:0006848) pyruvate transmembrane transport(GO:1901475) |
1.8 | 7.3 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
1.8 | 3.6 | GO:0010248 | establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
1.8 | 5.4 | GO:0015819 | lysine transport(GO:0015819) |
1.8 | 10.9 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
1.8 | 5.4 | GO:0030242 | pexophagy(GO:0030242) |
1.8 | 14.4 | GO:0051292 | nuclear pore complex assembly(GO:0051292) |
1.8 | 48.6 | GO:0043001 | Golgi to plasma membrane protein transport(GO:0043001) |
1.8 | 5.3 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
1.8 | 3.6 | GO:0007035 | vacuolar acidification(GO:0007035) |
1.8 | 7.1 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
1.8 | 7.1 | GO:0035589 | G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) |
1.8 | 3.5 | GO:0002309 | T cell proliferation involved in immune response(GO:0002309) |
1.8 | 3.5 | GO:0032079 | positive regulation of deoxyribonuclease activity(GO:0032077) positive regulation of endodeoxyribonuclease activity(GO:0032079) |
1.8 | 5.3 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
1.8 | 5.3 | GO:0036394 | amylase secretion(GO:0036394) |
1.7 | 1.7 | GO:0032962 | positive regulation of inositol trisphosphate biosynthetic process(GO:0032962) |
1.7 | 3.5 | GO:1901492 | positive regulation of lymphangiogenesis(GO:1901492) |
1.7 | 3.5 | GO:1903142 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
1.7 | 5.2 | GO:0033629 | negative regulation of cell adhesion mediated by integrin(GO:0033629) |
1.7 | 3.4 | GO:0060267 | positive regulation of respiratory burst(GO:0060267) |
1.7 | 3.4 | GO:0035313 | wound healing, spreading of epidermal cells(GO:0035313) |
1.7 | 3.4 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
1.7 | 1.7 | GO:0038089 | positive regulation of cell migration by vascular endothelial growth factor signaling pathway(GO:0038089) |
1.7 | 6.8 | GO:0046512 | diol biosynthetic process(GO:0034312) sphingosine biosynthetic process(GO:0046512) |
1.7 | 13.6 | GO:0090051 | negative regulation of cell migration involved in sprouting angiogenesis(GO:0090051) |
1.7 | 10.2 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) |
1.7 | 27.0 | GO:0061756 | leukocyte adhesion to vascular endothelial cell(GO:0061756) |
1.7 | 3.4 | GO:0042364 | water-soluble vitamin biosynthetic process(GO:0042364) |
1.7 | 1.7 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
1.7 | 8.4 | GO:0045842 | positive regulation of mitotic metaphase/anaphase transition(GO:0045842) positive regulation of metaphase/anaphase transition of cell cycle(GO:1902101) |
1.7 | 3.3 | GO:2000832 | negative regulation of steroid hormone secretion(GO:2000832) negative regulation of corticosteroid hormone secretion(GO:2000847) negative regulation of glucocorticoid secretion(GO:2000850) |
1.7 | 6.7 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
1.7 | 15.0 | GO:0090207 | regulation of triglyceride metabolic process(GO:0090207) |
1.7 | 5.0 | GO:2000834 | androgen secretion(GO:0035935) regulation of androgen secretion(GO:2000834) positive regulation of androgen secretion(GO:2000836) |
1.7 | 1.7 | GO:0071332 | cellular response to fructose stimulus(GO:0071332) |
1.7 | 5.0 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
1.7 | 5.0 | GO:0009182 | purine deoxyribonucleoside diphosphate metabolic process(GO:0009182) dGDP metabolic process(GO:0046066) |
1.6 | 9.9 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
1.6 | 1.6 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
1.6 | 4.9 | GO:0090156 | negative regulation of sphingolipid biosynthetic process(GO:0090155) cellular sphingolipid homeostasis(GO:0090156) negative regulation of ceramide biosynthetic process(GO:1900060) |
1.6 | 11.5 | GO:0070995 | NADPH oxidation(GO:0070995) |
1.6 | 35.7 | GO:0006687 | glycosphingolipid metabolic process(GO:0006687) |
1.6 | 9.7 | GO:0060710 | chorio-allantoic fusion(GO:0060710) |
1.6 | 1.6 | GO:0018894 | dibenzo-p-dioxin metabolic process(GO:0018894) |
1.6 | 8.1 | GO:0030449 | regulation of complement activation(GO:0030449) |
1.6 | 6.5 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
1.6 | 4.8 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
1.6 | 1.6 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
1.6 | 4.8 | GO:0070827 | chromatin maintenance(GO:0070827) |
1.6 | 3.2 | GO:1903376 | neuron intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0036480) regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903376) |
1.6 | 3.2 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
1.6 | 12.8 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
1.6 | 11.2 | GO:0032790 | ribosome disassembly(GO:0032790) |
1.6 | 4.8 | GO:0046292 | formaldehyde metabolic process(GO:0046292) |
1.6 | 4.8 | GO:0018094 | protein polyglycylation(GO:0018094) |
1.6 | 1.6 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
1.6 | 1.6 | GO:0035456 | response to interferon-beta(GO:0035456) |
1.6 | 4.8 | GO:0023021 | termination of signal transduction(GO:0023021) |
1.6 | 4.8 | GO:0060398 | regulation of growth hormone receptor signaling pathway(GO:0060398) |
1.6 | 6.3 | GO:0060283 | negative regulation of oocyte development(GO:0060283) negative regulation of oocyte maturation(GO:1900194) |
1.6 | 15.8 | GO:1904376 | negative regulation of protein localization to plasma membrane(GO:1903077) negative regulation of protein localization to cell periphery(GO:1904376) |
1.6 | 11.0 | GO:0015838 | amino-acid betaine transport(GO:0015838) |
1.6 | 4.7 | GO:0070842 | aggresome assembly(GO:0070842) |
1.6 | 17.2 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
1.6 | 4.7 | GO:0043578 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
1.6 | 4.7 | GO:0070669 | response to interleukin-2(GO:0070669) |
1.6 | 12.5 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
1.6 | 1.6 | GO:0046321 | positive regulation of fatty acid oxidation(GO:0046321) |
1.6 | 9.3 | GO:0015671 | oxygen transport(GO:0015671) |
1.6 | 4.7 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
1.6 | 6.2 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
1.6 | 6.2 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
1.5 | 10.8 | GO:0006817 | phosphate ion transport(GO:0006817) |
1.5 | 4.6 | GO:0044794 | positive regulation by host of viral process(GO:0044794) |
1.5 | 3.1 | GO:0009093 | cysteine catabolic process(GO:0009093) L-cysteine catabolic process(GO:0019448) L-cysteine metabolic process(GO:0046439) |
1.5 | 3.1 | GO:0001555 | oocyte growth(GO:0001555) |
1.5 | 1.5 | GO:1902591 | Golgi vesicle budding(GO:0048194) single-organism membrane budding(GO:1902591) |
1.5 | 4.6 | GO:0051121 | hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
1.5 | 12.3 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
1.5 | 3.1 | GO:0019377 | glycolipid catabolic process(GO:0019377) |
1.5 | 18.4 | GO:0043486 | histone exchange(GO:0043486) |
1.5 | 3.1 | GO:0045908 | negative regulation of vasodilation(GO:0045908) |
1.5 | 6.1 | GO:0046599 | regulation of centriole replication(GO:0046599) |
1.5 | 4.6 | GO:0090399 | replicative senescence(GO:0090399) |
1.5 | 12.2 | GO:0000052 | citrulline metabolic process(GO:0000052) |
1.5 | 6.1 | GO:0070314 | G1 to G0 transition(GO:0070314) |
1.5 | 1.5 | GO:0018904 | ether metabolic process(GO:0018904) |
1.5 | 1.5 | GO:0003162 | atrioventricular node development(GO:0003162) |
1.5 | 3.0 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
1.5 | 3.0 | GO:0090361 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
1.5 | 6.1 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
1.5 | 6.1 | GO:0042699 | follicle-stimulating hormone signaling pathway(GO:0042699) |
1.5 | 6.1 | GO:0042780 | tRNA 3'-end processing(GO:0042780) |
1.5 | 3.0 | GO:0045719 | negative regulation of glycogen biosynthetic process(GO:0045719) negative regulation of glycogen metabolic process(GO:0070874) |
1.5 | 7.6 | GO:0061669 | spontaneous neurotransmitter secretion(GO:0061669) spontaneous synaptic transmission(GO:0098814) |
1.5 | 1.5 | GO:1904124 | microglial cell migration(GO:1904124) regulation of microglial cell migration(GO:1904139) |
1.5 | 9.1 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
1.5 | 4.5 | GO:1903998 | regulation of eating behavior(GO:1903998) negative regulation of eating behavior(GO:1903999) |
1.5 | 6.0 | GO:0042090 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
1.5 | 4.5 | GO:1903849 | regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
1.5 | 1.5 | GO:0032466 | negative regulation of cytokinesis(GO:0032466) |
1.5 | 6.0 | GO:0043137 | DNA replication, removal of RNA primer(GO:0043137) |
1.5 | 3.0 | GO:0032252 | secretory granule localization(GO:0032252) |
1.5 | 4.5 | GO:0043619 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0043619) |
1.5 | 4.5 | GO:0072423 | response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) response to intra-S DNA damage checkpoint signaling(GO:0072429) |
1.5 | 1.5 | GO:0060397 | JAK-STAT cascade involved in growth hormone signaling pathway(GO:0060397) |
1.5 | 3.0 | GO:0009826 | unidimensional cell growth(GO:0009826) |
1.5 | 4.5 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
1.5 | 9.0 | GO:0018065 | protein-cofactor linkage(GO:0018065) |
1.5 | 6.0 | GO:0048254 | snoRNA localization(GO:0048254) |
1.5 | 4.5 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
1.5 | 5.9 | GO:1902035 | positive regulation of hematopoietic stem cell proliferation(GO:1902035) |
1.5 | 3.0 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
1.5 | 5.9 | GO:1900227 | positive regulation of NLRP3 inflammasome complex assembly(GO:1900227) |
1.5 | 2.9 | GO:0000957 | mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
1.5 | 4.4 | GO:0035590 | purinergic nucleotide receptor signaling pathway(GO:0035590) |
1.5 | 4.4 | GO:2001022 | positive regulation of response to DNA damage stimulus(GO:2001022) |
1.5 | 7.3 | GO:0048541 | mucosal-associated lymphoid tissue development(GO:0048537) Peyer's patch development(GO:0048541) |
1.5 | 10.2 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
1.4 | 5.8 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
1.4 | 10.1 | GO:0006750 | glutathione biosynthetic process(GO:0006750) |
1.4 | 4.3 | GO:0046149 | heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
1.4 | 2.9 | GO:0032696 | negative regulation of interleukin-13 production(GO:0032696) |
1.4 | 4.3 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
1.4 | 13.0 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
1.4 | 7.2 | GO:0033572 | transferrin transport(GO:0033572) |
1.4 | 30.2 | GO:0010591 | regulation of lamellipodium assembly(GO:0010591) |
1.4 | 2.9 | GO:0061535 | glutamate secretion, neurotransmission(GO:0061535) |
1.4 | 4.3 | GO:0071139 | resolution of recombination intermediates(GO:0071139) |
1.4 | 4.3 | GO:0006244 | pyrimidine nucleotide catabolic process(GO:0006244) |
1.4 | 4.3 | GO:0010603 | regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
1.4 | 1.4 | GO:0003331 | regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
1.4 | 2.9 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
1.4 | 2.8 | GO:0046122 | purine deoxyribonucleoside metabolic process(GO:0046122) |
1.4 | 7.1 | GO:0042448 | progesterone metabolic process(GO:0042448) |
1.4 | 21.3 | GO:0017144 | drug metabolic process(GO:0017144) |
1.4 | 7.1 | GO:0006012 | galactose metabolic process(GO:0006012) |
1.4 | 2.8 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
1.4 | 2.8 | GO:1902036 | regulation of hematopoietic stem cell differentiation(GO:1902036) |
1.4 | 7.1 | GO:0002756 | MyD88-independent toll-like receptor signaling pathway(GO:0002756) |
1.4 | 14.1 | GO:0051014 | actin filament severing(GO:0051014) |
1.4 | 4.2 | GO:0090168 | Golgi reassembly(GO:0090168) |
1.4 | 5.6 | GO:1902897 | regulation of postsynaptic density protein 95 clustering(GO:1902897) |
1.4 | 1.4 | GO:0006545 | glycine biosynthetic process(GO:0006545) |
1.4 | 7.0 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
1.4 | 1.4 | GO:0071545 | inositol phosphate catabolic process(GO:0071545) |
1.4 | 7.0 | GO:0043922 | negative regulation by host of viral transcription(GO:0043922) |
1.4 | 25.1 | GO:0030195 | negative regulation of blood coagulation(GO:0030195) negative regulation of hemostasis(GO:1900047) |
1.4 | 19.5 | GO:0043981 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
1.4 | 5.6 | GO:0060613 | fat pad development(GO:0060613) |
1.4 | 1.4 | GO:0045341 | MHC class I biosynthetic process(GO:0045341) regulation of MHC class I biosynthetic process(GO:0045343) positive regulation of MHC class I biosynthetic process(GO:0045345) |
1.4 | 2.8 | GO:0090241 | negative regulation of histone H4 acetylation(GO:0090241) |
1.4 | 4.2 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
1.4 | 1.4 | GO:0009438 | methylglyoxal metabolic process(GO:0009438) |
1.4 | 2.8 | GO:0002726 | positive regulation of T cell cytokine production(GO:0002726) |
1.4 | 5.5 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
1.4 | 6.9 | GO:0045629 | negative regulation of T-helper 2 cell differentiation(GO:0045629) |
1.4 | 2.8 | GO:0001705 | ectoderm formation(GO:0001705) |
1.4 | 2.8 | GO:0007039 | protein catabolic process in the vacuole(GO:0007039) |
1.4 | 22.0 | GO:0060337 | type I interferon signaling pathway(GO:0060337) |
1.4 | 6.9 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
1.4 | 6.9 | GO:0015669 | gas transport(GO:0015669) |
1.4 | 1.4 | GO:0009698 | phenylpropanoid metabolic process(GO:0009698) |
1.4 | 2.7 | GO:0086023 | adrenergic receptor signaling pathway involved in heart process(GO:0086023) |
1.4 | 2.7 | GO:0006059 | hexitol metabolic process(GO:0006059) |
1.4 | 4.1 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
1.4 | 19.0 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
1.4 | 2.7 | GO:1903677 | regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
1.4 | 1.4 | GO:0032075 | positive regulation of nuclease activity(GO:0032075) |
1.4 | 9.5 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
1.3 | 6.7 | GO:0071635 | negative regulation of transforming growth factor beta production(GO:0071635) |
1.3 | 5.4 | GO:0071569 | protein ufmylation(GO:0071569) |
1.3 | 5.4 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
1.3 | 6.7 | GO:0010875 | positive regulation of cholesterol efflux(GO:0010875) |
1.3 | 21.4 | GO:0006458 | 'de novo' protein folding(GO:0006458) 'de novo' posttranslational protein folding(GO:0051084) |
1.3 | 5.4 | GO:0070072 | vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
1.3 | 4.0 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
1.3 | 1.3 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
1.3 | 4.0 | GO:0046087 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
1.3 | 5.3 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
1.3 | 31.8 | GO:0008299 | isoprenoid biosynthetic process(GO:0008299) |
1.3 | 5.3 | GO:0035745 | T-helper 2 cell cytokine production(GO:0035745) |
1.3 | 2.6 | GO:1901164 | negative regulation of trophoblast cell migration(GO:1901164) |
1.3 | 10.6 | GO:0043248 | proteasome assembly(GO:0043248) |
1.3 | 5.3 | GO:0034141 | positive regulation of toll-like receptor 3 signaling pathway(GO:0034141) |
1.3 | 4.0 | GO:2001240 | negative regulation of signal transduction in absence of ligand(GO:1901099) negative regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001240) |
1.3 | 9.2 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
1.3 | 2.6 | GO:0003164 | His-Purkinje system development(GO:0003164) |
1.3 | 9.2 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
1.3 | 7.9 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
1.3 | 2.6 | GO:0060672 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
1.3 | 10.4 | GO:0045724 | positive regulation of cilium assembly(GO:0045724) |
1.3 | 1.3 | GO:0009451 | RNA modification(GO:0009451) |
1.3 | 2.6 | GO:0002426 | immunoglobulin production in mucosal tissue(GO:0002426) |
1.3 | 6.5 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
1.3 | 3.9 | GO:0009629 | response to gravity(GO:0009629) |
1.3 | 5.2 | GO:0060295 | regulation of cilium movement involved in cell motility(GO:0060295) regulation of cilium beat frequency involved in ciliary motility(GO:0060296) regulation of cilium-dependent cell motility(GO:1902019) |
1.3 | 2.6 | GO:0015889 | cobalamin transport(GO:0015889) |
1.3 | 10.3 | GO:1901798 | positive regulation of signal transduction by p53 class mediator(GO:1901798) |
1.3 | 2.6 | GO:2000828 | regulation of parathyroid hormone secretion(GO:2000828) |
1.3 | 6.4 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
1.3 | 12.8 | GO:0035994 | response to muscle stretch(GO:0035994) |
1.3 | 5.1 | GO:0060050 | positive regulation of protein glycosylation(GO:0060050) |
1.3 | 1.3 | GO:0006706 | steroid catabolic process(GO:0006706) |
1.3 | 1.3 | GO:0001840 | neural plate development(GO:0001840) |
1.3 | 8.9 | GO:0034244 | negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
1.3 | 3.8 | GO:0010536 | positive regulation of activation of Janus kinase activity(GO:0010536) |
1.3 | 6.3 | GO:1902916 | positive regulation of protein polyubiquitination(GO:1902916) |
1.3 | 12.6 | GO:0006032 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
1.3 | 3.8 | GO:0032971 | regulation of muscle filament sliding(GO:0032971) |
1.3 | 1.3 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
1.3 | 2.5 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
1.3 | 5.0 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
1.3 | 18.8 | GO:0046326 | positive regulation of glucose import(GO:0046326) |
1.2 | 8.7 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
1.2 | 3.7 | GO:0046642 | negative regulation of alpha-beta T cell proliferation(GO:0046642) |
1.2 | 3.7 | GO:0002445 | type IIa hypersensitivity(GO:0001794) regulation of type IIa hypersensitivity(GO:0001796) positive regulation of type IIa hypersensitivity(GO:0001798) type II hypersensitivity(GO:0002445) regulation of type II hypersensitivity(GO:0002892) positive regulation of type II hypersensitivity(GO:0002894) |
1.2 | 6.2 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
1.2 | 2.5 | GO:0045064 | T-helper 2 cell differentiation(GO:0045064) |
1.2 | 3.7 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) |
1.2 | 6.2 | GO:0044068 | modulation by symbiont of host cellular process(GO:0044068) |
1.2 | 1.2 | GO:0010572 | positive regulation of platelet activation(GO:0010572) |
1.2 | 23.4 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
1.2 | 1.2 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
1.2 | 6.1 | GO:1902400 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) signal transduction involved in mitotic cell cycle checkpoint(GO:0072413) signal transduction involved in mitotic G1 DNA damage checkpoint(GO:0072431) intracellular signal transduction involved in G1 DNA damage checkpoint(GO:1902400) signal transduction involved in mitotic DNA damage checkpoint(GO:1902402) signal transduction involved in mitotic DNA integrity checkpoint(GO:1902403) |
1.2 | 8.6 | GO:0040016 | embryonic cleavage(GO:0040016) |
1.2 | 1.2 | GO:0060300 | regulation of cytokine activity(GO:0060300) |
1.2 | 3.7 | GO:0015744 | succinate transport(GO:0015744) |
1.2 | 3.7 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
1.2 | 2.4 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
1.2 | 2.4 | GO:0048703 | embryonic viscerocranium morphogenesis(GO:0048703) |
1.2 | 3.7 | GO:2000169 | regulation of peptidyl-cysteine S-nitrosylation(GO:2000169) |
1.2 | 1.2 | GO:1900103 | positive regulation of endoplasmic reticulum unfolded protein response(GO:1900103) |
1.2 | 3.6 | GO:0051572 | negative regulation of histone H3-K4 methylation(GO:0051572) |
1.2 | 3.6 | GO:0034628 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
1.2 | 3.6 | GO:0055098 | response to low-density lipoprotein particle(GO:0055098) |
1.2 | 1.2 | GO:0043366 | beta selection(GO:0043366) |
1.2 | 3.6 | GO:0046460 | neutral lipid biosynthetic process(GO:0046460) acylglycerol biosynthetic process(GO:0046463) |
1.2 | 9.7 | GO:0002931 | response to ischemia(GO:0002931) |
1.2 | 3.6 | GO:0014857 | regulation of skeletal muscle cell proliferation(GO:0014857) |
1.2 | 2.4 | GO:0042505 | tyrosine phosphorylation of Stat6 protein(GO:0042505) regulation of tyrosine phosphorylation of Stat6 protein(GO:0042525) |
1.2 | 3.6 | GO:0009838 | abscission(GO:0009838) |
1.2 | 7.2 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
1.2 | 1.2 | GO:0010796 | regulation of multivesicular body size(GO:0010796) |
1.2 | 9.6 | GO:0052697 | xenobiotic glucuronidation(GO:0052697) |
1.2 | 8.4 | GO:0007288 | sperm axoneme assembly(GO:0007288) |
1.2 | 2.4 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
1.2 | 1.2 | GO:0003215 | cardiac right ventricle morphogenesis(GO:0003215) |
1.2 | 3.6 | GO:0090365 | regulation of mRNA modification(GO:0090365) |
1.2 | 1.2 | GO:0071107 | response to parathyroid hormone(GO:0071107) cellular response to parathyroid hormone stimulus(GO:0071374) |
1.2 | 16.7 | GO:0043968 | histone H2A acetylation(GO:0043968) |
1.2 | 9.5 | GO:0046685 | response to arsenic-containing substance(GO:0046685) |
1.2 | 5.9 | GO:0010543 | regulation of platelet activation(GO:0010543) |
1.2 | 18.9 | GO:0030488 | tRNA methylation(GO:0030488) |
1.2 | 4.7 | GO:2001256 | regulation of store-operated calcium entry(GO:2001256) |
1.2 | 1.2 | GO:1901896 | positive regulation of calcium-transporting ATPase activity(GO:1901896) |
1.2 | 9.4 | GO:0044090 | positive regulation of vacuole organization(GO:0044090) |
1.2 | 4.7 | GO:0043435 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
1.2 | 3.5 | GO:2000402 | negative regulation of lymphocyte migration(GO:2000402) |
1.2 | 10.4 | GO:0033194 | response to hydroperoxide(GO:0033194) |
1.2 | 3.5 | GO:1990036 | calcium ion import into sarcoplasmic reticulum(GO:1990036) |
1.2 | 1.2 | GO:0002439 | chronic inflammatory response to antigenic stimulus(GO:0002439) |
1.2 | 8.1 | GO:0043496 | regulation of protein homodimerization activity(GO:0043496) |
1.1 | 2.3 | GO:0035630 | bone mineralization involved in bone maturation(GO:0035630) |
1.1 | 2.3 | GO:0032785 | negative regulation of DNA-templated transcription, elongation(GO:0032785) |
1.1 | 1.1 | GO:0039530 | MDA-5 signaling pathway(GO:0039530) |
1.1 | 5.7 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
1.1 | 3.4 | GO:0002692 | negative regulation of cellular extravasation(GO:0002692) |
1.1 | 2.3 | GO:0034214 | protein hexamerization(GO:0034214) |
1.1 | 1.1 | GO:1901679 | nucleotide transmembrane transport(GO:1901679) |
1.1 | 9.1 | GO:0045947 | negative regulation of translational initiation(GO:0045947) |
1.1 | 1.1 | GO:0044788 | modulation by host of viral process(GO:0044788) |
1.1 | 11.4 | GO:1904293 | negative regulation of ERAD pathway(GO:1904293) |
1.1 | 2.3 | GO:0046487 | glyoxylate metabolic process(GO:0046487) |
1.1 | 2.3 | GO:0050427 | 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
1.1 | 2.3 | GO:0032988 | ribonucleoprotein complex disassembly(GO:0032988) |
1.1 | 1.1 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
1.1 | 12.4 | GO:0043206 | extracellular fibril organization(GO:0043206) |
1.1 | 2.3 | GO:0035166 | post-embryonic hemopoiesis(GO:0035166) |
1.1 | 1.1 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
1.1 | 9.0 | GO:0030575 | nuclear body organization(GO:0030575) |
1.1 | 22.4 | GO:0006491 | N-glycan processing(GO:0006491) |
1.1 | 11.2 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
1.1 | 8.9 | GO:0046697 | decidualization(GO:0046697) |
1.1 | 10.0 | GO:0009301 | snRNA transcription(GO:0009301) |
1.1 | 2.2 | GO:0090324 | negative regulation of oxidative phosphorylation(GO:0090324) |
1.1 | 4.4 | GO:0006353 | DNA-templated transcription, termination(GO:0006353) |
1.1 | 3.3 | GO:0060623 | regulation of chromosome condensation(GO:0060623) |
1.1 | 2.2 | GO:0090427 | activation of meiosis(GO:0090427) |
1.1 | 2.2 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
1.1 | 2.2 | GO:2001180 | negative regulation of interleukin-10 secretion(GO:2001180) |
1.1 | 13.3 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
1.1 | 1.1 | GO:1901538 | DNA methylation involved in embryo development(GO:0043045) changes to DNA methylation involved in embryo development(GO:1901538) |
1.1 | 1.1 | GO:1904706 | negative regulation of vascular smooth muscle cell proliferation(GO:1904706) |
1.1 | 1.1 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
1.1 | 5.5 | GO:0061014 | positive regulation of mRNA catabolic process(GO:0061014) |
1.1 | 3.3 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
1.1 | 6.6 | GO:0032460 | negative regulation of protein oligomerization(GO:0032460) |
1.1 | 13.1 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
1.1 | 1.1 | GO:0002566 | somatic diversification of immune receptors via somatic mutation(GO:0002566) |
1.1 | 9.8 | GO:0006337 | nucleosome disassembly(GO:0006337) chromatin disassembly(GO:0031498) protein-DNA complex disassembly(GO:0032986) |
1.1 | 1.1 | GO:0015695 | organic cation transport(GO:0015695) |
1.1 | 4.3 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
1.1 | 8.7 | GO:0045063 | T-helper 1 cell differentiation(GO:0045063) |
1.1 | 3.2 | GO:0009078 | alanine metabolic process(GO:0006522) pyruvate family amino acid metabolic process(GO:0009078) |
1.1 | 3.2 | GO:2000773 | negative regulation of cellular senescence(GO:2000773) |
1.1 | 3.2 | GO:0031442 | positive regulation of mRNA 3'-end processing(GO:0031442) |
1.1 | 6.5 | GO:0033262 | regulation of nuclear cell cycle DNA replication(GO:0033262) |
1.1 | 10.8 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
1.1 | 10.7 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
1.1 | 4.3 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
1.1 | 2.1 | GO:0045624 | positive regulation of T-helper cell differentiation(GO:0045624) |
1.1 | 26.8 | GO:0006953 | acute-phase response(GO:0006953) |
1.1 | 1.1 | GO:0072378 | blood coagulation, fibrin clot formation(GO:0072378) |
1.1 | 7.5 | GO:0051444 | negative regulation of ligase activity(GO:0051352) negative regulation of ubiquitin-protein transferase activity(GO:0051444) |
1.1 | 5.3 | GO:0035927 | RNA import into mitochondrion(GO:0035927) |
1.1 | 6.4 | GO:0035435 | phosphate ion transmembrane transport(GO:0035435) |
1.1 | 2.1 | GO:1901838 | regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901836) positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901838) |
1.1 | 2.1 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
1.1 | 4.2 | GO:0042420 | dopamine catabolic process(GO:0042420) |
1.1 | 1.1 | GO:1903203 | neuron death in response to oxidative stress(GO:0036475) regulation of oxidative stress-induced neuron death(GO:1903203) |
1.1 | 2.1 | GO:2000978 | negative regulation of pro-B cell differentiation(GO:2000974) negative regulation of forebrain neuron differentiation(GO:2000978) |
1.1 | 3.2 | GO:0032482 | Rab protein signal transduction(GO:0032482) |
1.1 | 7.4 | GO:0060009 | Sertoli cell development(GO:0060009) |
1.1 | 3.2 | GO:0002536 | respiratory burst involved in inflammatory response(GO:0002536) |
1.1 | 3.2 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
1.0 | 2.1 | GO:2000384 | regulation of ectoderm development(GO:2000383) negative regulation of ectoderm development(GO:2000384) |
1.0 | 3.1 | GO:0043518 | negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) |
1.0 | 1.0 | GO:0097503 | sialylation(GO:0097503) |
1.0 | 2.1 | GO:0032372 | negative regulation of sterol transport(GO:0032372) negative regulation of cholesterol transport(GO:0032375) |
1.0 | 1.0 | GO:0036493 | positive regulation of translation in response to endoplasmic reticulum stress(GO:0036493) |
1.0 | 5.2 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
1.0 | 3.1 | GO:0031642 | negative regulation of myelination(GO:0031642) |
1.0 | 3.1 | GO:1902109 | negative regulation of mitochondrial membrane permeability(GO:0035795) negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
1.0 | 4.1 | GO:1903300 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
1.0 | 2.1 | GO:0044838 | cell quiescence(GO:0044838) |
1.0 | 1.0 | GO:0045896 | regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
1.0 | 6.2 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
1.0 | 6.2 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
1.0 | 4.1 | GO:0071071 | regulation of phospholipid biosynthetic process(GO:0071071) positive regulation of phospholipid biosynthetic process(GO:0071073) |
1.0 | 13.4 | GO:0006879 | cellular iron ion homeostasis(GO:0006879) |
1.0 | 3.1 | GO:0031284 | positive regulation of guanylate cyclase activity(GO:0031284) |
1.0 | 1.0 | GO:0031635 | adenylate cyclase-inhibiting opioid receptor signaling pathway(GO:0031635) |
1.0 | 4.1 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
1.0 | 4.1 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
1.0 | 4.1 | GO:0008595 | tripartite regional subdivision(GO:0007351) anterior/posterior axis specification, embryo(GO:0008595) |
1.0 | 3.1 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
1.0 | 2.0 | GO:0043691 | reverse cholesterol transport(GO:0043691) |
1.0 | 3.1 | GO:2001270 | regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001270) negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
1.0 | 4.1 | GO:0044597 | polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
1.0 | 5.1 | GO:0033004 | negative regulation of mast cell activation(GO:0033004) |
1.0 | 5.1 | GO:1990001 | inhibition of cysteine-type endopeptidase activity(GO:0097340) zymogen inhibition(GO:0097341) inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
1.0 | 6.1 | GO:0009650 | UV protection(GO:0009650) |
1.0 | 3.0 | GO:0032594 | protein transport within lipid bilayer(GO:0032594) |
1.0 | 5.0 | GO:0034227 | tRNA thio-modification(GO:0034227) |
1.0 | 4.0 | GO:0040018 | positive regulation of multicellular organism growth(GO:0040018) |
1.0 | 1.0 | GO:0045342 | MHC class II biosynthetic process(GO:0045342) |
1.0 | 6.0 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
1.0 | 3.0 | GO:0042044 | fluid transport(GO:0042044) |
1.0 | 1.0 | GO:0045955 | negative regulation of calcium ion-dependent exocytosis(GO:0045955) |
1.0 | 1.0 | GO:0046337 | phosphatidylethanolamine metabolic process(GO:0046337) |
1.0 | 3.0 | GO:0007213 | G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) |
1.0 | 2.0 | GO:0002904 | positive regulation of B cell apoptotic process(GO:0002904) |
1.0 | 5.0 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
1.0 | 10.0 | GO:0009303 | rRNA transcription(GO:0009303) |
1.0 | 3.0 | GO:0010841 | regulation of circadian sleep/wake cycle, wakefulness(GO:0010840) positive regulation of circadian sleep/wake cycle, wakefulness(GO:0010841) circadian sleep/wake cycle, wakefulness(GO:0042746) |
1.0 | 2.0 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
1.0 | 1.0 | GO:1902176 | negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902176) |
1.0 | 32.8 | GO:0006406 | mRNA export from nucleus(GO:0006406) mRNA-containing ribonucleoprotein complex export from nucleus(GO:0071427) |
1.0 | 2.0 | GO:0032788 | saturated monocarboxylic acid metabolic process(GO:0032788) unsaturated monocarboxylic acid metabolic process(GO:0032789) |
1.0 | 2.0 | GO:0000710 | meiotic mismatch repair(GO:0000710) |
1.0 | 12.9 | GO:0007141 | male meiosis I(GO:0007141) |
1.0 | 3.0 | GO:0045603 | positive regulation of endothelial cell differentiation(GO:0045603) |
1.0 | 5.9 | GO:0048680 | positive regulation of axon regeneration(GO:0048680) |
1.0 | 1.0 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
1.0 | 1.0 | GO:2000564 | regulation of CD8-positive, alpha-beta T cell proliferation(GO:2000564) |
1.0 | 2.0 | GO:0009794 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
1.0 | 2.0 | GO:0010869 | regulation of receptor biosynthetic process(GO:0010869) |
1.0 | 1.0 | GO:0045080 | positive regulation of chemokine biosynthetic process(GO:0045080) |
1.0 | 2.9 | GO:0061158 | 3'-UTR-mediated mRNA destabilization(GO:0061158) |
1.0 | 2.9 | GO:0061643 | chemorepulsion of axon(GO:0061643) |
1.0 | 1.0 | GO:1903525 | regulation of membrane tubulation(GO:1903525) |
1.0 | 2.9 | GO:0021570 | rhombomere 4 development(GO:0021570) |
1.0 | 4.9 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
1.0 | 2.0 | GO:1903121 | regulation of TRAIL-activated apoptotic signaling pathway(GO:1903121) |
1.0 | 2.9 | GO:0002634 | regulation of germinal center formation(GO:0002634) |
1.0 | 3.9 | GO:0060126 | somatotropin secreting cell differentiation(GO:0060126) |
1.0 | 1.0 | GO:0065001 | specification of axis polarity(GO:0065001) |
1.0 | 14.6 | GO:0071800 | podosome assembly(GO:0071800) |
1.0 | 4.9 | GO:0060236 | regulation of mitotic spindle organization(GO:0060236) |
1.0 | 1.0 | GO:0003032 | detection of oxygen(GO:0003032) |
1.0 | 1.9 | GO:1903392 | negative regulation of adherens junction organization(GO:1903392) |
1.0 | 1.9 | GO:0033030 | negative regulation of neutrophil apoptotic process(GO:0033030) |
1.0 | 12.6 | GO:0043044 | ATP-dependent chromatin remodeling(GO:0043044) |
1.0 | 14.5 | GO:0006308 | DNA catabolic process(GO:0006308) |
1.0 | 18.3 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
1.0 | 5.8 | GO:0044130 | negative regulation of growth of symbiont in host(GO:0044130) negative regulation of growth of symbiont involved in interaction with host(GO:0044146) |
1.0 | 1.9 | GO:0048014 | Tie signaling pathway(GO:0048014) |
1.0 | 15.4 | GO:0001945 | lymph vessel development(GO:0001945) |
1.0 | 1.9 | GO:0034135 | regulation of toll-like receptor 2 signaling pathway(GO:0034135) negative regulation of toll-like receptor 2 signaling pathway(GO:0034136) |
1.0 | 3.8 | GO:0033227 | dsRNA transport(GO:0033227) |
1.0 | 10.6 | GO:0006907 | pinocytosis(GO:0006907) |
1.0 | 1.0 | GO:0060068 | vagina development(GO:0060068) |
1.0 | 1.9 | GO:0044819 | mitotic G1/S transition checkpoint(GO:0044819) |
1.0 | 7.7 | GO:0033622 | integrin activation(GO:0033622) |
1.0 | 1.9 | GO:0015760 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
1.0 | 1.0 | GO:0050729 | positive regulation of inflammatory response(GO:0050729) |
1.0 | 4.8 | GO:0006544 | glycine metabolic process(GO:0006544) |
1.0 | 4.8 | GO:0051013 | microtubule severing(GO:0051013) |
1.0 | 16.2 | GO:0019915 | lipid storage(GO:0019915) |
0.9 | 0.9 | GO:1902969 | mitotic DNA replication(GO:1902969) |
0.9 | 22.7 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
0.9 | 5.7 | GO:0031639 | plasminogen activation(GO:0031639) |
0.9 | 3.8 | GO:0009112 | nucleobase metabolic process(GO:0009112) |
0.9 | 3.8 | GO:0006265 | DNA topological change(GO:0006265) |
0.9 | 2.8 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
0.9 | 2.8 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
0.9 | 0.9 | GO:0035622 | intrahepatic bile duct development(GO:0035622) |
0.9 | 1.9 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
0.9 | 0.9 | GO:0002826 | negative regulation of T-helper 1 type immune response(GO:0002826) |
0.9 | 12.2 | GO:0031952 | regulation of protein autophosphorylation(GO:0031952) |
0.9 | 4.7 | GO:0010826 | negative regulation of centrosome duplication(GO:0010826) negative regulation of centrosome cycle(GO:0046606) |
0.9 | 4.7 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
0.9 | 3.7 | GO:1904752 | vascular associated smooth muscle cell migration(GO:1904738) regulation of vascular associated smooth muscle cell migration(GO:1904752) positive regulation of vascular associated smooth muscle cell migration(GO:1904754) |
0.9 | 0.9 | GO:0003321 | positive regulation of blood pressure by epinephrine-norepinephrine(GO:0003321) |
0.9 | 3.7 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.9 | 1.9 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
0.9 | 1.9 | GO:0010936 | negative regulation of macrophage cytokine production(GO:0010936) |
0.9 | 2.8 | GO:1901339 | regulation of store-operated calcium channel activity(GO:1901339) |
0.9 | 7.4 | GO:2000194 | regulation of female gonad development(GO:2000194) |
0.9 | 4.6 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
0.9 | 5.6 | GO:0030643 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.9 | 0.9 | GO:0046688 | response to copper ion(GO:0046688) |
0.9 | 9.3 | GO:1902653 | cholesterol biosynthetic process(GO:0006695) secondary alcohol biosynthetic process(GO:1902653) |
0.9 | 1.9 | GO:0031282 | regulation of guanylate cyclase activity(GO:0031282) |
0.9 | 1.9 | GO:0051890 | regulation of cardioblast differentiation(GO:0051890) |
0.9 | 1.9 | GO:0030952 | establishment or maintenance of cytoskeleton polarity(GO:0030952) |
0.9 | 1.8 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.9 | 0.9 | GO:0051902 | negative regulation of mitochondrial depolarization(GO:0051902) negative regulation of membrane depolarization(GO:1904180) |
0.9 | 2.8 | GO:0010958 | regulation of amino acid import(GO:0010958) |
0.9 | 5.5 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
0.9 | 1.8 | GO:0071425 | hematopoietic stem cell proliferation(GO:0071425) |
0.9 | 5.5 | GO:0060631 | regulation of meiosis I(GO:0060631) |
0.9 | 1.8 | GO:0006363 | termination of RNA polymerase I transcription(GO:0006363) |
0.9 | 0.9 | GO:0046349 | amino sugar biosynthetic process(GO:0046349) |
0.9 | 5.5 | GO:0035608 | protein deglutamylation(GO:0035608) |
0.9 | 30.1 | GO:0006635 | fatty acid beta-oxidation(GO:0006635) |
0.9 | 0.9 | GO:0003284 | septum primum development(GO:0003284) |
0.9 | 4.6 | GO:2000811 | negative regulation of anoikis(GO:2000811) |
0.9 | 8.2 | GO:0046051 | UTP metabolic process(GO:0046051) |
0.9 | 8.2 | GO:0048853 | forebrain morphogenesis(GO:0048853) |
0.9 | 2.7 | GO:0038094 | Fc-gamma receptor signaling pathway(GO:0038094) |
0.9 | 12.7 | GO:0034198 | cellular response to amino acid starvation(GO:0034198) |
0.9 | 4.5 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
0.9 | 8.2 | GO:0032801 | receptor catabolic process(GO:0032801) |
0.9 | 13.6 | GO:0030865 | cortical cytoskeleton organization(GO:0030865) |
0.9 | 0.9 | GO:0010694 | positive regulation of alkaline phosphatase activity(GO:0010694) |
0.9 | 2.7 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
0.9 | 11.7 | GO:0006465 | signal peptide processing(GO:0006465) |
0.9 | 4.5 | GO:0030049 | muscle filament sliding(GO:0030049) |
0.9 | 2.7 | GO:0045046 | peroxisomal membrane transport(GO:0015919) protein import into peroxisome membrane(GO:0045046) |
0.9 | 2.7 | GO:1900108 | negative regulation of nodal signaling pathway(GO:1900108) |
0.9 | 7.1 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
0.9 | 2.7 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.9 | 3.6 | GO:0008291 | acetylcholine metabolic process(GO:0008291) acetate ester metabolic process(GO:1900619) |
0.9 | 0.9 | GO:0071028 | nuclear RNA surveillance(GO:0071027) nuclear mRNA surveillance(GO:0071028) |
0.9 | 2.7 | GO:0038145 | macrophage colony-stimulating factor signaling pathway(GO:0038145) |
0.9 | 20.5 | GO:0007569 | cell aging(GO:0007569) |
0.9 | 7.1 | GO:0042492 | gamma-delta T cell differentiation(GO:0042492) |
0.9 | 0.9 | GO:0072367 | regulation of lipid transport by regulation of transcription from RNA polymerase II promoter(GO:0072367) |
0.9 | 1.8 | GO:0001865 | NK T cell differentiation(GO:0001865) |
0.9 | 3.5 | GO:0010459 | negative regulation of heart rate(GO:0010459) |
0.9 | 1.8 | GO:0019673 | GDP-mannose metabolic process(GO:0019673) |
0.9 | 10.6 | GO:0000305 | response to oxygen radical(GO:0000305) |
0.9 | 41.6 | GO:0031338 | regulation of vesicle fusion(GO:0031338) |
0.9 | 1.8 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
0.9 | 2.6 | GO:0046208 | spermine catabolic process(GO:0046208) |
0.9 | 7.9 | GO:0006354 | DNA-templated transcription, elongation(GO:0006354) |
0.9 | 2.6 | GO:0001866 | NK T cell proliferation(GO:0001866) |
0.9 | 2.6 | GO:1901796 | regulation of signal transduction by p53 class mediator(GO:1901796) |
0.9 | 3.5 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.9 | 1.8 | GO:1901979 | regulation of inward rectifier potassium channel activity(GO:1901979) |
0.9 | 0.9 | GO:0051446 | positive regulation of meiotic cell cycle(GO:0051446) |
0.9 | 1.7 | GO:0000730 | DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
0.9 | 2.6 | GO:0032227 | negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
0.9 | 7.9 | GO:0035278 | miRNA mediated inhibition of translation(GO:0035278) negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
0.9 | 3.5 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.9 | 1.7 | GO:0010165 | response to X-ray(GO:0010165) |
0.9 | 29.7 | GO:0006611 | protein export from nucleus(GO:0006611) |
0.9 | 2.6 | GO:0031087 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.9 | 1.7 | GO:0042376 | phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
0.9 | 5.2 | GO:1902229 | regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902229) |
0.9 | 0.9 | GO:0032094 | response to food(GO:0032094) |
0.9 | 0.9 | GO:0051001 | negative regulation of nitric-oxide synthase activity(GO:0051001) |
0.9 | 0.9 | GO:2000074 | regulation of type B pancreatic cell development(GO:2000074) |
0.9 | 6.9 | GO:0031648 | protein destabilization(GO:0031648) |
0.9 | 0.9 | GO:0033184 | positive regulation of histone ubiquitination(GO:0033184) |
0.9 | 2.6 | GO:1903054 | negative regulation of extracellular matrix organization(GO:1903054) |
0.9 | 0.9 | GO:0034035 | purine ribonucleoside bisphosphate metabolic process(GO:0034035) |
0.9 | 2.6 | GO:0060768 | epithelial cell proliferation involved in prostate gland development(GO:0060767) regulation of epithelial cell proliferation involved in prostate gland development(GO:0060768) |
0.9 | 2.6 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
0.9 | 2.6 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.9 | 12.9 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
0.9 | 1.7 | GO:0002924 | negative regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002924) |
0.9 | 0.9 | GO:0031047 | gene silencing by RNA(GO:0031047) |
0.9 | 15.4 | GO:0033209 | tumor necrosis factor-mediated signaling pathway(GO:0033209) |
0.9 | 2.6 | GO:0035509 | negative regulation of myosin-light-chain-phosphatase activity(GO:0035509) |
0.9 | 0.9 | GO:0051987 | positive regulation of attachment of spindle microtubules to kinetochore(GO:0051987) |
0.9 | 2.6 | GO:0046040 | IMP metabolic process(GO:0046040) |
0.9 | 2.6 | GO:0032066 | nucleolus to nucleoplasm transport(GO:0032066) |
0.9 | 1.7 | GO:0090289 | regulation of osteoclast proliferation(GO:0090289) positive regulation of osteoclast proliferation(GO:0090290) |
0.9 | 4.3 | GO:0016266 | O-glycan processing(GO:0016266) |
0.9 | 6.0 | GO:0035518 | histone H2A monoubiquitination(GO:0035518) |
0.8 | 15.3 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
0.8 | 2.5 | GO:0080182 | histone H3-K4 trimethylation(GO:0080182) |
0.8 | 1.7 | GO:2001044 | regulation of integrin-mediated signaling pathway(GO:2001044) |
0.8 | 1.7 | GO:0016553 | base conversion or substitution editing(GO:0016553) |
0.8 | 5.9 | GO:0051788 | response to misfolded protein(GO:0051788) cellular response to misfolded protein(GO:0071218) |
0.8 | 11.8 | GO:0045736 | negative regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045736) negative regulation of cyclin-dependent protein kinase activity(GO:1904030) |
0.8 | 8.4 | GO:0009226 | nucleotide-sugar biosynthetic process(GO:0009226) |
0.8 | 6.7 | GO:0090140 | regulation of mitochondrial fission(GO:0090140) |
0.8 | 4.2 | GO:0031065 | positive regulation of histone deacetylation(GO:0031065) |
0.8 | 5.9 | GO:0000338 | protein deneddylation(GO:0000338) cullin deneddylation(GO:0010388) |
0.8 | 1.7 | GO:1903894 | regulation of IRE1-mediated unfolded protein response(GO:1903894) |
0.8 | 7.6 | GO:2000251 | positive regulation of actin cytoskeleton reorganization(GO:2000251) |
0.8 | 0.8 | GO:0014835 | myoblast differentiation involved in skeletal muscle regeneration(GO:0014835) |
0.8 | 1.7 | GO:0006693 | prostanoid metabolic process(GO:0006692) prostaglandin metabolic process(GO:0006693) |
0.8 | 3.3 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
0.8 | 3.3 | GO:0002115 | store-operated calcium entry(GO:0002115) |
0.8 | 1.7 | GO:0006362 | transcription elongation from RNA polymerase I promoter(GO:0006362) |
0.8 | 4.2 | GO:0000059 | protein import into nucleus, docking(GO:0000059) |
0.8 | 1.7 | GO:0060037 | pharyngeal system development(GO:0060037) |
0.8 | 3.3 | GO:0030826 | regulation of cGMP biosynthetic process(GO:0030826) |
0.8 | 16.6 | GO:0046916 | cellular transition metal ion homeostasis(GO:0046916) |
0.8 | 0.8 | GO:0070922 | small RNA loading onto RISC(GO:0070922) |
0.8 | 2.5 | GO:0008594 | photoreceptor cell morphogenesis(GO:0008594) |
0.8 | 1.6 | GO:0002689 | negative regulation of leukocyte chemotaxis(GO:0002689) |
0.8 | 9.1 | GO:0035873 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
0.8 | 1.6 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
0.8 | 1.6 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
0.8 | 2.5 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
0.8 | 1.6 | GO:0045540 | regulation of cholesterol biosynthetic process(GO:0045540) |
0.8 | 0.8 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.8 | 2.4 | GO:0060318 | definitive erythrocyte differentiation(GO:0060318) |
0.8 | 5.7 | GO:0033235 | positive regulation of protein sumoylation(GO:0033235) |
0.8 | 0.8 | GO:0009137 | purine nucleoside diphosphate catabolic process(GO:0009137) purine ribonucleoside diphosphate catabolic process(GO:0009181) |
0.8 | 0.8 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
0.8 | 3.3 | GO:0015870 | acetylcholine transport(GO:0015870) acetate ester transport(GO:1901374) |
0.8 | 0.8 | GO:0071681 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
0.8 | 1.6 | GO:0000255 | allantoin metabolic process(GO:0000255) |
0.8 | 2.4 | GO:0009191 | ribonucleoside diphosphate catabolic process(GO:0009191) |
0.8 | 6.5 | GO:0007097 | nuclear migration(GO:0007097) |
0.8 | 1.6 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
0.8 | 1.6 | GO:0060971 | embryonic heart tube left/right pattern formation(GO:0060971) |
0.8 | 2.4 | GO:0043101 | purine-containing compound salvage(GO:0043101) |
0.8 | 4.8 | GO:0043278 | response to isoquinoline alkaloid(GO:0014072) response to morphine(GO:0043278) |
0.8 | 1.6 | GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
0.8 | 0.8 | GO:0019217 | regulation of fatty acid metabolic process(GO:0019217) |
0.8 | 0.8 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.8 | 1.6 | GO:0051197 | positive regulation of nucleotide catabolic process(GO:0030813) positive regulation of cofactor metabolic process(GO:0051194) positive regulation of coenzyme metabolic process(GO:0051197) |
0.8 | 3.2 | GO:0045940 | positive regulation of steroid metabolic process(GO:0045940) |
0.8 | 0.8 | GO:0045989 | positive regulation of striated muscle contraction(GO:0045989) |
0.8 | 1.6 | GO:0006772 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
0.8 | 5.6 | GO:0034724 | DNA replication-independent nucleosome assembly(GO:0006336) DNA replication-independent nucleosome organization(GO:0034724) |
0.8 | 1.6 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.8 | 0.8 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
0.8 | 0.8 | GO:0035964 | COPI-coated vesicle budding(GO:0035964) |
0.8 | 20.6 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
0.8 | 22.9 | GO:0016125 | sterol metabolic process(GO:0016125) |
0.8 | 0.8 | GO:0090181 | regulation of cholesterol metabolic process(GO:0090181) |
0.8 | 5.5 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
0.8 | 5.5 | GO:0006851 | mitochondrial calcium ion transport(GO:0006851) |
0.8 | 1.6 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
0.8 | 21.1 | GO:0051028 | mRNA transport(GO:0051028) |
0.8 | 0.8 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
0.8 | 5.5 | GO:0090026 | positive regulation of monocyte chemotaxis(GO:0090026) |
0.8 | 1.6 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
0.8 | 11.6 | GO:0014823 | response to activity(GO:0014823) |
0.8 | 2.3 | GO:0018343 | protein farnesylation(GO:0018343) |
0.8 | 0.8 | GO:0051683 | establishment of Golgi localization(GO:0051683) |
0.8 | 7.0 | GO:0006027 | glycosaminoglycan catabolic process(GO:0006027) |
0.8 | 4.6 | GO:0002934 | desmosome organization(GO:0002934) |
0.8 | 0.8 | GO:0042095 | interferon-gamma biosynthetic process(GO:0042095) |
0.8 | 3.9 | GO:0043116 | negative regulation of vascular permeability(GO:0043116) |
0.8 | 0.8 | GO:0036010 | protein localization to endosome(GO:0036010) |
0.8 | 4.6 | GO:0046037 | GMP metabolic process(GO:0046037) |
0.8 | 2.3 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.8 | 3.1 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
0.8 | 0.8 | GO:0021943 | formation of radial glial scaffolds(GO:0021943) |
0.8 | 1.5 | GO:0015781 | nucleotide-sugar transport(GO:0015780) pyrimidine nucleotide-sugar transport(GO:0015781) |
0.8 | 7.6 | GO:0008209 | androgen metabolic process(GO:0008209) |
0.8 | 2.3 | GO:0000707 | meiotic DNA recombinase assembly(GO:0000707) |
0.8 | 1.5 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.8 | 1.5 | GO:0032792 | negative regulation of CREB transcription factor activity(GO:0032792) |
0.8 | 2.3 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
0.8 | 0.8 | GO:0010046 | response to mycotoxin(GO:0010046) |
0.8 | 13.7 | GO:0030968 | endoplasmic reticulum unfolded protein response(GO:0030968) |
0.8 | 1.5 | GO:0000350 | generation of catalytic spliceosome for second transesterification step(GO:0000350) |
0.8 | 3.0 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
0.8 | 6.0 | GO:0006884 | cell volume homeostasis(GO:0006884) |
0.8 | 1.5 | GO:0090160 | Golgi to lysosome transport(GO:0090160) |
0.8 | 6.0 | GO:0010758 | regulation of macrophage chemotaxis(GO:0010758) |
0.8 | 0.8 | GO:0015791 | polyol transport(GO:0015791) |
0.8 | 1.5 | GO:0051106 | regulation of DNA ligation(GO:0051105) positive regulation of DNA ligation(GO:0051106) |
0.8 | 8.3 | GO:0046324 | regulation of glucose import(GO:0046324) |
0.8 | 2.3 | GO:0019086 | late viral transcription(GO:0019086) |
0.8 | 3.8 | GO:0000447 | endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000447) |
0.7 | 3.0 | GO:0001921 | positive regulation of receptor recycling(GO:0001921) |
0.7 | 1.5 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
0.7 | 9.7 | GO:0042149 | cellular response to glucose starvation(GO:0042149) |
0.7 | 2.2 | GO:2001198 | regulation of dendritic cell differentiation(GO:2001198) negative regulation of dendritic cell differentiation(GO:2001199) |
0.7 | 3.7 | GO:0050820 | positive regulation of coagulation(GO:0050820) |
0.7 | 6.7 | GO:0032418 | lysosome localization(GO:0032418) |
0.7 | 0.7 | GO:2000674 | type B pancreatic cell apoptotic process(GO:0097050) regulation of type B pancreatic cell apoptotic process(GO:2000674) |
0.7 | 5.9 | GO:0090200 | positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
0.7 | 0.7 | GO:2000810 | regulation of bicellular tight junction assembly(GO:2000810) |
0.7 | 3.7 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.7 | 1.5 | GO:0071514 | genetic imprinting(GO:0071514) |
0.7 | 1.5 | GO:0030656 | regulation of vitamin metabolic process(GO:0030656) |
0.7 | 5.9 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.7 | 19.1 | GO:0006749 | glutathione metabolic process(GO:0006749) |
0.7 | 5.9 | GO:0099514 | anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
0.7 | 0.7 | GO:0001893 | maternal placenta development(GO:0001893) |
0.7 | 0.7 | GO:0098528 | skeletal muscle fiber differentiation(GO:0098528) |
0.7 | 2.2 | GO:0051775 | response to redox state(GO:0051775) |
0.7 | 2.9 | GO:0033601 | positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
0.7 | 2.9 | GO:0098543 | detection of bacterium(GO:0016045) detection of other organism(GO:0098543) |
0.7 | 1.5 | GO:0060468 | prevention of polyspermy(GO:0060468) |
0.7 | 1.5 | GO:0035973 | aggrephagy(GO:0035973) |
0.7 | 1.4 | GO:0007525 | somatic muscle development(GO:0007525) |
0.7 | 2.2 | GO:0031572 | G2 DNA damage checkpoint(GO:0031572) |
0.7 | 0.7 | GO:0060856 | establishment of blood-brain barrier(GO:0060856) |
0.7 | 5.8 | GO:0000060 | protein import into nucleus, translocation(GO:0000060) |
0.7 | 2.2 | GO:0034377 | plasma lipoprotein particle assembly(GO:0034377) |
0.7 | 4.3 | GO:0042036 | negative regulation of cytokine biosynthetic process(GO:0042036) |
0.7 | 10.0 | GO:0000271 | polysaccharide biosynthetic process(GO:0000271) |
0.7 | 1.4 | GO:0050995 | negative regulation of lipid catabolic process(GO:0050995) |
0.7 | 5.0 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.7 | 2.1 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.7 | 4.3 | GO:0045005 | DNA-dependent DNA replication maintenance of fidelity(GO:0045005) |
0.7 | 8.5 | GO:0008211 | glucocorticoid metabolic process(GO:0008211) |
0.7 | 10.7 | GO:0032608 | interferon-beta production(GO:0032608) |
0.7 | 3.6 | GO:0019370 | leukotriene biosynthetic process(GO:0019370) |
0.7 | 2.1 | GO:0048305 | immunoglobulin secretion(GO:0048305) |
0.7 | 2.1 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
0.7 | 1.4 | GO:0071313 | cellular response to caffeine(GO:0071313) cellular response to purine-containing compound(GO:0071415) |
0.7 | 1.4 | GO:2000404 | regulation of T cell migration(GO:2000404) |
0.7 | 3.5 | GO:0003084 | positive regulation of systemic arterial blood pressure(GO:0003084) |
0.7 | 4.2 | GO:0042754 | negative regulation of circadian rhythm(GO:0042754) |
0.7 | 2.1 | GO:0016115 | terpenoid catabolic process(GO:0016115) |
0.7 | 0.7 | GO:0006505 | GPI anchor metabolic process(GO:0006505) |
0.7 | 1.4 | GO:0033599 | regulation of mammary gland epithelial cell proliferation(GO:0033599) |
0.7 | 2.1 | GO:0033344 | cholesterol efflux(GO:0033344) |
0.7 | 4.2 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
0.7 | 6.3 | GO:0033617 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
0.7 | 1.4 | GO:0030223 | neutrophil differentiation(GO:0030223) |
0.7 | 0.7 | GO:0046034 | ATP metabolic process(GO:0046034) |
0.7 | 0.7 | GO:0042891 | antibiotic transport(GO:0042891) |
0.7 | 0.7 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
0.7 | 0.7 | GO:0046185 | aldehyde catabolic process(GO:0046185) |
0.7 | 2.1 | GO:0071883 | activation of MAPK activity by adrenergic receptor signaling pathway(GO:0071883) |
0.7 | 2.1 | GO:0008582 | regulation of synaptic growth at neuromuscular junction(GO:0008582) |
0.7 | 2.1 | GO:0043467 | regulation of generation of precursor metabolites and energy(GO:0043467) |
0.7 | 0.7 | GO:0045416 | positive regulation of interleukin-8 biosynthetic process(GO:0045416) |
0.7 | 4.2 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.7 | 0.7 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
0.7 | 5.5 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
0.7 | 1.4 | GO:0070234 | positive regulation of T cell apoptotic process(GO:0070234) |
0.7 | 2.8 | GO:0032881 | regulation of polysaccharide metabolic process(GO:0032881) |
0.7 | 5.5 | GO:0006349 | regulation of gene expression by genetic imprinting(GO:0006349) |
0.7 | 2.1 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
0.7 | 8.9 | GO:0003351 | epithelial cilium movement(GO:0003351) |
0.7 | 2.1 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
0.7 | 0.7 | GO:0032755 | positive regulation of interleukin-6 production(GO:0032755) |
0.7 | 4.8 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
0.7 | 0.7 | GO:0035932 | mineralocorticoid secretion(GO:0035931) aldosterone secretion(GO:0035932) regulation of mineralocorticoid secretion(GO:2000855) regulation of aldosterone secretion(GO:2000858) |
0.7 | 0.7 | GO:0051351 | positive regulation of ligase activity(GO:0051351) |
0.7 | 0.7 | GO:0007191 | adenylate cyclase-activating dopamine receptor signaling pathway(GO:0007191) |
0.7 | 3.4 | GO:0007257 | activation of JUN kinase activity(GO:0007257) |
0.7 | 1.4 | GO:0007100 | mitotic centrosome separation(GO:0007100) |
0.7 | 2.7 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.7 | 1.4 | GO:0030050 | vesicle transport along actin filament(GO:0030050) |
0.7 | 1.3 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
0.7 | 3.4 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
0.7 | 21.6 | GO:0006661 | phosphatidylinositol biosynthetic process(GO:0006661) |
0.7 | 2.0 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
0.7 | 4.0 | GO:2000757 | negative regulation of peptidyl-lysine acetylation(GO:2000757) |
0.7 | 8.1 | GO:0070670 | response to interleukin-4(GO:0070670) |
0.7 | 0.7 | GO:0035493 | SNARE complex assembly(GO:0035493) |
0.7 | 17.4 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
0.7 | 2.0 | GO:0002551 | mast cell chemotaxis(GO:0002551) |
0.7 | 1.3 | GO:0061052 | negative regulation of cell growth involved in cardiac muscle cell development(GO:0061052) |
0.7 | 5.3 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) nucleoside bisphosphate biosynthetic process(GO:0033866) ribonucleoside bisphosphate biosynthetic process(GO:0034030) purine nucleoside bisphosphate biosynthetic process(GO:0034033) |
0.7 | 2.7 | GO:0060023 | soft palate development(GO:0060023) |
0.7 | 2.7 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
0.7 | 0.7 | GO:0032717 | negative regulation of interleukin-8 production(GO:0032717) |
0.7 | 3.3 | GO:0010971 | positive regulation of G2/M transition of mitotic cell cycle(GO:0010971) positive regulation of cell cycle G2/M phase transition(GO:1902751) |
0.7 | 2.7 | GO:0036089 | cleavage furrow formation(GO:0036089) |
0.7 | 0.7 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
0.7 | 1.3 | GO:1904742 | regulation of telomeric DNA binding(GO:1904742) |
0.7 | 2.0 | GO:0046329 | negative regulation of JNK cascade(GO:0046329) |
0.7 | 1.3 | GO:0042789 | mRNA transcription from RNA polymerase II promoter(GO:0042789) |
0.7 | 10.6 | GO:0033120 | positive regulation of RNA splicing(GO:0033120) |
0.7 | 1.3 | GO:0016188 | synaptic vesicle maturation(GO:0016188) |
0.7 | 1.3 | GO:1902455 | negative regulation of stem cell population maintenance(GO:1902455) |
0.7 | 1.3 | GO:1903334 | positive regulation of protein folding(GO:1903334) |
0.7 | 0.7 | GO:0090210 | regulation of establishment of blood-brain barrier(GO:0090210) |
0.7 | 0.7 | GO:0010912 | regulation of isomerase activity(GO:0010911) positive regulation of isomerase activity(GO:0010912) |
0.7 | 4.6 | GO:0007099 | centriole replication(GO:0007099) |
0.7 | 0.7 | GO:0006933 | negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
0.7 | 5.9 | GO:0000470 | maturation of LSU-rRNA(GO:0000470) |
0.7 | 3.3 | GO:0045070 | positive regulation of viral genome replication(GO:0045070) |
0.7 | 0.7 | GO:0070889 | platelet alpha granule organization(GO:0070889) |
0.7 | 0.7 | GO:0071727 | response to triacyl bacterial lipopeptide(GO:0071725) cellular response to triacyl bacterial lipopeptide(GO:0071727) |
0.7 | 15.7 | GO:0030168 | platelet activation(GO:0030168) |
0.7 | 2.6 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.7 | 2.0 | GO:0007549 | dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
0.7 | 0.7 | GO:0001998 | angiotensin mediated vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001998) |
0.7 | 0.7 | GO:0006533 | aspartate catabolic process(GO:0006533) |
0.7 | 2.0 | GO:0045943 | positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
0.6 | 10.4 | GO:0016575 | histone deacetylation(GO:0016575) |
0.6 | 2.6 | GO:0010624 | regulation of Schwann cell proliferation(GO:0010624) |
0.6 | 0.6 | GO:0098735 | positive regulation of the force of heart contraction(GO:0098735) |
0.6 | 7.1 | GO:0045824 | negative regulation of innate immune response(GO:0045824) |
0.6 | 2.6 | GO:0014002 | astrocyte development(GO:0014002) |
0.6 | 0.6 | GO:0051602 | response to electrical stimulus(GO:0051602) |
0.6 | 4.5 | GO:0001845 | phagolysosome assembly(GO:0001845) |
0.6 | 1.3 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
0.6 | 9.7 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
0.6 | 1.9 | GO:0007008 | outer mitochondrial membrane organization(GO:0007008) |
0.6 | 1.3 | GO:0045835 | negative regulation of meiotic nuclear division(GO:0045835) |
0.6 | 1.9 | GO:0070986 | left/right axis specification(GO:0070986) |
0.6 | 25.6 | GO:0043433 | negative regulation of sequence-specific DNA binding transcription factor activity(GO:0043433) |
0.6 | 1.3 | GO:0002098 | tRNA wobble uridine modification(GO:0002098) |
0.6 | 0.6 | GO:0046878 | positive regulation of saliva secretion(GO:0046878) |
0.6 | 2.6 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
0.6 | 2.6 | GO:0006857 | oligopeptide transport(GO:0006857) |
0.6 | 5.1 | GO:0070897 | DNA-templated transcriptional preinitiation complex assembly(GO:0070897) |
0.6 | 12.7 | GO:2001056 | positive regulation of cysteine-type endopeptidase activity(GO:2001056) |
0.6 | 2.5 | GO:0018317 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.6 | 0.6 | GO:0052055 | modulation by symbiont of host molecular function(GO:0052055) |
0.6 | 14.6 | GO:0000245 | spliceosomal complex assembly(GO:0000245) |
0.6 | 1.9 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.6 | 5.1 | GO:0002347 | response to tumor cell(GO:0002347) |
0.6 | 3.8 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
0.6 | 27.1 | GO:0006633 | fatty acid biosynthetic process(GO:0006633) |
0.6 | 11.3 | GO:0016073 | snRNA metabolic process(GO:0016073) snRNA processing(GO:0016180) |
0.6 | 1.3 | GO:0015846 | polyamine transport(GO:0015846) |
0.6 | 0.6 | GO:0044340 | canonical Wnt signaling pathway involved in regulation of cell proliferation(GO:0044340) |
0.6 | 1.3 | GO:0044704 | mating plug formation(GO:0042628) single-organism reproductive behavior(GO:0044704) post-mating behavior(GO:0045297) |
0.6 | 0.6 | GO:0043652 | engulfment of apoptotic cell(GO:0043652) |
0.6 | 0.6 | GO:0034393 | positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
0.6 | 16.2 | GO:0032436 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032436) |
0.6 | 0.6 | GO:0006116 | NADH oxidation(GO:0006116) |
0.6 | 0.6 | GO:0060766 | negative regulation of androgen receptor signaling pathway(GO:0060766) |
0.6 | 1.9 | GO:0002584 | negative regulation of antigen processing and presentation(GO:0002578) negative regulation of antigen processing and presentation of peptide antigen(GO:0002584) |
0.6 | 1.2 | GO:0060534 | trachea cartilage development(GO:0060534) |
0.6 | 1.2 | GO:0042255 | ribosome assembly(GO:0042255) |
0.6 | 1.9 | GO:0002225 | positive regulation of antimicrobial peptide production(GO:0002225) positive regulation of antibacterial peptide production(GO:0002803) |
0.6 | 1.9 | GO:0070830 | bicellular tight junction assembly(GO:0070830) |
0.6 | 9.3 | GO:0033003 | regulation of mast cell activation(GO:0033003) |
0.6 | 1.2 | GO:0007202 | activation of phospholipase C activity(GO:0007202) |
0.6 | 0.6 | GO:0002036 | regulation of L-glutamate transport(GO:0002036) |
0.6 | 2.5 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.6 | 3.7 | GO:0002183 | cytoplasmic translational initiation(GO:0002183) |
0.6 | 1.2 | GO:0060718 | chorionic trophoblast cell differentiation(GO:0060718) |
0.6 | 53.2 | GO:0006457 | protein folding(GO:0006457) |
0.6 | 0.6 | GO:0032781 | positive regulation of ATPase activity(GO:0032781) |
0.6 | 0.6 | GO:1904683 | regulation of metalloendopeptidase activity(GO:1904683) |
0.6 | 2.4 | GO:0019720 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.6 | 0.6 | GO:0003051 | angiotensin-mediated drinking behavior(GO:0003051) |
0.6 | 4.9 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
0.6 | 3.0 | GO:0021670 | lateral ventricle development(GO:0021670) |
0.6 | 3.0 | GO:0032060 | bleb assembly(GO:0032060) |
0.6 | 3.6 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
0.6 | 1.8 | GO:0015697 | quaternary ammonium group transport(GO:0015697) |
0.6 | 12.1 | GO:0006081 | cellular aldehyde metabolic process(GO:0006081) |
0.6 | 1.2 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
0.6 | 2.4 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.6 | 1.8 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
0.6 | 1.2 | GO:0051971 | positive regulation of transmission of nerve impulse(GO:0051971) |
0.6 | 1.2 | GO:0006563 | L-serine metabolic process(GO:0006563) |
0.6 | 0.6 | GO:0036297 | interstrand cross-link repair(GO:0036297) |
0.6 | 1.2 | GO:0010838 | positive regulation of keratinocyte proliferation(GO:0010838) |
0.6 | 0.6 | GO:0051657 | maintenance of organelle location(GO:0051657) |
0.6 | 2.3 | GO:0042535 | positive regulation of tumor necrosis factor biosynthetic process(GO:0042535) |
0.6 | 5.3 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
0.6 | 0.6 | GO:0035811 | negative regulation of urine volume(GO:0035811) |
0.6 | 2.3 | GO:0035330 | regulation of hippo signaling(GO:0035330) |
0.6 | 1.2 | GO:0010820 | positive regulation of T cell chemotaxis(GO:0010820) |
0.6 | 1.7 | GO:0045116 | protein neddylation(GO:0045116) |
0.6 | 27.9 | GO:1903955 | positive regulation of establishment of protein localization to mitochondrion(GO:1903749) positive regulation of protein targeting to mitochondrion(GO:1903955) |
0.6 | 1.7 | GO:1902473 | regulation of protein localization to synapse(GO:1902473) |
0.6 | 1.7 | GO:0001659 | temperature homeostasis(GO:0001659) |
0.6 | 3.5 | GO:0035095 | behavioral response to nicotine(GO:0035095) |
0.6 | 3.5 | GO:0097194 | execution phase of apoptosis(GO:0097194) |
0.6 | 1.2 | GO:0071895 | odontoblast differentiation(GO:0071895) |
0.6 | 0.6 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
0.6 | 12.7 | GO:0006367 | transcription initiation from RNA polymerase II promoter(GO:0006367) |
0.6 | 1.7 | GO:0033313 | meiotic cell cycle checkpoint(GO:0033313) |
0.6 | 0.6 | GO:0050994 | regulation of lipid catabolic process(GO:0050994) |
0.6 | 1.2 | GO:0051029 | rRNA transport(GO:0051029) |
0.6 | 0.6 | GO:0006278 | RNA-dependent DNA biosynthetic process(GO:0006278) telomere maintenance via telomerase(GO:0007004) |
0.6 | 0.6 | GO:0070071 | proton-transporting two-sector ATPase complex assembly(GO:0070071) |
0.6 | 0.6 | GO:0006532 | aspartate biosynthetic process(GO:0006532) |
0.6 | 12.1 | GO:0009206 | purine ribonucleoside triphosphate biosynthetic process(GO:0009206) |
0.6 | 2.3 | GO:1902042 | negative regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902042) |
0.6 | 0.6 | GO:0061668 | mitochondrial ribosome assembly(GO:0061668) |
0.6 | 1.7 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
0.6 | 4.6 | GO:0046580 | negative regulation of Ras protein signal transduction(GO:0046580) |
0.6 | 4.0 | GO:0046085 | adenosine metabolic process(GO:0046085) |
0.6 | 0.6 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.6 | 0.6 | GO:0043300 | regulation of leukocyte degranulation(GO:0043300) |
0.6 | 2.3 | GO:0002281 | macrophage activation involved in immune response(GO:0002281) |
0.6 | 1.1 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.6 | 1.1 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
0.6 | 4.0 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.6 | 6.2 | GO:1901998 | toxin transport(GO:1901998) |
0.6 | 0.6 | GO:2000698 | positive regulation of epithelial cell differentiation involved in kidney development(GO:2000698) |
0.6 | 1.1 | GO:1902031 | regulation of NADP metabolic process(GO:1902031) |
0.6 | 0.6 | GO:0010482 | epidermal cell division(GO:0010481) regulation of epidermal cell division(GO:0010482) |
0.6 | 0.6 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.6 | 4.5 | GO:0001967 | suckling behavior(GO:0001967) |
0.6 | 14.5 | GO:0007596 | blood coagulation(GO:0007596) |
0.6 | 0.6 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.6 | 1.1 | GO:0072678 | T cell migration(GO:0072678) |
0.6 | 1.7 | GO:0060455 | negative regulation of gastric acid secretion(GO:0060455) |
0.6 | 1.1 | GO:0060948 | cardiac vascular smooth muscle cell development(GO:0060948) |
0.6 | 2.8 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.6 | 1.1 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
0.6 | 0.6 | GO:2001185 | regulation of CD8-positive, alpha-beta T cell activation(GO:2001185) |
0.6 | 2.8 | GO:0009115 | xanthine catabolic process(GO:0009115) |
0.5 | 1.1 | GO:0002313 | mature B cell differentiation involved in immune response(GO:0002313) |
0.5 | 4.4 | GO:0051382 | kinetochore assembly(GO:0051382) kinetochore organization(GO:0051383) |
0.5 | 0.5 | GO:1902075 | cellular response to salt(GO:1902075) |
0.5 | 2.7 | GO:0031100 | organ regeneration(GO:0031100) |
0.5 | 1.1 | GO:0060405 | regulation of penile erection(GO:0060405) |
0.5 | 0.5 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
0.5 | 0.5 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
0.5 | 13.1 | GO:0050829 | defense response to Gram-negative bacterium(GO:0050829) |
0.5 | 0.5 | GO:1990035 | calcium ion import into cell(GO:1990035) |
0.5 | 4.9 | GO:0008272 | sulfate transport(GO:0008272) |
0.5 | 2.2 | GO:0035966 | response to unfolded protein(GO:0006986) response to topologically incorrect protein(GO:0035966) |
0.5 | 1.1 | GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
0.5 | 2.7 | GO:0034063 | stress granule assembly(GO:0034063) |
0.5 | 2.2 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.5 | 2.2 | GO:0006561 | proline biosynthetic process(GO:0006561) |
0.5 | 2.2 | GO:0007060 | male meiosis chromosome segregation(GO:0007060) |
0.5 | 1.6 | GO:0000012 | single strand break repair(GO:0000012) |
0.5 | 8.6 | GO:0002687 | positive regulation of leukocyte migration(GO:0002687) |
0.5 | 0.5 | GO:0000212 | meiotic spindle organization(GO:0000212) |
0.5 | 27.5 | GO:0034976 | response to endoplasmic reticulum stress(GO:0034976) |
0.5 | 1.1 | GO:2000643 | positive regulation of early endosome to late endosome transport(GO:2000643) |
0.5 | 1.1 | GO:0071397 | cellular response to sterol(GO:0036315) cellular response to cholesterol(GO:0071397) |
0.5 | 2.7 | GO:0051220 | cytoplasmic sequestering of protein(GO:0051220) |
0.5 | 15.0 | GO:0009060 | aerobic respiration(GO:0009060) |
0.5 | 1.6 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.5 | 3.7 | GO:0032098 | regulation of appetite(GO:0032098) |
0.5 | 6.9 | GO:0007602 | phototransduction(GO:0007602) |
0.5 | 0.5 | GO:0061032 | visceral serous pericardium development(GO:0061032) |
0.5 | 1.1 | GO:0048563 | post-embryonic organ morphogenesis(GO:0048563) |
0.5 | 3.2 | GO:0031440 | regulation of mRNA 3'-end processing(GO:0031440) |
0.5 | 4.2 | GO:0032465 | regulation of cytokinesis(GO:0032465) |
0.5 | 0.5 | GO:0033762 | response to glucagon(GO:0033762) |
0.5 | 2.1 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.5 | 12.6 | GO:0071356 | cellular response to tumor necrosis factor(GO:0071356) |
0.5 | 0.5 | GO:0021564 | vagus nerve development(GO:0021564) |
0.5 | 2.1 | GO:0070266 | necroptotic process(GO:0070266) |
0.5 | 16.3 | GO:0006888 | ER to Golgi vesicle-mediated transport(GO:0006888) |
0.5 | 4.7 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
0.5 | 1.6 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
0.5 | 11.0 | GO:0090662 | energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) ATP hydrolysis coupled proton transport(GO:0015991) ATP hydrolysis coupled transmembrane transport(GO:0090662) |
0.5 | 4.2 | GO:0050830 | defense response to Gram-positive bacterium(GO:0050830) |
0.5 | 1.6 | GO:0060693 | regulation of branching involved in salivary gland morphogenesis(GO:0060693) |
0.5 | 5.7 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
0.5 | 1.6 | GO:0044821 | telomere tethering at nuclear periphery(GO:0034398) meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
0.5 | 0.5 | GO:0034134 | toll-like receptor 2 signaling pathway(GO:0034134) |
0.5 | 1.0 | GO:0031017 | exocrine pancreas development(GO:0031017) |
0.5 | 1.6 | GO:0060973 | cell migration involved in heart development(GO:0060973) |
0.5 | 1.0 | GO:0050926 | regulation of positive chemotaxis(GO:0050926) |
0.5 | 0.5 | GO:0045730 | respiratory burst(GO:0045730) |
0.5 | 80.8 | GO:0008380 | RNA splicing(GO:0008380) |
0.5 | 1.0 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.5 | 0.5 | GO:0032527 | protein exit from endoplasmic reticulum(GO:0032527) |
0.5 | 2.1 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.5 | 11.3 | GO:0006289 | nucleotide-excision repair(GO:0006289) |
0.5 | 1.0 | GO:1903862 | positive regulation of oxidative phosphorylation(GO:1903862) |
0.5 | 1.0 | GO:0046653 | tetrahydrofolate metabolic process(GO:0046653) |
0.5 | 0.5 | GO:2000359 | regulation of binding of sperm to zona pellucida(GO:2000359) |
0.5 | 0.5 | GO:0097709 | connective tissue replacement involved in inflammatory response wound healing(GO:0002248) connective tissue replacement(GO:0097709) |
0.5 | 0.5 | GO:0000729 | DNA double-strand break processing(GO:0000729) |
0.5 | 0.5 | GO:0043650 | dicarboxylic acid biosynthetic process(GO:0043650) |
0.5 | 1.0 | GO:0070989 | oxidative demethylation(GO:0070989) |
0.5 | 2.5 | GO:0042168 | heme metabolic process(GO:0042168) |
0.5 | 3.5 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
0.5 | 2.0 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
0.5 | 1.0 | GO:0002467 | germinal center formation(GO:0002467) |
0.5 | 1.0 | GO:0080154 | regulation of fertilization(GO:0080154) |
0.5 | 1.0 | GO:0016556 | mRNA modification(GO:0016556) |
0.5 | 5.0 | GO:0032006 | regulation of TOR signaling(GO:0032006) |
0.5 | 2.0 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
0.5 | 0.5 | GO:0006543 | glutamine catabolic process(GO:0006543) |
0.5 | 1.5 | GO:2000756 | regulation of peptidyl-lysine acetylation(GO:2000756) |
0.5 | 1.0 | GO:0090315 | negative regulation of protein targeting to membrane(GO:0090315) |
0.5 | 0.5 | GO:1904528 | regulation of microtubule binding(GO:1904526) positive regulation of microtubule binding(GO:1904528) |
0.5 | 1.0 | GO:0006624 | vacuolar protein processing(GO:0006624) |
0.5 | 2.0 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
0.5 | 1.0 | GO:0042078 | germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
0.5 | 1.0 | GO:0032823 | regulation of natural killer cell differentiation(GO:0032823) |
0.5 | 0.5 | GO:0009208 | pyrimidine ribonucleoside triphosphate metabolic process(GO:0009208) pyrimidine ribonucleotide metabolic process(GO:0009218) |
0.5 | 2.5 | GO:0036159 | inner dynein arm assembly(GO:0036159) |
0.5 | 1.0 | GO:0046640 | regulation of alpha-beta T cell proliferation(GO:0046640) |
0.5 | 2.5 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.5 | 2.0 | GO:0048304 | positive regulation of isotype switching to IgG isotypes(GO:0048304) |
0.5 | 3.0 | GO:0071361 | cellular response to ethanol(GO:0071361) |
0.5 | 2.0 | GO:0032402 | melanosome transport(GO:0032402) |
0.5 | 1.0 | GO:0019695 | choline metabolic process(GO:0019695) |
0.5 | 1.0 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
0.5 | 2.0 | GO:0018202 | peptidyl-histidine modification(GO:0018202) |
0.5 | 0.5 | GO:0033630 | positive regulation of cell adhesion mediated by integrin(GO:0033630) |
0.5 | 1.5 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
0.5 | 3.9 | GO:0050860 | negative regulation of T cell receptor signaling pathway(GO:0050860) |
0.5 | 2.9 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
0.5 | 1.5 | GO:0030225 | macrophage differentiation(GO:0030225) |
0.5 | 1.9 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
0.5 | 1.0 | GO:0060591 | chondroblast differentiation(GO:0060591) |
0.5 | 5.8 | GO:0097186 | amelogenesis(GO:0097186) |
0.5 | 2.4 | GO:0046348 | amino sugar catabolic process(GO:0046348) |
0.5 | 0.5 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
0.5 | 1.9 | GO:0045069 | regulation of viral genome replication(GO:0045069) |
0.5 | 18.2 | GO:0043039 | tRNA aminoacylation for protein translation(GO:0006418) amino acid activation(GO:0043038) tRNA aminoacylation(GO:0043039) |
0.5 | 1.0 | GO:0003356 | regulation of cilium movement(GO:0003352) regulation of cilium beat frequency(GO:0003356) |
0.5 | 1.0 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
0.5 | 0.5 | GO:0035930 | corticosteroid hormone secretion(GO:0035930) regulation of corticosteroid hormone secretion(GO:2000846) |
0.5 | 0.5 | GO:0035524 | proline transmembrane transport(GO:0035524) |
0.5 | 6.2 | GO:0006446 | regulation of translational initiation(GO:0006446) |
0.5 | 3.8 | GO:0042181 | ketone biosynthetic process(GO:0042181) |
0.5 | 0.5 | GO:0046718 | viral entry into host cell(GO:0046718) |
0.5 | 0.9 | GO:0033690 | positive regulation of osteoblast proliferation(GO:0033690) |
0.5 | 2.4 | GO:0070525 | tRNA threonylcarbamoyladenosine metabolic process(GO:0070525) |
0.5 | 0.5 | GO:1902275 | regulation of chromatin organization(GO:1902275) |
0.5 | 9.9 | GO:0015914 | phospholipid transport(GO:0015914) |
0.5 | 3.8 | GO:0048538 | thymus development(GO:0048538) |
0.5 | 2.4 | GO:0014041 | regulation of neuron maturation(GO:0014041) |
0.5 | 0.5 | GO:0000101 | sulfur amino acid transport(GO:0000101) |
0.5 | 1.4 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
0.5 | 1.4 | GO:2000344 | positive regulation of acrosome reaction(GO:2000344) |
0.5 | 1.9 | GO:0010906 | regulation of glucose metabolic process(GO:0010906) |
0.5 | 0.9 | GO:1903800 | positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
0.5 | 1.4 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
0.5 | 0.9 | GO:1900186 | negative regulation of clathrin-mediated endocytosis(GO:1900186) |
0.5 | 1.4 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.5 | 2.3 | GO:0045086 | positive regulation of interleukin-2 biosynthetic process(GO:0045086) |
0.5 | 0.9 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
0.5 | 3.3 | GO:2001252 | positive regulation of chromosome organization(GO:2001252) |
0.5 | 0.9 | GO:0034637 | cellular carbohydrate biosynthetic process(GO:0034637) |
0.5 | 0.5 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.5 | 0.9 | GO:0048069 | eye pigmentation(GO:0048069) |
0.5 | 1.4 | GO:0035188 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
0.5 | 1.8 | GO:0031570 | DNA integrity checkpoint(GO:0031570) |
0.5 | 1.8 | GO:0016572 | histone phosphorylation(GO:0016572) |
0.5 | 0.5 | GO:0034032 | nucleoside bisphosphate metabolic process(GO:0033865) ribonucleoside bisphosphate metabolic process(GO:0033875) purine nucleoside bisphosphate metabolic process(GO:0034032) |
0.5 | 0.9 | GO:0006356 | regulation of transcription from RNA polymerase I promoter(GO:0006356) |
0.5 | 0.9 | GO:0042447 | hormone catabolic process(GO:0042447) |
0.5 | 0.5 | GO:0048819 | regulation of hair follicle maturation(GO:0048819) |
0.5 | 0.5 | GO:0010693 | negative regulation of alkaline phosphatase activity(GO:0010693) |
0.5 | 0.5 | GO:0044783 | G1 DNA damage checkpoint(GO:0044783) |
0.5 | 0.9 | GO:0051450 | myoblast proliferation(GO:0051450) |
0.5 | 0.5 | GO:0045945 | positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
0.5 | 0.5 | GO:0045815 | positive regulation of gene expression, epigenetic(GO:0045815) |
0.5 | 0.9 | GO:2000653 | regulation of genetic imprinting(GO:2000653) |
0.5 | 0.9 | GO:0060060 | post-embryonic retina morphogenesis in camera-type eye(GO:0060060) |
0.5 | 2.3 | GO:0016574 | histone ubiquitination(GO:0016574) |
0.5 | 7.2 | GO:0000079 | regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0000079) |
0.5 | 6.3 | GO:0032012 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.5 | 1.4 | GO:0023035 | CD40 signaling pathway(GO:0023035) |
0.5 | 6.3 | GO:2000134 | negative regulation of G1/S transition of mitotic cell cycle(GO:2000134) |
0.5 | 0.9 | GO:0046461 | neutral lipid catabolic process(GO:0046461) acylglycerol catabolic process(GO:0046464) |
0.4 | 2.7 | GO:0071265 | amino acid salvage(GO:0043102) L-methionine biosynthetic process(GO:0071265) L-methionine salvage(GO:0071267) |
0.4 | 0.9 | GO:0045651 | positive regulation of macrophage differentiation(GO:0045651) |
0.4 | 0.4 | GO:0035814 | negative regulation of renal sodium excretion(GO:0035814) |
0.4 | 1.3 | GO:0010807 | regulation of synaptic vesicle priming(GO:0010807) |
0.4 | 1.3 | GO:0000711 | meiotic DNA repair synthesis(GO:0000711) |
0.4 | 0.9 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
0.4 | 1.3 | GO:0015012 | heparan sulfate proteoglycan biosynthetic process(GO:0015012) |
0.4 | 2.7 | GO:0002026 | regulation of the force of heart contraction(GO:0002026) |
0.4 | 0.4 | GO:1902714 | negative regulation of interferon-gamma secretion(GO:1902714) |
0.4 | 2.2 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
0.4 | 3.1 | GO:0050892 | intestinal absorption(GO:0050892) |
0.4 | 2.6 | GO:1900262 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
0.4 | 0.4 | GO:0001993 | regulation of systemic arterial blood pressure by norepinephrine-epinephrine(GO:0001993) |
0.4 | 1.3 | GO:0033273 | response to vitamin(GO:0033273) |
0.4 | 8.3 | GO:1905039 | organic acid transmembrane transport(GO:1903825) carboxylic acid transmembrane transport(GO:1905039) |
0.4 | 7.0 | GO:0072332 | intrinsic apoptotic signaling pathway by p53 class mediator(GO:0072332) |
0.4 | 2.2 | GO:0071260 | cellular response to mechanical stimulus(GO:0071260) |
0.4 | 0.9 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.4 | 2.2 | GO:0001514 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.4 | 3.1 | GO:0035458 | cellular response to interferon-beta(GO:0035458) |
0.4 | 0.9 | GO:0009446 | putrescine biosynthetic process(GO:0009446) |
0.4 | 0.4 | GO:0072526 | pyridine-containing compound catabolic process(GO:0072526) |
0.4 | 0.4 | GO:0045648 | positive regulation of erythrocyte differentiation(GO:0045648) |
0.4 | 1.3 | GO:1902414 | protein localization to cell junction(GO:1902414) |
0.4 | 0.4 | GO:0015884 | folic acid transport(GO:0015884) |
0.4 | 0.4 | GO:0061097 | regulation of protein tyrosine kinase activity(GO:0061097) |
0.4 | 0.4 | GO:0098532 | histone H3-K27 trimethylation(GO:0098532) |
0.4 | 0.4 | GO:0071462 | cellular response to water stimulus(GO:0071462) |
0.4 | 0.4 | GO:2000138 | positive regulation of cell proliferation involved in heart morphogenesis(GO:2000138) |
0.4 | 4.3 | GO:0051601 | exocyst localization(GO:0051601) |
0.4 | 0.4 | GO:0009084 | glutamine family amino acid biosynthetic process(GO:0009084) |
0.4 | 0.4 | GO:0006924 | activation-induced cell death of T cells(GO:0006924) |
0.4 | 2.1 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.4 | 0.4 | GO:0042348 | regulation of NF-kappaB import into nucleus(GO:0042345) NF-kappaB import into nucleus(GO:0042348) |
0.4 | 3.8 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.4 | 0.4 | GO:0072337 | modified amino acid transport(GO:0072337) |
0.4 | 2.5 | GO:0045672 | positive regulation of osteoclast differentiation(GO:0045672) |
0.4 | 9.3 | GO:0002181 | cytoplasmic translation(GO:0002181) |
0.4 | 4.6 | GO:0010257 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.4 | 3.4 | GO:0051310 | metaphase plate congression(GO:0051310) |
0.4 | 2.5 | GO:0072520 | seminiferous tubule development(GO:0072520) |
0.4 | 0.4 | GO:0072600 | establishment of protein localization to Golgi(GO:0072600) |
0.4 | 2.5 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.4 | 6.3 | GO:0051168 | nuclear export(GO:0051168) |
0.4 | 0.8 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
0.4 | 0.4 | GO:0044872 | lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
0.4 | 3.3 | GO:0043407 | negative regulation of MAP kinase activity(GO:0043407) |
0.4 | 2.1 | GO:0006656 | phosphatidylcholine biosynthetic process(GO:0006656) |
0.4 | 0.8 | GO:0043485 | endosome to melanosome transport(GO:0035646) endosome to pigment granule transport(GO:0043485) pigment granule maturation(GO:0048757) |
0.4 | 2.5 | GO:0006622 | protein targeting to lysosome(GO:0006622) |
0.4 | 3.7 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) protein targeting to ER(GO:0045047) |
0.4 | 1.2 | GO:2000609 | regulation of thyroid hormone generation(GO:2000609) |
0.4 | 2.9 | GO:0001539 | cilium or flagellum-dependent cell motility(GO:0001539) cilium-dependent cell motility(GO:0060285) |
0.4 | 5.3 | GO:0019319 | hexose biosynthetic process(GO:0019319) |
0.4 | 0.4 | GO:0007144 | female meiosis I(GO:0007144) |
0.4 | 1.2 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.4 | 0.4 | GO:0060484 | lung-associated mesenchyme development(GO:0060484) |
0.4 | 8.9 | GO:0051865 | protein autoubiquitination(GO:0051865) |
0.4 | 0.4 | GO:0006473 | protein acetylation(GO:0006473) |
0.4 | 0.8 | GO:0036376 | sodium ion export from cell(GO:0036376) sodium ion export(GO:0071436) |
0.4 | 4.0 | GO:0090263 | positive regulation of canonical Wnt signaling pathway(GO:0090263) |
0.4 | 0.4 | GO:0014827 | intestine smooth muscle contraction(GO:0014827) |
0.4 | 2.8 | GO:0001570 | vasculogenesis(GO:0001570) |
0.4 | 1.6 | GO:0030330 | DNA damage response, signal transduction by p53 class mediator(GO:0030330) |
0.4 | 2.4 | GO:0031365 | N-terminal protein amino acid modification(GO:0031365) |
0.4 | 0.8 | GO:0019081 | viral translation(GO:0019081) |
0.4 | 2.0 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
0.4 | 0.8 | GO:0002215 | defense response to nematode(GO:0002215) |
0.4 | 3.6 | GO:0042035 | regulation of cytokine biosynthetic process(GO:0042035) |
0.4 | 2.0 | GO:0003229 | ventricular cardiac muscle tissue development(GO:0003229) |
0.4 | 2.8 | GO:0033561 | regulation of water loss via skin(GO:0033561) |
0.4 | 0.8 | GO:0072079 | nephron tubule formation(GO:0072079) |
0.4 | 0.4 | GO:0006598 | polyamine catabolic process(GO:0006598) |
0.4 | 1.2 | GO:0048012 | hepatocyte growth factor receptor signaling pathway(GO:0048012) |
0.4 | 0.4 | GO:0007182 | common-partner SMAD protein phosphorylation(GO:0007182) |
0.4 | 7.9 | GO:0009267 | cellular response to starvation(GO:0009267) |
0.4 | 0.4 | GO:0070828 | heterochromatin organization(GO:0070828) |
0.4 | 0.8 | GO:0014063 | negative regulation of serotonin secretion(GO:0014063) |
0.4 | 1.6 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
0.4 | 0.4 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.4 | 1.2 | GO:0002583 | regulation of antigen processing and presentation of peptide antigen(GO:0002583) |
0.4 | 4.7 | GO:0042832 | defense response to protozoan(GO:0042832) |
0.4 | 1.9 | GO:0042347 | negative regulation of NF-kappaB import into nucleus(GO:0042347) |
0.4 | 2.3 | GO:0097484 | dendrite extension(GO:0097484) |
0.4 | 7.8 | GO:0000956 | nuclear-transcribed mRNA catabolic process(GO:0000956) |
0.4 | 0.8 | GO:0010458 | exit from mitosis(GO:0010458) |
0.4 | 1.5 | GO:0055090 | acylglycerol homeostasis(GO:0055090) triglyceride homeostasis(GO:0070328) |
0.4 | 0.4 | GO:0015808 | L-alanine transport(GO:0015808) |
0.4 | 0.8 | GO:2001021 | negative regulation of response to DNA damage stimulus(GO:2001021) |
0.4 | 2.3 | GO:1902750 | negative regulation of cell cycle G2/M phase transition(GO:1902750) |
0.4 | 0.8 | GO:0035162 | embryonic hemopoiesis(GO:0035162) |
0.4 | 0.8 | GO:0070243 | regulation of thymocyte apoptotic process(GO:0070243) |
0.4 | 1.2 | GO:0045579 | positive regulation of B cell differentiation(GO:0045579) |
0.4 | 0.8 | GO:0006091 | generation of precursor metabolites and energy(GO:0006091) |
0.4 | 3.1 | GO:0044804 | nucleophagy(GO:0044804) |
0.4 | 14.2 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.4 | 0.8 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
0.4 | 4.6 | GO:0007029 | endoplasmic reticulum organization(GO:0007029) |
0.4 | 1.1 | GO:0032310 | prostaglandin secretion(GO:0032310) |
0.4 | 0.8 | GO:0014819 | regulation of skeletal muscle contraction(GO:0014819) |
0.4 | 1.5 | GO:0009186 | deoxyribonucleoside diphosphate metabolic process(GO:0009186) |
0.4 | 9.4 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
0.4 | 4.9 | GO:0007585 | respiratory gaseous exchange(GO:0007585) |
0.4 | 0.4 | GO:0050703 | interleukin-1 alpha secretion(GO:0050703) |
0.4 | 2.3 | GO:0042753 | positive regulation of circadian rhythm(GO:0042753) |
0.4 | 1.1 | GO:0048535 | lymph node development(GO:0048535) |
0.4 | 3.0 | GO:0043029 | T cell homeostasis(GO:0043029) |
0.4 | 2.2 | GO:1903019 | negative regulation of glycoprotein metabolic process(GO:1903019) |
0.4 | 3.0 | GO:0035058 | nonmotile primary cilium assembly(GO:0035058) |
0.4 | 0.7 | GO:0097012 | cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) response to granulocyte macrophage colony-stimulating factor(GO:0097012) |
0.4 | 1.5 | GO:0002385 | mucosal immune response(GO:0002385) |
0.4 | 0.4 | GO:0071257 | cellular response to electrical stimulus(GO:0071257) |
0.4 | 0.4 | GO:0048009 | insulin-like growth factor receptor signaling pathway(GO:0048009) |
0.4 | 0.7 | GO:0071670 | smooth muscle cell chemotaxis(GO:0071670) |
0.4 | 1.1 | GO:0033136 | serine phosphorylation of STAT3 protein(GO:0033136) |
0.4 | 0.4 | GO:0061512 | protein localization to cilium(GO:0061512) |
0.4 | 4.8 | GO:1902806 | regulation of cell cycle G1/S phase transition(GO:1902806) |
0.4 | 0.4 | GO:0045875 | negative regulation of sister chromatid cohesion(GO:0045875) |
0.4 | 1.1 | GO:0045793 | positive regulation of cell size(GO:0045793) |
0.4 | 0.7 | GO:0018023 | peptidyl-lysine trimethylation(GO:0018023) |
0.4 | 1.1 | GO:0008631 | intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0008631) |
0.4 | 5.1 | GO:0072583 | clathrin-mediated endocytosis(GO:0072583) |
0.4 | 5.5 | GO:0019835 | cytolysis(GO:0019835) |
0.4 | 1.5 | GO:0048730 | epidermis morphogenesis(GO:0048730) |
0.4 | 0.4 | GO:0016078 | tRNA catabolic process(GO:0016078) |
0.4 | 12.0 | GO:0046488 | phosphatidylinositol metabolic process(GO:0046488) |
0.4 | 1.1 | GO:0045838 | positive regulation of membrane potential(GO:0045838) |
0.4 | 0.4 | GO:0002707 | negative regulation of lymphocyte mediated immunity(GO:0002707) |
0.4 | 1.8 | GO:0006302 | double-strand break repair(GO:0006302) |
0.4 | 5.0 | GO:0006885 | regulation of pH(GO:0006885) |
0.4 | 0.4 | GO:0032513 | negative regulation of protein phosphatase type 2B activity(GO:0032513) |
0.4 | 0.4 | GO:1903232 | melanosome assembly(GO:1903232) |
0.4 | 1.1 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
0.4 | 0.7 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.4 | 4.3 | GO:0060976 | coronary vasculature development(GO:0060976) |
0.4 | 0.4 | GO:0042226 | interleukin-6 biosynthetic process(GO:0042226) |
0.4 | 0.7 | GO:0038061 | NIK/NF-kappaB signaling(GO:0038061) |
0.4 | 1.8 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
0.4 | 0.7 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.4 | 0.4 | GO:2000254 | regulation of male germ cell proliferation(GO:2000254) |
0.4 | 0.7 | GO:0000076 | DNA replication checkpoint(GO:0000076) |
0.4 | 0.7 | GO:0000731 | DNA synthesis involved in DNA repair(GO:0000731) |
0.4 | 29.6 | GO:0051607 | defense response to virus(GO:0051607) |
0.4 | 0.7 | GO:0070542 | response to fatty acid(GO:0070542) |
0.4 | 0.7 | GO:0051452 | intracellular pH reduction(GO:0051452) |
0.4 | 0.4 | GO:0032490 | detection of molecule of bacterial origin(GO:0032490) |
0.4 | 0.4 | GO:0035963 | response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) |
0.4 | 0.4 | GO:0046889 | positive regulation of lipid biosynthetic process(GO:0046889) |
0.3 | 22.4 | GO:0006310 | DNA recombination(GO:0006310) |
0.3 | 0.3 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
0.3 | 0.3 | GO:0099515 | actin filament-based transport(GO:0099515) |
0.3 | 0.3 | GO:0035384 | thioester biosynthetic process(GO:0035384) acyl-CoA biosynthetic process(GO:0071616) |
0.3 | 3.1 | GO:0019933 | cAMP-mediated signaling(GO:0019933) |
0.3 | 3.8 | GO:0035825 | reciprocal meiotic recombination(GO:0007131) reciprocal DNA recombination(GO:0035825) |
0.3 | 2.1 | GO:0050869 | negative regulation of B cell activation(GO:0050869) |
0.3 | 0.3 | GO:0018879 | biphenyl metabolic process(GO:0018879) |
0.3 | 0.3 | GO:0019042 | viral latency(GO:0019042) |
0.3 | 3.1 | GO:0045744 | negative regulation of G-protein coupled receptor protein signaling pathway(GO:0045744) |
0.3 | 0.7 | GO:0048597 | post-embryonic camera-type eye morphogenesis(GO:0048597) |
0.3 | 1.0 | GO:0030539 | male genitalia development(GO:0030539) |
0.3 | 0.3 | GO:0030241 | skeletal muscle myosin thick filament assembly(GO:0030241) striated muscle myosin thick filament assembly(GO:0071688) |
0.3 | 2.1 | GO:0008625 | extrinsic apoptotic signaling pathway via death domain receptors(GO:0008625) |
0.3 | 0.3 | GO:1902807 | negative regulation of cell cycle G1/S phase transition(GO:1902807) |
0.3 | 0.3 | GO:0010668 | ectodermal cell differentiation(GO:0010668) |
0.3 | 4.4 | GO:0010107 | potassium ion import(GO:0010107) |
0.3 | 0.7 | GO:0031268 | pseudopodium organization(GO:0031268) |
0.3 | 0.7 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
0.3 | 1.0 | GO:0048662 | negative regulation of smooth muscle cell proliferation(GO:0048662) |
0.3 | 0.3 | GO:0035751 | regulation of lysosomal lumen pH(GO:0035751) |
0.3 | 1.3 | GO:0035562 | negative regulation of chromatin binding(GO:0035562) |
0.3 | 1.3 | GO:0044247 | glycogen catabolic process(GO:0005980) glucan catabolic process(GO:0009251) cellular polysaccharide catabolic process(GO:0044247) |
0.3 | 1.7 | GO:0050710 | negative regulation of cytokine secretion(GO:0050710) |
0.3 | 0.3 | GO:0036119 | response to platelet-derived growth factor(GO:0036119) |
0.3 | 1.7 | GO:0043616 | keratinocyte proliferation(GO:0043616) |
0.3 | 1.0 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.3 | 0.7 | GO:0030240 | skeletal muscle thin filament assembly(GO:0030240) |
0.3 | 1.0 | GO:0034505 | tooth mineralization(GO:0034505) |
0.3 | 0.3 | GO:0043320 | natural killer cell degranulation(GO:0043320) |
0.3 | 3.9 | GO:0045599 | negative regulation of fat cell differentiation(GO:0045599) |
0.3 | 1.9 | GO:0070189 | kynurenine metabolic process(GO:0070189) |
0.3 | 2.6 | GO:0071875 | adrenergic receptor signaling pathway(GO:0071875) |
0.3 | 0.3 | GO:0036515 | serotonergic neuron axon guidance(GO:0036515) |
0.3 | 13.9 | GO:0007051 | spindle organization(GO:0007051) |
0.3 | 0.6 | GO:0051767 | nitric-oxide synthase biosynthetic process(GO:0051767) regulation of nitric-oxide synthase biosynthetic process(GO:0051769) |
0.3 | 8.7 | GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I(GO:0002474) |
0.3 | 0.6 | GO:0045907 | positive regulation of vasoconstriction(GO:0045907) |
0.3 | 1.3 | GO:0035563 | positive regulation of chromatin binding(GO:0035563) |
0.3 | 0.3 | GO:0045589 | regulation of regulatory T cell differentiation(GO:0045589) |
0.3 | 0.6 | GO:0060149 | negative regulation of posttranscriptional gene silencing(GO:0060149) negative regulation of gene silencing by miRNA(GO:0060965) negative regulation of gene silencing by RNA(GO:0060967) negative regulation of gene silencing(GO:0060969) |
0.3 | 0.3 | GO:0001842 | neural fold formation(GO:0001842) |
0.3 | 3.1 | GO:0051496 | positive regulation of stress fiber assembly(GO:0051496) |
0.3 | 1.6 | GO:0000469 | cleavage involved in rRNA processing(GO:0000469) |
0.3 | 0.6 | GO:0060536 | cartilage morphogenesis(GO:0060536) |
0.3 | 3.4 | GO:0006637 | acyl-CoA metabolic process(GO:0006637) thioester metabolic process(GO:0035383) |
0.3 | 3.1 | GO:0098656 | anion transmembrane transport(GO:0098656) |
0.3 | 0.6 | GO:0045986 | negative regulation of smooth muscle contraction(GO:0045986) |
0.3 | 0.9 | GO:2001012 | mesenchymal cell differentiation involved in kidney development(GO:0072161) mesenchymal cell differentiation involved in renal system development(GO:2001012) |
0.3 | 4.9 | GO:0031123 | RNA 3'-end processing(GO:0031123) |
0.3 | 0.3 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.3 | 0.6 | GO:0040020 | regulation of meiotic nuclear division(GO:0040020) |
0.3 | 0.9 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.3 | 1.5 | GO:0090503 | RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
0.3 | 0.3 | GO:0051503 | adenine nucleotide transport(GO:0051503) |
0.3 | 0.9 | GO:0032602 | chemokine production(GO:0032602) |
0.3 | 4.0 | GO:0055076 | transition metal ion homeostasis(GO:0055076) |
0.3 | 7.0 | GO:0006956 | complement activation(GO:0006956) |
0.3 | 0.3 | GO:0070255 | regulation of mucus secretion(GO:0070255) |
0.3 | 1.5 | GO:0018279 | peptidyl-asparagine modification(GO:0018196) protein N-linked glycosylation via asparagine(GO:0018279) |
0.3 | 0.3 | GO:1902093 | positive regulation of sperm motility(GO:1902093) |
0.3 | 0.6 | GO:0072528 | pyrimidine-containing compound biosynthetic process(GO:0072528) |
0.3 | 0.3 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.3 | 0.3 | GO:0035733 | hepatic stellate cell activation(GO:0035733) |
0.3 | 0.3 | GO:1900016 | negative regulation of cytokine production involved in inflammatory response(GO:1900016) |
0.3 | 1.2 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.3 | 0.3 | GO:0043415 | positive regulation of skeletal muscle tissue regeneration(GO:0043415) |
0.3 | 0.9 | GO:0046104 | thymidine metabolic process(GO:0046104) |
0.3 | 3.8 | GO:0045454 | cell redox homeostasis(GO:0045454) |
0.3 | 0.3 | GO:0070303 | negative regulation of stress-activated MAPK cascade(GO:0032873) negative regulation of stress-activated protein kinase signaling cascade(GO:0070303) |
0.3 | 0.9 | GO:0010447 | response to acidic pH(GO:0010447) |
0.3 | 0.3 | GO:0090666 | scaRNA localization to Cajal body(GO:0090666) |
0.3 | 0.9 | GO:0001773 | myeloid dendritic cell activation(GO:0001773) |
0.3 | 0.3 | GO:0001562 | response to protozoan(GO:0001562) |
0.3 | 1.4 | GO:0019359 | nicotinamide nucleotide biosynthetic process(GO:0019359) |
0.3 | 2.9 | GO:0045621 | positive regulation of lymphocyte differentiation(GO:0045621) |
0.3 | 0.3 | GO:0035813 | renal sodium excretion(GO:0035812) regulation of renal sodium excretion(GO:0035813) |
0.3 | 1.1 | GO:0006801 | superoxide metabolic process(GO:0006801) |
0.3 | 1.7 | GO:0003081 | regulation of systemic arterial blood pressure by renin-angiotensin(GO:0003081) |
0.3 | 2.3 | GO:0006493 | protein O-linked glycosylation(GO:0006493) |
0.3 | 5.7 | GO:0000462 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
0.3 | 0.6 | GO:1900078 | positive regulation of cellular response to insulin stimulus(GO:1900078) |
0.3 | 0.6 | GO:0051584 | regulation of dopamine uptake involved in synaptic transmission(GO:0051584) regulation of catecholamine uptake involved in synaptic transmission(GO:0051940) |
0.3 | 0.6 | GO:0016264 | gap junction assembly(GO:0016264) |
0.3 | 0.6 | GO:0044154 | histone H3-K14 acetylation(GO:0044154) |
0.3 | 1.1 | GO:0060438 | trachea development(GO:0060438) |
0.3 | 0.3 | GO:0090598 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
0.3 | 0.6 | GO:0071467 | cellular response to pH(GO:0071467) |
0.3 | 2.0 | GO:0046850 | regulation of bone remodeling(GO:0046850) |
0.3 | 1.1 | GO:0031061 | negative regulation of histone methylation(GO:0031061) |
0.3 | 0.3 | GO:0070586 | cell-cell adhesion involved in gastrulation(GO:0070586) |
0.3 | 0.3 | GO:0042983 | amyloid precursor protein biosynthetic process(GO:0042983) regulation of amyloid precursor protein biosynthetic process(GO:0042984) |
0.3 | 1.1 | GO:0045576 | mast cell activation(GO:0045576) |
0.3 | 0.3 | GO:0003105 | negative regulation of glomerular filtration(GO:0003105) |
0.3 | 0.8 | GO:0007032 | endosome organization(GO:0007032) |
0.3 | 0.3 | GO:0045019 | negative regulation of nitric oxide biosynthetic process(GO:0045019) negative regulation of nitric oxide metabolic process(GO:1904406) |
0.3 | 0.3 | GO:0010533 | regulation of activation of Janus kinase activity(GO:0010533) |
0.3 | 1.1 | GO:0035094 | response to nicotine(GO:0035094) |
0.3 | 0.3 | GO:2000382 | positive regulation of mesoderm development(GO:2000382) |
0.3 | 2.9 | GO:0006352 | DNA-templated transcription, initiation(GO:0006352) |
0.3 | 20.9 | GO:0016568 | chromatin modification(GO:0016568) |
0.3 | 1.1 | GO:0042516 | regulation of tyrosine phosphorylation of Stat3 protein(GO:0042516) |
0.3 | 0.3 | GO:0030908 | intein-mediated protein splicing(GO:0016539) protein splicing(GO:0030908) |
0.3 | 0.5 | GO:0046039 | GTP metabolic process(GO:0046039) |
0.3 | 0.5 | GO:0048875 | chemical homeostasis within a tissue(GO:0048875) |
0.3 | 0.5 | GO:0031958 | corticosteroid receptor signaling pathway(GO:0031958) |
0.3 | 1.6 | GO:1902017 | regulation of cilium assembly(GO:1902017) |
0.3 | 1.3 | GO:0034308 | primary alcohol metabolic process(GO:0034308) retinol metabolic process(GO:0042572) |
0.3 | 1.0 | GO:0031167 | rRNA methylation(GO:0031167) |
0.3 | 0.8 | GO:2000253 | positive regulation of feeding behavior(GO:2000253) |
0.3 | 6.2 | GO:0043123 | positive regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043123) |
0.3 | 2.8 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.3 | 0.5 | GO:0050651 | dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
0.3 | 4.6 | GO:0007041 | lysosomal transport(GO:0007041) |
0.3 | 7.4 | GO:0019439 | aromatic compound catabolic process(GO:0019439) |
0.3 | 0.3 | GO:0045932 | negative regulation of muscle contraction(GO:0045932) |
0.3 | 1.8 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.3 | 0.3 | GO:0031049 | programmed DNA elimination(GO:0031049) chromosome breakage(GO:0031052) |
0.3 | 2.0 | GO:0030593 | neutrophil chemotaxis(GO:0030593) |
0.3 | 1.5 | GO:0060271 | cilium morphogenesis(GO:0060271) |
0.3 | 0.3 | GO:0006664 | glycolipid metabolic process(GO:0006664) |
0.3 | 0.5 | GO:0009146 | purine nucleoside triphosphate catabolic process(GO:0009146) |
0.3 | 0.5 | GO:0051177 | meiotic sister chromatid segregation(GO:0045144) meiotic sister chromatid cohesion(GO:0051177) |
0.3 | 1.8 | GO:0003170 | heart valve development(GO:0003170) |
0.3 | 0.3 | GO:0050849 | negative regulation of calcium-mediated signaling(GO:0050849) |
0.3 | 1.5 | GO:0030261 | chromosome condensation(GO:0030261) |
0.3 | 0.5 | GO:0021940 | positive regulation of cerebellar granule cell precursor proliferation(GO:0021940) |
0.2 | 1.7 | GO:0016926 | protein desumoylation(GO:0016926) |
0.2 | 1.0 | GO:0010640 | regulation of platelet-derived growth factor receptor signaling pathway(GO:0010640) |
0.2 | 3.7 | GO:0015807 | L-amino acid transport(GO:0015807) |
0.2 | 1.0 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.2 | 16.7 | GO:0042742 | defense response to bacterium(GO:0042742) |
0.2 | 0.5 | GO:0036265 | RNA (guanine-N7)-methylation(GO:0036265) |
0.2 | 0.2 | GO:0051799 | negative regulation of hair follicle development(GO:0051799) |
0.2 | 0.2 | GO:0009394 | 2'-deoxyribonucleotide metabolic process(GO:0009394) deoxyribose phosphate metabolic process(GO:0019692) |
0.2 | 0.5 | GO:0006213 | pyrimidine nucleoside metabolic process(GO:0006213) |
0.2 | 0.7 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
0.2 | 1.0 | GO:0010039 | response to iron ion(GO:0010039) |
0.2 | 0.5 | GO:0061154 | endothelial tube morphogenesis(GO:0061154) |
0.2 | 5.1 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.2 | 0.2 | GO:0036112 | medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
0.2 | 1.2 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.2 | 0.5 | GO:2000378 | negative regulation of reactive oxygen species metabolic process(GO:2000378) |
0.2 | 0.5 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
0.2 | 0.5 | GO:2000300 | regulation of synaptic vesicle exocytosis(GO:2000300) |
0.2 | 0.2 | GO:0071577 | zinc II ion transmembrane transport(GO:0071577) |
0.2 | 1.4 | GO:0002861 | regulation of inflammatory response to antigenic stimulus(GO:0002861) |
0.2 | 1.2 | GO:0002437 | inflammatory response to antigenic stimulus(GO:0002437) |
0.2 | 2.1 | GO:0003341 | cilium movement(GO:0003341) |
0.2 | 0.5 | GO:0031935 | regulation of chromatin silencing(GO:0031935) |
0.2 | 0.7 | GO:0006109 | regulation of carbohydrate metabolic process(GO:0006109) |
0.2 | 0.9 | GO:0009132 | nucleoside diphosphate metabolic process(GO:0009132) |
0.2 | 1.6 | GO:0097499 | protein localization to nonmotile primary cilium(GO:0097499) |
0.2 | 2.5 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.2 | 0.5 | GO:0000963 | mitochondrial RNA processing(GO:0000963) |
0.2 | 1.4 | GO:0008206 | bile acid metabolic process(GO:0008206) |
0.2 | 1.3 | GO:0001938 | positive regulation of endothelial cell proliferation(GO:0001938) |
0.2 | 0.7 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
0.2 | 0.7 | GO:0055092 | cholesterol homeostasis(GO:0042632) sterol homeostasis(GO:0055092) |
0.2 | 1.3 | GO:0001947 | heart looping(GO:0001947) |
0.2 | 2.7 | GO:0043161 | proteasome-mediated ubiquitin-dependent protein catabolic process(GO:0043161) |
0.2 | 0.4 | GO:0097211 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
0.2 | 0.2 | GO:0070316 | G0 to G1 transition(GO:0045023) regulation of G0 to G1 transition(GO:0070316) |
0.2 | 0.4 | GO:0036465 | synaptic vesicle recycling(GO:0036465) |
0.2 | 0.4 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
0.2 | 1.1 | GO:0006182 | cGMP biosynthetic process(GO:0006182) |
0.2 | 2.6 | GO:0006672 | ceramide metabolic process(GO:0006672) |
0.2 | 1.3 | GO:0090305 | nucleic acid phosphodiester bond hydrolysis(GO:0090305) |
0.2 | 0.2 | GO:0007000 | nucleolus organization(GO:0007000) |
0.2 | 17.7 | GO:0002237 | response to molecule of bacterial origin(GO:0002237) |
0.2 | 1.3 | GO:0060716 | labyrinthine layer blood vessel development(GO:0060716) |
0.2 | 0.2 | GO:0072053 | renal inner medulla development(GO:0072053) |
0.2 | 0.2 | GO:0032656 | regulation of interleukin-13 production(GO:0032656) |
0.2 | 0.6 | GO:0006342 | chromatin silencing(GO:0006342) |
0.2 | 0.2 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
0.2 | 0.4 | GO:0048599 | oocyte development(GO:0048599) |
0.2 | 0.4 | GO:0048854 | brain morphogenesis(GO:0048854) |
0.2 | 0.2 | GO:0001834 | trophectodermal cell proliferation(GO:0001834) |
0.2 | 2.1 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
0.2 | 0.2 | GO:0003419 | growth plate cartilage chondrocyte proliferation(GO:0003419) |
0.2 | 0.4 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
0.2 | 19.3 | GO:0032259 | methylation(GO:0032259) |
0.2 | 0.2 | GO:0048147 | negative regulation of fibroblast proliferation(GO:0048147) |
0.2 | 2.2 | GO:0010508 | positive regulation of autophagy(GO:0010508) |
0.2 | 10.8 | GO:0016579 | protein deubiquitination(GO:0016579) |
0.2 | 1.4 | GO:0050852 | T cell receptor signaling pathway(GO:0050852) |
0.2 | 1.6 | GO:0006940 | regulation of smooth muscle contraction(GO:0006940) |
0.2 | 0.4 | GO:0038092 | nodal signaling pathway(GO:0038092) |
0.2 | 0.2 | GO:0021558 | trochlear nerve development(GO:0021558) |
0.2 | 9.0 | GO:0050909 | sensory perception of taste(GO:0050909) |
0.2 | 0.2 | GO:0051132 | NK T cell activation(GO:0051132) |
0.2 | 1.0 | GO:0035024 | negative regulation of Rho protein signal transduction(GO:0035024) |
0.2 | 0.2 | GO:0009262 | deoxyribonucleotide metabolic process(GO:0009262) |
0.2 | 0.2 | GO:1902309 | negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
0.2 | 0.6 | GO:1903311 | regulation of mRNA metabolic process(GO:1903311) |
0.2 | 0.4 | GO:0009299 | mRNA transcription(GO:0009299) |
0.2 | 0.8 | GO:0006767 | water-soluble vitamin metabolic process(GO:0006767) |
0.2 | 0.4 | GO:0048711 | positive regulation of astrocyte differentiation(GO:0048711) |
0.2 | 0.4 | GO:0002024 | diet induced thermogenesis(GO:0002024) adaptive thermogenesis(GO:1990845) |
0.2 | 0.4 | GO:0045620 | negative regulation of lymphocyte differentiation(GO:0045620) |
0.2 | 0.6 | GO:0060433 | bronchus development(GO:0060433) |
0.2 | 0.4 | GO:0051350 | negative regulation of cyclase activity(GO:0031280) negative regulation of lyase activity(GO:0051350) |
0.2 | 2.0 | GO:0042246 | tissue regeneration(GO:0042246) |
0.2 | 0.2 | GO:0032732 | positive regulation of interleukin-1 production(GO:0032732) |
0.2 | 4.1 | GO:0008654 | phospholipid biosynthetic process(GO:0008654) |
0.2 | 0.2 | GO:0046174 | polyol catabolic process(GO:0046174) |
0.2 | 0.4 | GO:0016137 | glycoside metabolic process(GO:0016137) |
0.2 | 0.4 | GO:0021615 | glossopharyngeal nerve development(GO:0021563) glossopharyngeal nerve morphogenesis(GO:0021615) |
0.2 | 1.3 | GO:0046849 | bone remodeling(GO:0046849) |
0.2 | 8.4 | GO:0044257 | cellular protein catabolic process(GO:0044257) |
0.2 | 0.2 | GO:0045991 | carbon catabolite regulation of transcription(GO:0045990) carbon catabolite activation of transcription(GO:0045991) |
0.2 | 0.2 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.2 | 2.5 | GO:0030032 | lamellipodium assembly(GO:0030032) |
0.2 | 2.7 | GO:0034314 | Arp2/3 complex-mediated actin nucleation(GO:0034314) |
0.2 | 4.4 | GO:0030101 | natural killer cell activation(GO:0030101) |
0.2 | 0.5 | GO:0032233 | positive regulation of actin filament bundle assembly(GO:0032233) |
0.2 | 0.4 | GO:0014898 | muscle hypertrophy in response to stress(GO:0003299) cardiac muscle adaptation(GO:0014887) cardiac muscle hypertrophy in response to stress(GO:0014898) |
0.2 | 0.5 | GO:0061117 | negative regulation of cardiac muscle tissue growth(GO:0055022) negative regulation of heart growth(GO:0061117) |
0.2 | 0.2 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
0.2 | 7.3 | GO:0010876 | lipid localization(GO:0010876) |
0.2 | 0.7 | GO:0050884 | neuromuscular process controlling posture(GO:0050884) |
0.2 | 0.5 | GO:0046146 | tetrahydrobiopterin metabolic process(GO:0046146) |
0.2 | 0.2 | GO:0050657 | nucleic acid transport(GO:0050657) RNA transport(GO:0050658) |
0.2 | 0.7 | GO:0006383 | transcription from RNA polymerase III promoter(GO:0006383) |
0.2 | 1.4 | GO:0018205 | peptidyl-lysine modification(GO:0018205) |
0.2 | 1.0 | GO:0015804 | neutral amino acid transport(GO:0015804) |
0.2 | 0.2 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
0.2 | 1.6 | GO:0051438 | regulation of ubiquitin-protein transferase activity(GO:0051438) |
0.2 | 0.7 | GO:0070633 | transepithelial transport(GO:0070633) |
0.2 | 2.3 | GO:0003009 | skeletal muscle contraction(GO:0003009) |
0.2 | 0.2 | GO:0008078 | mesodermal cell migration(GO:0008078) |
0.2 | 1.0 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.2 | 14.4 | GO:0010466 | negative regulation of peptidase activity(GO:0010466) |
0.2 | 0.8 | GO:0042159 | lipoprotein catabolic process(GO:0042159) |
0.2 | 0.2 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
0.2 | 1.9 | GO:0016052 | carbohydrate catabolic process(GO:0016052) |
0.2 | 0.5 | GO:0006968 | cellular defense response(GO:0006968) |
0.2 | 0.2 | GO:0006734 | NADH metabolic process(GO:0006734) |
0.2 | 0.8 | GO:0003334 | keratinocyte development(GO:0003334) |
0.2 | 0.2 | GO:0015755 | fructose transport(GO:0015755) |
0.2 | 0.2 | GO:0097286 | iron ion import(GO:0097286) |
0.1 | 5.7 | GO:0008033 | tRNA processing(GO:0008033) |
0.1 | 0.3 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
0.1 | 0.4 | GO:0043153 | entrainment of circadian clock by photoperiod(GO:0043153) |
0.1 | 0.1 | GO:0090185 | negative regulation of kidney development(GO:0090185) |
0.1 | 0.4 | GO:0051481 | negative regulation of cytosolic calcium ion concentration(GO:0051481) |
0.1 | 0.1 | GO:0002200 | somatic diversification of immune receptors(GO:0002200) |
0.1 | 7.2 | GO:0006821 | chloride transport(GO:0006821) |
0.1 | 9.6 | GO:0048515 | spermatid differentiation(GO:0048515) |
0.1 | 0.3 | GO:0002320 | lymphoid progenitor cell differentiation(GO:0002320) |
0.1 | 0.1 | GO:0042398 | cellular modified amino acid biosynthetic process(GO:0042398) |
0.1 | 0.3 | GO:0008089 | anterograde axonal transport(GO:0008089) |
0.1 | 1.7 | GO:0009812 | flavonoid metabolic process(GO:0009812) |
0.1 | 0.7 | GO:0007129 | synapsis(GO:0007129) |
0.1 | 2.4 | GO:0045103 | intermediate filament-based process(GO:0045103) |
0.1 | 0.3 | GO:0070286 | axonemal dynein complex assembly(GO:0070286) |
0.1 | 0.6 | GO:2001238 | positive regulation of extrinsic apoptotic signaling pathway(GO:2001238) |
0.1 | 10.6 | GO:0007067 | mitotic nuclear division(GO:0007067) |
0.1 | 0.1 | GO:0000038 | very long-chain fatty acid metabolic process(GO:0000038) |
0.1 | 0.1 | GO:1902606 | regulation of large conductance calcium-activated potassium channel activity(GO:1902606) positive regulation of large conductance calcium-activated potassium channel activity(GO:1902608) |
0.1 | 1.9 | GO:0006694 | steroid biosynthetic process(GO:0006694) |
0.1 | 0.1 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
0.1 | 0.1 | GO:0060707 | trophoblast giant cell differentiation(GO:0060707) |
0.1 | 0.3 | GO:0048520 | positive regulation of behavior(GO:0048520) |
0.1 | 0.3 | GO:0086043 | bundle of His cell to Purkinje myocyte signaling(GO:0086028) bundle of His cell action potential(GO:0086043) |
0.1 | 0.3 | GO:0033108 | mitochondrial respiratory chain complex assembly(GO:0033108) |
0.1 | 0.3 | GO:0060242 | contact inhibition(GO:0060242) |
0.1 | 0.8 | GO:0045742 | positive regulation of epidermal growth factor receptor signaling pathway(GO:0045742) positive regulation of ERBB signaling pathway(GO:1901186) |
0.1 | 1.5 | GO:0030500 | regulation of bone mineralization(GO:0030500) |
0.1 | 0.2 | GO:0035865 | response to potassium ion(GO:0035864) cellular response to potassium ion(GO:0035865) |
0.1 | 2.5 | GO:0031424 | keratinization(GO:0031424) |
0.1 | 0.1 | GO:0010578 | regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010578) positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010579) |
0.1 | 0.1 | GO:0003044 | regulation of systemic arterial blood pressure mediated by a chemical signal(GO:0003044) |
0.1 | 0.7 | GO:0051297 | centrosome organization(GO:0051297) |
0.1 | 0.2 | GO:0007343 | egg activation(GO:0007343) |
0.1 | 0.8 | GO:0051289 | protein homotetramerization(GO:0051289) |
0.1 | 0.1 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.1 | 0.6 | GO:0007007 | inner mitochondrial membrane organization(GO:0007007) cristae formation(GO:0042407) |
0.1 | 13.9 | GO:0032446 | protein modification by small protein conjugation(GO:0032446) |
0.1 | 0.1 | GO:1903541 | regulation of exosomal secretion(GO:1903541) positive regulation of exosomal secretion(GO:1903543) |
0.1 | 1.2 | GO:0045600 | positive regulation of fat cell differentiation(GO:0045600) |
0.1 | 0.1 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
0.1 | 0.1 | GO:0051385 | response to mineralocorticoid(GO:0051385) |
0.1 | 0.1 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
0.1 | 0.2 | GO:0070305 | response to cGMP(GO:0070305) |
0.1 | 2.1 | GO:0042273 | ribosomal large subunit biogenesis(GO:0042273) |
0.1 | 3.8 | GO:0016072 | rRNA metabolic process(GO:0016072) |
0.1 | 0.1 | GO:0030825 | positive regulation of cGMP metabolic process(GO:0030825) |
0.1 | 0.4 | GO:0048011 | neurotrophin TRK receptor signaling pathway(GO:0048011) |
0.1 | 0.8 | GO:0045981 | positive regulation of nucleotide metabolic process(GO:0045981) positive regulation of purine nucleotide metabolic process(GO:1900544) |
0.1 | 0.1 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
0.1 | 1.3 | GO:0007229 | integrin-mediated signaling pathway(GO:0007229) |
0.1 | 0.2 | GO:0002155 | thyroid hormone mediated signaling pathway(GO:0002154) regulation of thyroid hormone mediated signaling pathway(GO:0002155) |
0.1 | 19.9 | GO:0055114 | oxidation-reduction process(GO:0055114) |
0.1 | 0.2 | GO:0090189 | regulation of branching involved in ureteric bud morphogenesis(GO:0090189) |
0.1 | 0.1 | GO:0007199 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger(GO:0007199) |
0.1 | 0.1 | GO:0002238 | response to molecule of fungal origin(GO:0002238) |
0.1 | 0.2 | GO:0002755 | MyD88-dependent toll-like receptor signaling pathway(GO:0002755) |
0.1 | 0.1 | GO:0060968 | regulation of posttranscriptional gene silencing(GO:0060147) regulation of gene silencing by miRNA(GO:0060964) regulation of gene silencing by RNA(GO:0060966) regulation of gene silencing(GO:0060968) positive regulation of gene silencing by miRNA(GO:2000637) |
0.1 | 0.1 | GO:0046716 | muscle cell cellular homeostasis(GO:0046716) |
0.1 | 0.1 | GO:0060019 | radial glial cell differentiation(GO:0060019) |
0.1 | 0.7 | GO:0043267 | negative regulation of potassium ion transport(GO:0043267) |
0.1 | 0.8 | GO:0044042 | glycogen metabolic process(GO:0005977) cellular glucan metabolic process(GO:0006073) glucan metabolic process(GO:0044042) |
0.1 | 0.1 | GO:0008355 | olfactory learning(GO:0008355) |
0.1 | 0.1 | GO:0001692 | histamine metabolic process(GO:0001692) |
0.1 | 0.4 | GO:0010800 | positive regulation of peptidyl-threonine phosphorylation(GO:0010800) |
0.1 | 13.9 | GO:0006412 | translation(GO:0006412) |
0.1 | 9.6 | GO:0019236 | response to pheromone(GO:0019236) |
0.1 | 0.5 | GO:0048536 | spleen development(GO:0048536) |
0.1 | 0.4 | GO:1904385 | cellular response to angiotensin(GO:1904385) response to angiotensin(GO:1990776) |
0.1 | 0.1 | GO:0043687 | post-translational protein modification(GO:0043687) |
0.1 | 0.2 | GO:0034501 | protein localization to kinetochore(GO:0034501) protein localization to chromosome, centromeric region(GO:0071459) |
0.1 | 0.3 | GO:0040029 | regulation of gene expression, epigenetic(GO:0040029) |
0.1 | 0.2 | GO:0060216 | definitive hemopoiesis(GO:0060216) |
0.1 | 0.5 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
0.1 | 0.1 | GO:0033686 | positive regulation of luteinizing hormone secretion(GO:0033686) |
0.1 | 0.1 | GO:0044062 | regulation of excretion(GO:0044062) |
0.1 | 0.2 | GO:0030202 | heparin metabolic process(GO:0030202) |
0.1 | 0.9 | GO:0051092 | positive regulation of NF-kappaB transcription factor activity(GO:0051092) |
0.1 | 0.1 | GO:0032703 | negative regulation of interleukin-2 production(GO:0032703) |
0.1 | 0.1 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.1 | 0.4 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
0.1 | 0.1 | GO:2000737 | negative regulation of stem cell differentiation(GO:2000737) |
0.1 | 1.3 | GO:0006909 | phagocytosis(GO:0006909) |
0.1 | 0.1 | GO:0010799 | regulation of peptidyl-threonine phosphorylation(GO:0010799) |
0.1 | 0.1 | GO:0006553 | lysine metabolic process(GO:0006553) |
0.1 | 0.2 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.1 | 0.3 | GO:0032515 | negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
0.1 | 3.7 | GO:0044782 | cilium organization(GO:0044782) |
0.1 | 0.1 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
0.1 | 0.1 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
0.1 | 0.1 | GO:0006805 | xenobiotic metabolic process(GO:0006805) |
0.1 | 3.2 | GO:0001701 | in utero embryonic development(GO:0001701) |
0.1 | 0.1 | GO:0009448 | gamma-aminobutyric acid metabolic process(GO:0009448) |
0.1 | 0.1 | GO:1905144 | acetylcholine receptor signaling pathway(GO:0095500) postsynaptic signal transduction(GO:0098926) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
0.1 | 0.1 | GO:0042274 | ribosomal small subunit biogenesis(GO:0042274) |
0.0 | 0.0 | GO:0002294 | CD4-positive, alpha-beta T cell differentiation involved in immune response(GO:0002294) T-helper cell differentiation(GO:0042093) |
0.0 | 0.2 | GO:0014044 | Schwann cell development(GO:0014044) |
0.0 | 0.0 | GO:0006103 | 2-oxoglutarate metabolic process(GO:0006103) |
0.0 | 1.6 | GO:0006954 | inflammatory response(GO:0006954) |
0.0 | 0.4 | GO:1904018 | positive regulation of vasculature development(GO:1904018) |
0.0 | 0.0 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
0.0 | 0.4 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
0.0 | 0.0 | GO:1902866 | regulation of retina development in camera-type eye(GO:1902866) |
0.0 | 0.1 | GO:0009142 | nucleoside triphosphate biosynthetic process(GO:0009142) |
0.0 | 0.4 | GO:0030512 | negative regulation of transforming growth factor beta receptor signaling pathway(GO:0030512) negative regulation of cellular response to transforming growth factor beta stimulus(GO:1903845) |
0.0 | 0.1 | GO:0045577 | regulation of B cell differentiation(GO:0045577) |
0.0 | 39.5 | GO:0007606 | sensory perception of chemical stimulus(GO:0007606) |
0.0 | 0.0 | GO:0033688 | regulation of osteoblast proliferation(GO:0033688) |
0.0 | 0.0 | GO:0033631 | cell-cell adhesion mediated by integrin(GO:0033631) |
0.0 | 0.1 | GO:0033563 | dorsal/ventral axon guidance(GO:0033563) |
0.0 | 2.7 | GO:0007283 | spermatogenesis(GO:0007283) male gamete generation(GO:0048232) |
0.0 | 0.0 | GO:0042634 | regulation of hair cycle(GO:0042634) |
0.0 | 0.1 | GO:0015747 | urate transport(GO:0015747) |
0.0 | 0.0 | GO:0009068 | aspartate family amino acid catabolic process(GO:0009068) |
0.0 | 0.1 | GO:0007406 | negative regulation of neuroblast proliferation(GO:0007406) |
0.0 | 0.1 | GO:0016053 | organic acid biosynthetic process(GO:0016053) carboxylic acid biosynthetic process(GO:0046394) |
0.0 | 0.0 | GO:0097113 | AMPA glutamate receptor clustering(GO:0097113) glutamate receptor clustering(GO:0097688) |
0.0 | 0.3 | GO:0007030 | Golgi organization(GO:0007030) |
0.0 | 0.0 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.0 | 0.0 | GO:0032675 | regulation of interleukin-6 production(GO:0032675) |
0.0 | 0.0 | GO:0030823 | regulation of cGMP metabolic process(GO:0030823) |
0.0 | 0.0 | GO:0009066 | aspartate family amino acid metabolic process(GO:0009066) |
0.0 | 0.0 | GO:1902600 | hydrogen ion transmembrane transport(GO:1902600) |
0.0 | 0.1 | GO:0009615 | response to virus(GO:0009615) |
0.0 | 0.0 | GO:0071435 | potassium ion export(GO:0071435) |
0.0 | 0.0 | GO:0061469 | regulation of type B pancreatic cell proliferation(GO:0061469) |
0.0 | 0.0 | GO:0072524 | pyridine-containing compound metabolic process(GO:0072524) |
0.0 | 0.0 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
7.3 | 21.8 | GO:0097629 | extrinsic component of omegasome membrane(GO:0097629) |
5.9 | 17.8 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
5.8 | 23.1 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
5.4 | 27.1 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
5.1 | 35.9 | GO:0034366 | spherical high-density lipoprotein particle(GO:0034366) |
5.1 | 10.2 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
5.1 | 30.4 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
5.0 | 29.9 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
4.6 | 18.4 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
4.3 | 25.7 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
4.1 | 16.5 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
4.1 | 12.3 | GO:0071818 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
4.1 | 24.6 | GO:0042627 | chylomicron(GO:0042627) |
3.8 | 15.3 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
3.7 | 11.0 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
3.6 | 3.6 | GO:0097427 | microtubule bundle(GO:0097427) |
3.5 | 10.4 | GO:0032127 | dense core granule membrane(GO:0032127) |
3.3 | 16.4 | GO:0033093 | Weibel-Palade body(GO:0033093) |
3.1 | 9.4 | GO:0005833 | hemoglobin complex(GO:0005833) |
3.1 | 21.8 | GO:0005577 | fibrinogen complex(GO:0005577) |
3.1 | 9.2 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
2.9 | 2.9 | GO:0097422 | tubular endosome(GO:0097422) |
2.9 | 2.9 | GO:0098827 | endoplasmic reticulum subcompartment(GO:0098827) |
2.8 | 22.6 | GO:0005677 | chromatin silencing complex(GO:0005677) |
2.8 | 28.1 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
2.8 | 13.9 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
2.8 | 8.4 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
2.8 | 8.3 | GO:0005899 | insulin receptor complex(GO:0005899) |
2.7 | 10.9 | GO:0097425 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
2.7 | 10.9 | GO:1990130 | Iml1 complex(GO:1990130) |
2.7 | 8.1 | GO:0097057 | TRAF2-GSTP1 complex(GO:0097057) |
2.7 | 10.7 | GO:0031094 | platelet dense tubular network(GO:0031094) |
2.6 | 18.2 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
2.6 | 20.5 | GO:0043203 | axon hillock(GO:0043203) |
2.5 | 12.7 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
2.5 | 12.4 | GO:0030870 | Mre11 complex(GO:0030870) |
2.4 | 9.6 | GO:0030130 | clathrin coat of trans-Golgi network vesicle(GO:0030130) |
2.4 | 7.1 | GO:0036488 | CHOP-C/EBP complex(GO:0036488) |
2.3 | 7.0 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
2.3 | 6.9 | GO:0097443 | sorting endosome(GO:0097443) |
2.3 | 4.6 | GO:0016272 | prefoldin complex(GO:0016272) |
2.2 | 6.7 | GO:0097451 | glial limiting end-foot(GO:0097451) |
2.2 | 11.0 | GO:0044326 | dendritic spine neck(GO:0044326) |
2.2 | 8.7 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
2.2 | 10.8 | GO:0005828 | kinetochore microtubule(GO:0005828) |
2.2 | 2.2 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
2.1 | 8.5 | GO:0030478 | actin cap(GO:0030478) |
2.1 | 19.2 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
2.1 | 4.2 | GO:0031523 | Myb complex(GO:0031523) |
2.1 | 4.2 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
2.1 | 29.2 | GO:0000421 | autophagosome membrane(GO:0000421) |
2.1 | 8.2 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
2.1 | 10.3 | GO:0044294 | dendritic growth cone(GO:0044294) |
2.0 | 8.0 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
2.0 | 5.9 | GO:0030125 | clathrin vesicle coat(GO:0030125) |
2.0 | 11.8 | GO:0000796 | condensin complex(GO:0000796) |
2.0 | 23.5 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
2.0 | 5.9 | GO:0042583 | chromaffin granule(GO:0042583) |
1.9 | 9.5 | GO:0031983 | vesicle lumen(GO:0031983) |
1.9 | 15.1 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
1.9 | 20.8 | GO:0031616 | spindle pole centrosome(GO:0031616) |
1.9 | 5.6 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
1.9 | 7.5 | GO:0097440 | apical dendrite(GO:0097440) |
1.8 | 110.8 | GO:0000118 | histone deacetylase complex(GO:0000118) |
1.8 | 3.7 | GO:0031595 | nuclear proteasome complex(GO:0031595) |
1.8 | 3.7 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
1.8 | 23.8 | GO:0019898 | extrinsic component of membrane(GO:0019898) |
1.8 | 5.5 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
1.8 | 74.0 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
1.8 | 12.5 | GO:0005901 | caveola(GO:0005901) |
1.8 | 12.4 | GO:0002102 | podosome(GO:0002102) |
1.8 | 8.8 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
1.8 | 7.0 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
1.7 | 8.7 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
1.7 | 3.5 | GO:0002142 | stereocilia ankle link complex(GO:0002142) |
1.7 | 1.7 | GO:0032592 | integral component of mitochondrial membrane(GO:0032592) |
1.7 | 20.3 | GO:0045239 | tricarboxylic acid cycle enzyme complex(GO:0045239) |
1.7 | 1.7 | GO:0043220 | Schmidt-Lanterman incisure(GO:0043220) |
1.6 | 4.9 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
1.6 | 35.4 | GO:0055038 | recycling endosome membrane(GO:0055038) |
1.6 | 3.2 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
1.6 | 6.4 | GO:0072487 | MSL complex(GO:0072487) |
1.6 | 8.0 | GO:0016461 | unconventional myosin complex(GO:0016461) |
1.6 | 1.6 | GO:0098799 | outer mitochondrial membrane protein complex(GO:0098799) |
1.6 | 11.2 | GO:0031931 | TORC1 complex(GO:0031931) |
1.6 | 22.0 | GO:0001891 | phagocytic cup(GO:0001891) |
1.6 | 4.7 | GO:0097255 | R2TP complex(GO:0097255) |
1.6 | 21.7 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
1.5 | 10.7 | GO:0043219 | lateral loop(GO:0043219) |
1.5 | 13.7 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
1.5 | 35.1 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
1.5 | 4.6 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
1.5 | 9.1 | GO:0000812 | Swr1 complex(GO:0000812) |
1.5 | 7.6 | GO:0005683 | U7 snRNP(GO:0005683) |
1.5 | 7.6 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
1.5 | 19.6 | GO:0005753 | mitochondrial proton-transporting ATP synthase complex(GO:0005753) |
1.5 | 4.5 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
1.5 | 6.0 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
1.5 | 4.5 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
1.5 | 4.5 | GO:0071141 | SMAD protein complex(GO:0071141) |
1.5 | 13.4 | GO:0097208 | alveolar lamellar body(GO:0097208) |
1.5 | 10.4 | GO:0070688 | MLL5-L complex(GO:0070688) |
1.5 | 3.0 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
1.5 | 4.4 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
1.5 | 1.5 | GO:0030119 | AP-type membrane coat adaptor complex(GO:0030119) |
1.5 | 5.9 | GO:0071203 | WASH complex(GO:0071203) |
1.5 | 10.2 | GO:0044666 | MLL3/4 complex(GO:0044666) |
1.5 | 13.1 | GO:0005869 | dynactin complex(GO:0005869) |
1.4 | 14.5 | GO:0046581 | intercellular canaliculus(GO:0046581) |
1.4 | 63.5 | GO:0031228 | intrinsic component of Golgi membrane(GO:0031228) |
1.4 | 27.4 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
1.4 | 60.4 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
1.4 | 2.9 | GO:0034679 | integrin alpha9-beta1 complex(GO:0034679) |
1.4 | 7.1 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
1.4 | 4.2 | GO:0035838 | growing cell tip(GO:0035838) |
1.4 | 15.4 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
1.4 | 60.1 | GO:0009295 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
1.4 | 22.1 | GO:0030904 | retromer complex(GO:0030904) |
1.4 | 4.1 | GO:0097512 | cardiac myofibril(GO:0097512) |
1.4 | 46.5 | GO:0016592 | mediator complex(GO:0016592) |
1.4 | 4.1 | GO:0090661 | box H/ACA telomerase RNP complex(GO:0090661) |
1.4 | 13.6 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
1.4 | 6.8 | GO:0001651 | dense fibrillar component(GO:0001651) |
1.4 | 12.2 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
1.4 | 9.5 | GO:0045179 | apical cortex(GO:0045179) |
1.3 | 4.0 | GO:0044354 | pinosome(GO:0044352) macropinosome(GO:0044354) |
1.3 | 9.4 | GO:0042382 | paraspeckles(GO:0042382) |
1.3 | 1.3 | GO:1990423 | RZZ complex(GO:1990423) |
1.3 | 27.7 | GO:0005719 | nuclear euchromatin(GO:0005719) |
1.3 | 6.5 | GO:0031932 | TORC2 complex(GO:0031932) |
1.3 | 3.9 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
1.3 | 12.8 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
1.3 | 6.4 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
1.3 | 1.3 | GO:0032010 | phagolysosome(GO:0032010) |
1.3 | 67.4 | GO:0005811 | lipid particle(GO:0005811) |
1.3 | 10.2 | GO:0015629 | actin cytoskeleton(GO:0015629) |
1.3 | 25.4 | GO:0035145 | exon-exon junction complex(GO:0035145) |
1.3 | 5.1 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
1.3 | 3.8 | GO:0000322 | storage vacuole(GO:0000322) |
1.3 | 3.8 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
1.3 | 2.5 | GO:0044233 | ER-mitochondrion membrane contact site(GO:0044233) |
1.3 | 3.8 | GO:0097413 | Lewy body(GO:0097413) |
1.2 | 1.2 | GO:0061574 | ASAP complex(GO:0061574) |
1.2 | 25.9 | GO:0030863 | cortical cytoskeleton(GO:0030863) |
1.2 | 2.5 | GO:0033177 | proton-transporting two-sector ATPase complex, proton-transporting domain(GO:0033177) |
1.2 | 1.2 | GO:0000125 | PCAF complex(GO:0000125) |
1.2 | 4.9 | GO:0035339 | SPOTS complex(GO:0035339) |
1.2 | 4.9 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
1.2 | 7.3 | GO:0042587 | glycogen granule(GO:0042587) |
1.2 | 2.4 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
1.2 | 37.6 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
1.2 | 4.8 | GO:0045298 | tubulin complex(GO:0045298) |
1.2 | 17.8 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
1.2 | 23.7 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
1.2 | 7.1 | GO:0022624 | proteasome accessory complex(GO:0022624) |
1.2 | 10.7 | GO:0000346 | transcription export complex(GO:0000346) |
1.2 | 3.5 | GO:0000811 | GINS complex(GO:0000811) |
1.2 | 7.1 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
1.2 | 5.8 | GO:0005638 | lamin filament(GO:0005638) |
1.2 | 5.8 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
1.2 | 7.0 | GO:0072687 | meiotic spindle(GO:0072687) |
1.2 | 10.5 | GO:0000813 | ESCRT I complex(GO:0000813) |
1.2 | 12.8 | GO:0000974 | Prp19 complex(GO:0000974) |
1.2 | 8.1 | GO:0032591 | dendritic spine membrane(GO:0032591) |
1.2 | 3.5 | GO:0042612 | MHC class I protein complex(GO:0042612) |
1.1 | 12.6 | GO:0032039 | integrator complex(GO:0032039) |
1.1 | 8.0 | GO:0030667 | secretory granule membrane(GO:0030667) |
1.1 | 2.3 | GO:0000835 | ER ubiquitin ligase complex(GO:0000835) Hrd1p ubiquitin ligase complex(GO:0000836) |
1.1 | 16.9 | GO:0030120 | vesicle coat(GO:0030120) |
1.1 | 36.0 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
1.1 | 4.5 | GO:0005642 | annulate lamellae(GO:0005642) |
1.1 | 52.4 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
1.1 | 14.5 | GO:0071565 | nBAF complex(GO:0071565) |
1.1 | 6.7 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
1.1 | 10.0 | GO:0000815 | ESCRT III complex(GO:0000815) |
1.1 | 4.4 | GO:0070545 | PeBoW complex(GO:0070545) |
1.1 | 19.9 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
1.1 | 4.4 | GO:0071439 | clathrin complex(GO:0071439) |
1.1 | 8.8 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
1.1 | 25.3 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
1.1 | 5.5 | GO:0061700 | GATOR2 complex(GO:0061700) |
1.1 | 19.7 | GO:0044665 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
1.1 | 16.2 | GO:0045120 | pronucleus(GO:0045120) |
1.1 | 4.3 | GO:1990909 | Wnt signalosome(GO:1990909) |
1.1 | 3.2 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
1.1 | 3.2 | GO:1990923 | PET complex(GO:1990923) |
1.1 | 21.5 | GO:0035861 | site of double-strand break(GO:0035861) |
1.1 | 8.6 | GO:0090544 | BAF-type complex(GO:0090544) |
1.1 | 6.4 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
1.1 | 16.0 | GO:0032587 | ruffle membrane(GO:0032587) |
1.1 | 4.3 | GO:0033063 | Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
1.1 | 14.9 | GO:0005682 | U5 snRNP(GO:0005682) |
1.1 | 4.2 | GO:0045098 | type III intermediate filament(GO:0045098) |
1.1 | 27.5 | GO:0009925 | basal plasma membrane(GO:0009925) |
1.1 | 1.1 | GO:0043218 | compact myelin(GO:0043218) |
1.0 | 36.5 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
1.0 | 50.6 | GO:0016363 | nuclear matrix(GO:0016363) |
1.0 | 2.1 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
1.0 | 7.2 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
1.0 | 2.0 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
1.0 | 6.1 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
1.0 | 128.1 | GO:0000139 | Golgi membrane(GO:0000139) |
1.0 | 4.1 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
1.0 | 14.9 | GO:0031907 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
1.0 | 49.5 | GO:0016605 | PML body(GO:0016605) |
1.0 | 2.0 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
1.0 | 7.9 | GO:0032797 | SMN complex(GO:0032797) |
1.0 | 4.8 | GO:0005927 | muscle tendon junction(GO:0005927) |
1.0 | 5.8 | GO:0005796 | Golgi lumen(GO:0005796) |
1.0 | 3.9 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
1.0 | 11.6 | GO:0005669 | transcription factor TFIID complex(GO:0005669) |
1.0 | 1.9 | GO:0005610 | laminin-5 complex(GO:0005610) |
1.0 | 16.2 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
0.9 | 2.8 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
0.9 | 2.8 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
0.9 | 1.9 | GO:0097431 | mitotic spindle pole(GO:0097431) |
0.9 | 83.6 | GO:0036064 | ciliary basal body(GO:0036064) |
0.9 | 0.9 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
0.9 | 9.2 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
0.9 | 2.7 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
0.9 | 3.7 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
0.9 | 2.7 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
0.9 | 10.9 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
0.9 | 14.4 | GO:0000145 | exocyst(GO:0000145) |
0.9 | 7.2 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.9 | 8.0 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
0.9 | 5.3 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
0.9 | 4.4 | GO:0033503 | HULC complex(GO:0033503) |
0.9 | 1.8 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
0.9 | 4.4 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
0.9 | 5.3 | GO:0034518 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.9 | 7.0 | GO:0036157 | outer dynein arm(GO:0036157) |
0.9 | 33.2 | GO:0005643 | nuclear pore(GO:0005643) |
0.9 | 5.2 | GO:0005916 | fascia adherens(GO:0005916) |
0.9 | 11.3 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.9 | 28.7 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.9 | 4.3 | GO:1990204 | oxidoreductase complex(GO:1990204) |
0.9 | 2.6 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.9 | 13.8 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.9 | 11.2 | GO:0031941 | filamentous actin(GO:0031941) |
0.9 | 0.9 | GO:0097433 | dense body(GO:0097433) |
0.9 | 1.7 | GO:0044393 | microspike(GO:0044393) |
0.9 | 1.7 | GO:0005955 | calcineurin complex(GO:0005955) |
0.9 | 1.7 | GO:0000805 | X chromosome(GO:0000805) |
0.9 | 7.7 | GO:0071004 | U2-type prespliceosome(GO:0071004) |
0.8 | 8.5 | GO:0031528 | microvillus membrane(GO:0031528) |
0.8 | 0.8 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
0.8 | 1.7 | GO:0071817 | MMXD complex(GO:0071817) |
0.8 | 1.7 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.8 | 4.2 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.8 | 6.6 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.8 | 25.6 | GO:0045335 | phagocytic vesicle(GO:0045335) |
0.8 | 15.7 | GO:0005776 | autophagosome(GO:0005776) |
0.8 | 1.6 | GO:0097452 | GAIT complex(GO:0097452) |
0.8 | 251.7 | GO:0005764 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.8 | 251.4 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
0.8 | 1.6 | GO:0070820 | tertiary granule(GO:0070820) |
0.8 | 13.6 | GO:0015030 | Cajal body(GO:0015030) |
0.8 | 61.6 | GO:0072562 | blood microparticle(GO:0072562) |
0.8 | 3.2 | GO:0032389 | MutLalpha complex(GO:0032389) |
0.8 | 3.2 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.8 | 9.6 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.8 | 6.4 | GO:0031209 | SCAR complex(GO:0031209) |
0.8 | 2.4 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.8 | 2.4 | GO:0000243 | commitment complex(GO:0000243) |
0.8 | 28.6 | GO:0005938 | cell cortex(GO:0005938) |
0.8 | 6.3 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
0.8 | 0.8 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
0.8 | 2.4 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
0.8 | 0.8 | GO:0032993 | protein-DNA complex(GO:0032993) |
0.8 | 0.8 | GO:0032432 | actin filament bundle(GO:0032432) |
0.8 | 1.6 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.8 | 3.9 | GO:0031091 | platelet alpha granule(GO:0031091) |
0.8 | 5.4 | GO:0000788 | nuclear nucleosome(GO:0000788) |
0.8 | 9.3 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.8 | 34.1 | GO:0031526 | brush border membrane(GO:0031526) |
0.8 | 2.3 | GO:0048179 | activin receptor complex(GO:0048179) |
0.8 | 8.4 | GO:0035371 | microtubule plus-end(GO:0035371) |
0.8 | 1.5 | GO:0033269 | internode region of axon(GO:0033269) |
0.8 | 0.8 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.8 | 3.8 | GO:0034709 | methylosome(GO:0034709) |
0.8 | 0.8 | GO:0036452 | ESCRT complex(GO:0036452) |
0.8 | 47.0 | GO:0005681 | spliceosomal complex(GO:0005681) |
0.8 | 2.3 | GO:0051233 | spindle midzone(GO:0051233) |
0.8 | 1.5 | GO:0044316 | cone cell pedicle(GO:0044316) |
0.8 | 24.1 | GO:0042641 | actomyosin(GO:0042641) |
0.8 | 12.8 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.7 | 2.2 | GO:0005849 | mRNA cleavage factor complex(GO:0005849) |
0.7 | 7.4 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.7 | 12.6 | GO:0035869 | ciliary transition zone(GO:0035869) |
0.7 | 2.2 | GO:0097149 | centralspindlin complex(GO:0097149) |
0.7 | 25.0 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.7 | 0.7 | GO:0002139 | stereocilia coupling link(GO:0002139) |
0.7 | 1.5 | GO:0010369 | chromocenter(GO:0010369) |
0.7 | 2.2 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.7 | 3.6 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.7 | 11.7 | GO:0005876 | spindle microtubule(GO:0005876) |
0.7 | 2.2 | GO:1990745 | EARP complex(GO:1990745) |
0.7 | 5.8 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.7 | 0.7 | GO:0034361 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
0.7 | 2.9 | GO:0089701 | U2AF(GO:0089701) |
0.7 | 1.4 | GO:0005579 | membrane attack complex(GO:0005579) |
0.7 | 2.1 | GO:0048500 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
0.7 | 14.2 | GO:0000502 | proteasome complex(GO:0000502) |
0.7 | 30.6 | GO:0005770 | late endosome(GO:0005770) |
0.7 | 2.1 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.7 | 0.7 | GO:0001652 | granular component(GO:0001652) |
0.7 | 3.5 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
0.7 | 4.2 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.7 | 15.3 | GO:0005903 | brush border(GO:0005903) |
0.7 | 21.6 | GO:0005762 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
0.7 | 2.1 | GO:0071953 | elastic fiber(GO:0071953) |
0.7 | 1.4 | GO:0044292 | dendrite terminus(GO:0044292) |
0.7 | 1.4 | GO:0005914 | spot adherens junction(GO:0005914) |
0.7 | 20.1 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.7 | 4.8 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
0.7 | 7.6 | GO:0005884 | actin filament(GO:0005884) |
0.7 | 1.4 | GO:0097470 | ribbon synapse(GO:0097470) |
0.7 | 2.1 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.7 | 18.5 | GO:0005795 | Golgi stack(GO:0005795) |
0.7 | 1.4 | GO:0033061 | DNA recombinase mediator complex(GO:0033061) |
0.7 | 2.0 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.7 | 64.1 | GO:0005777 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.7 | 12.2 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.7 | 2.7 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
0.7 | 2.0 | GO:0046691 | intracellular canaliculus(GO:0046691) |
0.7 | 40.5 | GO:0030496 | midbody(GO:0030496) |
0.7 | 103.7 | GO:0005925 | focal adhesion(GO:0005925) |
0.7 | 18.8 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
0.7 | 1.3 | GO:0030056 | hemidesmosome(GO:0030056) |
0.7 | 2.0 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.7 | 0.7 | GO:0035355 | Toll-like receptor 2-Toll-like receptor 6 protein complex(GO:0035355) |
0.7 | 0.7 | GO:0045177 | apical part of cell(GO:0045177) |
0.7 | 2.7 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
0.7 | 1.3 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.7 | 39.2 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.7 | 27.2 | GO:0016459 | myosin complex(GO:0016459) |
0.7 | 653.5 | GO:0005829 | cytosol(GO:0005829) |
0.7 | 1.3 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
0.7 | 1.3 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.7 | 2.6 | GO:0060091 | kinocilium(GO:0060091) |
0.7 | 17.0 | GO:0016591 | DNA-directed RNA polymerase II, holoenzyme(GO:0016591) |
0.6 | 3.9 | GO:0031970 | organelle envelope lumen(GO:0031970) |
0.6 | 0.6 | GO:0042585 | germinal vesicle(GO:0042585) |
0.6 | 18.5 | GO:0072372 | primary cilium(GO:0072372) |
0.6 | 0.6 | GO:0030175 | filopodium(GO:0030175) |
0.6 | 41.9 | GO:0000793 | condensed chromosome(GO:0000793) |
0.6 | 1.3 | GO:0044327 | dendritic spine head(GO:0044327) |
0.6 | 25.8 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.6 | 1.3 | GO:0001650 | fibrillar center(GO:0001650) |
0.6 | 10.7 | GO:0045171 | intercellular bridge(GO:0045171) |
0.6 | 22.9 | GO:0012505 | endomembrane system(GO:0012505) |
0.6 | 2.5 | GO:0098536 | deuterosome(GO:0098536) |
0.6 | 4.9 | GO:0043196 | varicosity(GO:0043196) |
0.6 | 0.6 | GO:0033270 | paranode region of axon(GO:0033270) |
0.6 | 3.1 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.6 | 1.8 | GO:0070876 | SOSS complex(GO:0070876) |
0.6 | 12.2 | GO:0001726 | ruffle(GO:0001726) |
0.6 | 1.2 | GO:0031298 | replication fork protection complex(GO:0031298) |
0.6 | 6.7 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.6 | 2.4 | GO:0000922 | spindle pole(GO:0000922) |
0.6 | 0.6 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
0.6 | 0.6 | GO:0005879 | axonemal microtubule(GO:0005879) |
0.6 | 3.5 | GO:0097386 | glial cell projection(GO:0097386) |
0.6 | 12.9 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.6 | 5.9 | GO:0072546 | ER membrane protein complex(GO:0072546) |
0.6 | 5.9 | GO:0005657 | replication fork(GO:0005657) |
0.6 | 12.3 | GO:0010008 | endosome membrane(GO:0010008) |
0.6 | 0.6 | GO:0097223 | sperm part(GO:0097223) |
0.6 | 0.6 | GO:0009279 | cell outer membrane(GO:0009279) cell envelope(GO:0030313) external encapsulating structure part(GO:0044462) |
0.6 | 1.2 | GO:0071797 | LUBAC complex(GO:0071797) |
0.6 | 1.7 | GO:0031417 | NatC complex(GO:0031417) |
0.6 | 1.2 | GO:0019815 | immunoglobulin complex(GO:0019814) B cell receptor complex(GO:0019815) |
0.6 | 0.6 | GO:0010009 | cytoplasmic side of endosome membrane(GO:0010009) |
0.6 | 1.7 | GO:0044232 | organelle membrane contact site(GO:0044232) |
0.6 | 535.7 | GO:0005654 | nucleoplasm(GO:0005654) |
0.6 | 0.6 | GO:0005915 | zonula adherens(GO:0005915) |
0.6 | 0.6 | GO:0005652 | nuclear lamina(GO:0005652) |
0.6 | 29.1 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
0.6 | 1.1 | GO:0034708 | methyltransferase complex(GO:0034708) |
0.6 | 3.3 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.5 | 3.3 | GO:0031519 | PcG protein complex(GO:0031519) |
0.5 | 2.7 | GO:0070852 | cell body fiber(GO:0070852) |
0.5 | 2.6 | GO:0000242 | pericentriolar material(GO:0000242) |
0.5 | 619.1 | GO:0070062 | extracellular exosome(GO:0070062) |
0.5 | 2.6 | GO:0070652 | HAUS complex(GO:0070652) |
0.5 | 8.8 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.5 | 1.5 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
0.5 | 2.0 | GO:0001520 | outer dense fiber(GO:0001520) |
0.5 | 0.5 | GO:0036454 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
0.5 | 2.4 | GO:0008305 | integrin complex(GO:0008305) |
0.5 | 87.3 | GO:0005730 | nucleolus(GO:0005730) |
0.5 | 1.4 | GO:0098636 | protein complex involved in cell adhesion(GO:0098636) |
0.5 | 2.8 | GO:0001772 | immunological synapse(GO:0001772) |
0.5 | 3.2 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.5 | 1.8 | GO:0031211 | palmitoyltransferase complex(GO:0002178) serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
0.5 | 59.6 | GO:0005815 | microtubule organizing center(GO:0005815) |
0.5 | 1.8 | GO:0031010 | ISWI-type complex(GO:0031010) |
0.5 | 0.5 | GO:0019867 | outer membrane(GO:0019867) |
0.4 | 0.4 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
0.4 | 1.8 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.4 | 1.7 | GO:0098642 | collagen type IV trimer(GO:0005587) network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) basement membrane collagen trimer(GO:0098651) |
0.4 | 11.6 | GO:0043234 | protein complex(GO:0043234) |
0.4 | 1.3 | GO:0016600 | flotillin complex(GO:0016600) |
0.4 | 1.6 | GO:0033202 | DNA helicase complex(GO:0033202) |
0.4 | 0.4 | GO:0033178 | proton-transporting two-sector ATPase complex, catalytic domain(GO:0033178) |
0.4 | 7.1 | GO:0000152 | nuclear ubiquitin ligase complex(GO:0000152) |
0.4 | 2.0 | GO:0098533 | ATPase dependent transmembrane transport complex(GO:0098533) ATPase complex(GO:1904949) |
0.4 | 1.6 | GO:0000808 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.4 | 0.4 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.4 | 0.4 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.4 | 3.1 | GO:0033391 | chromatoid body(GO:0033391) |
0.4 | 1.1 | GO:0034399 | nuclear periphery(GO:0034399) |
0.4 | 214.3 | GO:0005739 | mitochondrion(GO:0005739) |
0.4 | 30.1 | GO:0000785 | chromatin(GO:0000785) |
0.4 | 54.4 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.4 | 1.1 | GO:0031502 | dolichyl-phosphate-mannose-protein mannosyltransferase complex(GO:0031502) |
0.4 | 0.4 | GO:0000439 | core TFIIH complex(GO:0000439) |
0.4 | 24.6 | GO:0005694 | chromosome(GO:0005694) |
0.3 | 0.3 | GO:0097526 | spliceosomal tri-snRNP complex(GO:0097526) |
0.3 | 206.2 | GO:0005783 | endoplasmic reticulum(GO:0005783) |
0.3 | 0.3 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
0.3 | 18.9 | GO:0045111 | intermediate filament cytoskeleton(GO:0045111) |
0.3 | 4.0 | GO:0019866 | organelle inner membrane(GO:0019866) |
0.3 | 12.4 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.3 | 0.3 | GO:0097651 | phosphatidylinositol 3-kinase complex, class I(GO:0097651) |
0.3 | 4.9 | GO:0005604 | basement membrane(GO:0005604) |
0.3 | 34.8 | GO:0005667 | transcription factor complex(GO:0005667) |
0.3 | 1.6 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.3 | 0.3 | GO:1902911 | protein kinase complex(GO:1902911) |
0.3 | 0.9 | GO:0002177 | manchette(GO:0002177) |
0.3 | 2.2 | GO:0005861 | troponin complex(GO:0005861) |
0.3 | 1.2 | GO:1902555 | endoribonuclease complex(GO:1902555) |
0.3 | 1.2 | GO:0031988 | membrane-bounded vesicle(GO:0031988) |
0.3 | 0.6 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
0.3 | 1.8 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.3 | 1.2 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.3 | 2.9 | GO:0030286 | dynein complex(GO:0030286) |
0.3 | 4.1 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.3 | 2.0 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.3 | 0.3 | GO:0035749 | myelin sheath adaxonal region(GO:0035749) |
0.3 | 1.1 | GO:0030057 | desmosome(GO:0030057) |
0.3 | 0.6 | GO:0042555 | MCM complex(GO:0042555) |
0.3 | 0.3 | GO:0034464 | BBSome(GO:0034464) |
0.3 | 1.7 | GO:0005874 | microtubule(GO:0005874) |
0.3 | 0.8 | GO:0030027 | lamellipodium(GO:0030027) |
0.3 | 0.3 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.3 | 0.5 | GO:0043296 | apical junction complex(GO:0043296) |
0.2 | 7.2 | GO:0000151 | ubiquitin ligase complex(GO:0000151) |
0.2 | 10.6 | GO:0005581 | collagen trimer(GO:0005581) |
0.2 | 3.9 | GO:0005922 | connexon complex(GO:0005922) |
0.2 | 0.7 | GO:0032426 | stereocilium tip(GO:0032426) |
0.2 | 0.5 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
0.2 | 5.8 | GO:0009986 | cell surface(GO:0009986) |
0.2 | 0.7 | GO:0048770 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.2 | 1.3 | GO:0005732 | small nucleolar ribonucleoprotein complex(GO:0005732) |
0.2 | 0.4 | GO:0060170 | ciliary membrane(GO:0060170) |
0.2 | 0.6 | GO:0097225 | sperm midpiece(GO:0097225) |
0.2 | 0.2 | GO:0071437 | invadopodium(GO:0071437) |
0.2 | 0.2 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.2 | 19.8 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.2 | 0.6 | GO:0001673 | male germ cell nucleus(GO:0001673) |
0.2 | 0.2 | GO:0072534 | perineuronal net(GO:0072534) |
0.2 | 8.0 | GO:0001669 | acrosomal vesicle(GO:0001669) |
0.2 | 406.1 | GO:0005737 | cytoplasm(GO:0005737) |
0.2 | 0.2 | GO:0030312 | external encapsulating structure(GO:0030312) |
0.2 | 0.2 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.2 | 63.3 | GO:0005615 | extracellular space(GO:0005615) |
0.1 | 0.2 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.1 | 1.8 | GO:0016324 | apical plasma membrane(GO:0016324) |
0.1 | 300.0 | GO:0016020 | membrane(GO:0016020) |
0.1 | 0.1 | GO:0044447 | axoneme part(GO:0044447) |
0.0 | 0.0 | GO:0005819 | spindle(GO:0005819) |
0.0 | 13.8 | GO:0005576 | extracellular region(GO:0005576) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
13.3 | 39.8 | GO:0102007 | lactonohydrolase activity(GO:0046573) acyl-L-homoserine-lactone lactonohydrolase activity(GO:0102007) |
11.8 | 35.3 | GO:0005350 | purine nucleobase transmembrane transporter activity(GO:0005345) pyrimidine nucleobase transmembrane transporter activity(GO:0005350) nucleobase transmembrane transporter activity(GO:0015205) |
7.9 | 23.6 | GO:0031711 | bradykinin receptor binding(GO:0031711) |
7.2 | 21.5 | GO:0047623 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
6.9 | 20.8 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
6.6 | 19.9 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
6.3 | 18.8 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
6.1 | 24.3 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
5.6 | 22.5 | GO:0031721 | hemoglobin alpha binding(GO:0031721) |
5.5 | 16.6 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
5.5 | 22.1 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
5.3 | 37.3 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
4.9 | 14.8 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
4.9 | 34.2 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
4.7 | 4.7 | GO:0070538 | oleic acid binding(GO:0070538) |
4.6 | 13.9 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
4.5 | 13.6 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
4.5 | 13.5 | GO:0055100 | adiponectin binding(GO:0055100) |
4.5 | 13.4 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
4.3 | 17.2 | GO:0009374 | biotin binding(GO:0009374) |
4.1 | 16.6 | GO:0035615 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
4.1 | 12.4 | GO:0038181 | bile acid receptor activity(GO:0038181) |
4.1 | 12.3 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
4.1 | 24.5 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
4.0 | 19.9 | GO:0042015 | interleukin-20 binding(GO:0042015) |
3.9 | 7.9 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
3.8 | 22.8 | GO:0008199 | ferric iron binding(GO:0008199) |
3.7 | 15.0 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
3.7 | 11.2 | GO:0008142 | oxysterol binding(GO:0008142) |
3.7 | 33.0 | GO:0015194 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
3.6 | 14.4 | GO:0035276 | ethanol binding(GO:0035276) |
3.6 | 14.3 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
3.6 | 10.7 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
3.6 | 7.1 | GO:0070644 | vitamin D response element binding(GO:0070644) |
3.5 | 10.5 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
3.4 | 10.3 | GO:0004064 | arylesterase activity(GO:0004064) |
3.4 | 10.1 | GO:0019770 | IgG receptor activity(GO:0019770) |
3.4 | 10.1 | GO:1990460 | leptin receptor binding(GO:1990460) |
3.4 | 10.1 | GO:2001069 | glycogen binding(GO:2001069) |
3.4 | 10.1 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
3.3 | 23.4 | GO:0019966 | interleukin-1 binding(GO:0019966) |
3.3 | 9.9 | GO:0030350 | iron-responsive element binding(GO:0030350) |
3.3 | 13.1 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
3.2 | 9.7 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
3.2 | 25.8 | GO:0060229 | lipase activator activity(GO:0060229) |
3.2 | 9.6 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
3.2 | 6.4 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
3.2 | 9.5 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
3.1 | 22.0 | GO:0016443 | bidentate ribonuclease III activity(GO:0016443) |
3.1 | 9.4 | GO:0030492 | hemoglobin binding(GO:0030492) |
3.1 | 18.5 | GO:0043559 | insulin binding(GO:0043559) |
3.1 | 12.3 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
3.0 | 54.4 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
3.0 | 8.9 | GO:0070698 | type I activin receptor binding(GO:0070698) |
3.0 | 32.6 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
3.0 | 11.8 | GO:0004046 | aminoacylase activity(GO:0004046) |
2.9 | 29.5 | GO:0008432 | JUN kinase binding(GO:0008432) |
2.9 | 23.4 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
2.9 | 11.7 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
2.9 | 14.4 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
2.9 | 22.9 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
2.8 | 14.2 | GO:0070061 | fructose binding(GO:0070061) |
2.8 | 8.5 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
2.8 | 11.3 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
2.8 | 8.5 | GO:0080130 | L-phenylalanine:2-oxoglutarate aminotransferase activity(GO:0080130) |
2.8 | 11.1 | GO:0008430 | selenium binding(GO:0008430) |
2.8 | 5.5 | GO:0035175 | histone kinase activity (H3-S10 specific)(GO:0035175) |
2.7 | 16.4 | GO:0070324 | thyroid hormone binding(GO:0070324) |
2.7 | 16.3 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
2.7 | 10.7 | GO:0015232 | heme transporter activity(GO:0015232) |
2.7 | 8.0 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) |
2.6 | 15.8 | GO:0004768 | stearoyl-CoA 9-desaturase activity(GO:0004768) |
2.6 | 10.5 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
2.6 | 7.9 | GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
2.6 | 20.9 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
2.6 | 7.7 | GO:0004724 | magnesium-dependent protein serine/threonine phosphatase activity(GO:0004724) |
2.5 | 10.2 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
2.5 | 10.1 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
2.5 | 12.6 | GO:0070728 | leucine binding(GO:0070728) |
2.5 | 10.0 | GO:0004849 | uridine kinase activity(GO:0004849) |
2.5 | 7.4 | GO:0030620 | U2 snRNA binding(GO:0030620) |
2.5 | 7.4 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
2.4 | 2.4 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
2.4 | 9.7 | GO:0002060 | purine nucleobase binding(GO:0002060) |
2.4 | 9.7 | GO:0001224 | RNA polymerase II transcription cofactor binding(GO:0001224) |
2.4 | 16.9 | GO:0046790 | virion binding(GO:0046790) |
2.4 | 14.5 | GO:0003918 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
2.4 | 14.2 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
2.4 | 2.4 | GO:0051434 | BH3 domain binding(GO:0051434) |
2.4 | 7.1 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) DNA (cytosine-5-)-methyltransferase activity, acting on CpG substrates(GO:0051718) |
2.3 | 7.0 | GO:0015065 | uridine nucleotide receptor activity(GO:0015065) G-protein coupled pyrimidinergic nucleotide receptor activity(GO:0071553) |
2.3 | 9.3 | GO:0050693 | LBD domain binding(GO:0050693) |
2.3 | 9.3 | GO:0043515 | kinetochore binding(GO:0043515) |
2.3 | 7.0 | GO:0000171 | ribonuclease MRP activity(GO:0000171) |
2.3 | 2.3 | GO:0050692 | DBD domain binding(GO:0050692) |
2.3 | 4.6 | GO:0019957 | C-C chemokine binding(GO:0019957) |
2.3 | 6.9 | GO:0051033 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
2.3 | 6.9 | GO:0016880 | acid-ammonia (or amide) ligase activity(GO:0016880) |
2.3 | 9.2 | GO:0019145 | aminobutyraldehyde dehydrogenase activity(GO:0019145) 4-trimethylammoniobutyraldehyde dehydrogenase activity(GO:0047105) |
2.3 | 6.9 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
2.3 | 6.8 | GO:0005290 | L-histidine transmembrane transporter activity(GO:0005290) |
2.2 | 15.7 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
2.2 | 13.4 | GO:0050733 | RS domain binding(GO:0050733) |
2.2 | 2.2 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
2.2 | 22.1 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
2.2 | 4.4 | GO:0031720 | haptoglobin binding(GO:0031720) |
2.2 | 13.1 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
2.2 | 19.7 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
2.2 | 6.5 | GO:0005347 | ATP transmembrane transporter activity(GO:0005347) |
2.2 | 10.8 | GO:0000405 | bubble DNA binding(GO:0000405) |
2.1 | 8.6 | GO:0052794 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
2.1 | 12.9 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
2.1 | 6.4 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
2.1 | 2.1 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
2.1 | 12.6 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
2.1 | 10.4 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
2.1 | 2.1 | GO:0016289 | CoA hydrolase activity(GO:0016289) |
2.1 | 6.2 | GO:0015157 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
2.1 | 16.4 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
2.0 | 10.2 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
2.0 | 16.4 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
2.0 | 30.7 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
2.0 | 10.2 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
2.0 | 6.1 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
2.0 | 73.1 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
2.0 | 6.1 | GO:0035515 | oxidative RNA demethylase activity(GO:0035515) |
2.0 | 36.4 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
2.0 | 30.1 | GO:1900750 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
2.0 | 16.0 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
2.0 | 2.0 | GO:0070410 | co-SMAD binding(GO:0070410) |
2.0 | 11.9 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
2.0 | 9.9 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
2.0 | 41.3 | GO:0001221 | transcription cofactor binding(GO:0001221) |
2.0 | 70.6 | GO:0048487 | beta-tubulin binding(GO:0048487) |
1.9 | 3.9 | GO:0000403 | Y-form DNA binding(GO:0000403) |
1.9 | 5.8 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
1.9 | 3.8 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
1.9 | 26.9 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
1.9 | 15.3 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
1.9 | 1.9 | GO:1904680 | peptide transmembrane transporter activity(GO:1904680) |
1.9 | 13.3 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
1.9 | 7.5 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
1.9 | 7.5 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
1.9 | 5.6 | GO:0016401 | palmitoyl-CoA oxidase activity(GO:0016401) |
1.8 | 9.2 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
1.8 | 22.0 | GO:0017166 | vinculin binding(GO:0017166) |
1.8 | 1.8 | GO:0004549 | tRNA-specific ribonuclease activity(GO:0004549) |
1.8 | 3.6 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
1.8 | 10.9 | GO:0001104 | RNA polymerase II transcription cofactor activity(GO:0001104) |
1.8 | 9.1 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
1.8 | 5.4 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
1.8 | 5.4 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
1.8 | 7.2 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
1.8 | 9.0 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
1.8 | 32.1 | GO:0071949 | FAD binding(GO:0071949) |
1.8 | 23.1 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
1.8 | 5.3 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
1.8 | 17.6 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
1.8 | 26.4 | GO:0015106 | bicarbonate transmembrane transporter activity(GO:0015106) |
1.8 | 7.0 | GO:0045340 | mercury ion binding(GO:0045340) |
1.7 | 3.5 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
1.7 | 5.2 | GO:0004487 | methenyltetrahydrofolate cyclohydrolase activity(GO:0004477) methylenetetrahydrofolate dehydrogenase (NAD+) activity(GO:0004487) |
1.7 | 13.9 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
1.7 | 1.7 | GO:0089720 | caspase binding(GO:0089720) |
1.7 | 12.1 | GO:0017127 | cholesterol transporter activity(GO:0017127) |
1.7 | 8.6 | GO:1990239 | steroid hormone binding(GO:1990239) |
1.7 | 8.6 | GO:0005072 | transforming growth factor beta receptor, cytoplasmic mediator activity(GO:0005072) |
1.7 | 8.6 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
1.7 | 13.7 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
1.7 | 15.4 | GO:0004774 | succinate-CoA ligase activity(GO:0004774) |
1.7 | 1.7 | GO:0032552 | deoxyribonucleotide binding(GO:0032552) |
1.7 | 8.5 | GO:0004445 | inositol-polyphosphate 5-phosphatase activity(GO:0004445) |
1.7 | 1.7 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
1.7 | 8.5 | GO:0030291 | protein serine/threonine kinase inhibitor activity(GO:0030291) |
1.7 | 8.4 | GO:0034416 | bisphosphoglycerate phosphatase activity(GO:0034416) |
1.7 | 8.4 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
1.7 | 16.7 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
1.7 | 13.3 | GO:0043996 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
1.6 | 16.5 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
1.6 | 28.0 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
1.6 | 3.3 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
1.6 | 1.6 | GO:0004698 | calcium-dependent protein kinase C activity(GO:0004698) |
1.6 | 3.3 | GO:0034648 | histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
1.6 | 4.9 | GO:0070137 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
1.6 | 1.6 | GO:0017098 | sulfonylurea receptor binding(GO:0017098) |
1.6 | 4.8 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
1.6 | 11.2 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
1.6 | 1.6 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
1.6 | 6.4 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
1.6 | 4.8 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
1.6 | 34.8 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
1.6 | 6.3 | GO:0005329 | dopamine transmembrane transporter activity(GO:0005329) |
1.6 | 9.5 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
1.6 | 6.3 | GO:0050897 | cobalt ion binding(GO:0050897) |
1.6 | 15.7 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
1.6 | 9.4 | GO:0043426 | MRF binding(GO:0043426) |
1.6 | 14.1 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
1.6 | 6.2 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
1.5 | 4.6 | GO:0022833 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
1.5 | 6.2 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
1.5 | 3.0 | GO:0016803 | ether hydrolase activity(GO:0016803) |
1.5 | 21.3 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
1.5 | 4.5 | GO:0015116 | sulfate transmembrane transporter activity(GO:0015116) |
1.5 | 3.0 | GO:0030984 | kininogen binding(GO:0030984) |
1.5 | 3.0 | GO:0035673 | oligopeptide transmembrane transporter activity(GO:0035673) |
1.5 | 7.5 | GO:0005168 | neurotrophin TRKA receptor binding(GO:0005168) |
1.5 | 6.0 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
1.5 | 19.5 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
1.5 | 5.9 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
1.5 | 11.8 | GO:0050649 | testosterone 6-beta-hydroxylase activity(GO:0050649) |
1.5 | 47.2 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
1.5 | 5.9 | GO:0051525 | NFAT protein binding(GO:0051525) |
1.5 | 4.4 | GO:0008732 | threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
1.5 | 13.2 | GO:0004438 | phosphatidylinositol-3-phosphatase activity(GO:0004438) |
1.5 | 14.6 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
1.5 | 5.8 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
1.5 | 10.2 | GO:0016892 | endoribonuclease activity, producing 3'-phosphomonoesters(GO:0016892) |
1.4 | 17.3 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
1.4 | 4.3 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
1.4 | 11.5 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
1.4 | 1.4 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
1.4 | 11.5 | GO:0016894 | endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 3'-phosphomonoesters(GO:0016894) |
1.4 | 2.8 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
1.4 | 2.8 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
1.4 | 86.1 | GO:0051087 | chaperone binding(GO:0051087) |
1.4 | 4.2 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
1.4 | 7.0 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
1.4 | 1.4 | GO:0032135 | DNA insertion or deletion binding(GO:0032135) |
1.4 | 4.2 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
1.4 | 19.5 | GO:0005521 | lamin binding(GO:0005521) |
1.4 | 20.9 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
1.4 | 4.2 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
1.4 | 24.8 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
1.4 | 2.7 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
1.4 | 4.1 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
1.4 | 9.5 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
1.4 | 5.4 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
1.4 | 4.1 | GO:0015645 | fatty acid ligase activity(GO:0015645) |
1.4 | 38.0 | GO:0097472 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) cyclin-dependent protein kinase activity(GO:0097472) |
1.4 | 146.2 | GO:0017137 | Rab GTPase binding(GO:0017137) |
1.3 | 6.7 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
1.3 | 4.0 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
1.3 | 25.5 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
1.3 | 4.0 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
1.3 | 22.8 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
1.3 | 2.7 | GO:0016748 | succinyltransferase activity(GO:0016748) N-succinyltransferase activity(GO:0016749) |
1.3 | 4.0 | GO:1990405 | protein antigen binding(GO:1990405) |
1.3 | 4.0 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
1.3 | 1.3 | GO:0097157 | pre-mRNA intronic binding(GO:0097157) |
1.3 | 8.0 | GO:0001094 | TFIID-class transcription factor binding(GO:0001094) |
1.3 | 1.3 | GO:0036222 | dITP diphosphatase activity(GO:0035870) XTP diphosphatase activity(GO:0036222) |
1.3 | 17.1 | GO:0005123 | death receptor binding(GO:0005123) |
1.3 | 3.9 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
1.3 | 3.9 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
1.3 | 3.9 | GO:0036033 | mediator complex binding(GO:0036033) |
1.3 | 3.9 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
1.3 | 5.1 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
1.3 | 7.7 | GO:0051787 | misfolded protein binding(GO:0051787) |
1.3 | 8.9 | GO:0010485 | H4 histone acetyltransferase activity(GO:0010485) |
1.3 | 17.8 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
1.3 | 12.6 | GO:0004568 | chitinase activity(GO:0004568) |
1.3 | 7.5 | GO:0043786 | enoyl-[acyl-carrier-protein] reductase activity(GO:0016631) 2,3-dihydroxy-2,3-dihydro-phenylpropionate dehydrogenase activity(GO:0018498) cis-2,3-dihydrodiol DDT dehydrogenase activity(GO:0018499) trans-9R,10R-dihydrodiolphenanthrene dehydrogenase activity(GO:0018500) cis-chlorobenzene dihydrodiol dehydrogenase activity(GO:0018501) 2,5-dichloro-2,5-cyclohexadiene-1,4-diol dehydrogenase activity(GO:0018502) trans-1,2-dihydrodiolphenanthrene dehydrogenase activity(GO:0018503) 3,4-dihydroxy-3,4-dihydrofluorene dehydrogenase activity(GO:0034790) benzo(a)pyrene-trans-11,12-dihydrodiol dehydrogenase activity(GO:0034805) benzo(a)pyrene-cis-4,5-dihydrodiol dehydrogenase activity(GO:0034809) citronellyl-CoA dehydrogenase activity(GO:0034824) menthone dehydrogenase activity(GO:0034838) phthalate 3,4-cis-dihydrodiol dehydrogenase activity(GO:0034912) cinnamate reductase activity(GO:0043786) NADPH-dependent curcumin reductase activity(GO:0052849) NADPH-dependent dihydrocurcumin reductase activity(GO:0052850) |
1.3 | 36.4 | GO:0004177 | aminopeptidase activity(GO:0004177) |
1.2 | 6.2 | GO:0031419 | cobalamin binding(GO:0031419) |
1.2 | 8.7 | GO:0015321 | sodium:phosphate symporter activity(GO:0005436) sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
1.2 | 5.0 | GO:0031779 | melanocortin receptor binding(GO:0031779) type 3 melanocortin receptor binding(GO:0031781) type 4 melanocortin receptor binding(GO:0031782) |
1.2 | 5.0 | GO:0005534 | galactose binding(GO:0005534) |
1.2 | 8.7 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
1.2 | 7.4 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
1.2 | 2.4 | GO:0070717 | poly-purine tract binding(GO:0070717) |
1.2 | 3.7 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
1.2 | 3.6 | GO:0004515 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
1.2 | 13.3 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
1.2 | 15.7 | GO:0008307 | structural constituent of muscle(GO:0008307) |
1.2 | 9.7 | GO:0001608 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
1.2 | 15.7 | GO:0008519 | ammonium transmembrane transporter activity(GO:0008519) |
1.2 | 6.0 | GO:0098811 | transcriptional activator activity, RNA polymerase II transcription factor binding(GO:0001190) transcriptional repressor activity, RNA polymerase II activating transcription factor binding(GO:0098811) |
1.2 | 11.9 | GO:0043274 | phospholipase binding(GO:0043274) |
1.2 | 5.9 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
1.2 | 2.4 | GO:0050051 | leukotriene-B4 20-monooxygenase activity(GO:0050051) |
1.2 | 4.7 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
1.2 | 5.9 | GO:0016936 | galactoside binding(GO:0016936) |
1.2 | 14.1 | GO:0019206 | nucleoside kinase activity(GO:0019206) |
1.2 | 5.9 | GO:0000828 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) inositol hexakisphosphate 1-kinase activity(GO:0052723) inositol hexakisphosphate 3-kinase activity(GO:0052724) |
1.2 | 3.5 | GO:0004103 | choline kinase activity(GO:0004103) |
1.2 | 3.5 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
1.2 | 3.5 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
1.2 | 2.3 | GO:0031994 | insulin-like growth factor I binding(GO:0031994) |
1.2 | 5.8 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
1.2 | 4.6 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) fructose-2,6-bisphosphate 2-phosphatase activity(GO:0004331) |
1.2 | 3.5 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
1.2 | 3.5 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
1.2 | 20.8 | GO:0017025 | TBP-class protein binding(GO:0017025) |
1.2 | 2.3 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
1.2 | 6.9 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
1.2 | 3.5 | GO:0071209 | U7 snRNA binding(GO:0071209) |
1.1 | 4.6 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
1.1 | 3.4 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
1.1 | 3.4 | GO:0042979 | ornithine decarboxylase regulator activity(GO:0042979) |
1.1 | 50.3 | GO:0003684 | damaged DNA binding(GO:0003684) |
1.1 | 4.6 | GO:0070492 | oligosaccharide binding(GO:0070492) |
1.1 | 3.4 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
1.1 | 8.0 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
1.1 | 2.3 | GO:0004779 | sulfate adenylyltransferase activity(GO:0004779) |
1.1 | 6.8 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
1.1 | 3.4 | GO:0045294 | alpha-catenin binding(GO:0045294) |
1.1 | 2.2 | GO:0016015 | morphogen activity(GO:0016015) |
1.1 | 6.7 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
1.1 | 2.2 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
1.1 | 5.6 | GO:0008417 | fucosyltransferase activity(GO:0008417) |
1.1 | 6.7 | GO:0016830 | carbon-carbon lyase activity(GO:0016830) |
1.1 | 1.1 | GO:0050816 | phosphothreonine binding(GO:0050816) |
1.1 | 2.2 | GO:0034618 | arginine binding(GO:0034618) |
1.1 | 1.1 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) |
1.1 | 2.2 | GO:0004938 | alpha2-adrenergic receptor activity(GO:0004938) |
1.1 | 19.9 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
1.1 | 1.1 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
1.1 | 2.2 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
1.1 | 12.1 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
1.1 | 20.9 | GO:0017069 | snRNA binding(GO:0017069) |
1.1 | 1.1 | GO:0030284 | estrogen receptor activity(GO:0030284) |
1.1 | 6.6 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
1.1 | 1.1 | GO:0016532 | superoxide dismutase copper chaperone activity(GO:0016532) |
1.1 | 2.2 | GO:0008192 | RNA guanylyltransferase activity(GO:0008192) |
1.1 | 9.8 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
1.1 | 3.2 | GO:0004459 | lactate dehydrogenase activity(GO:0004457) L-lactate dehydrogenase activity(GO:0004459) |
1.1 | 21.6 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
1.1 | 4.3 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
1.1 | 10.8 | GO:0005451 | monovalent cation:proton antiporter activity(GO:0005451) |
1.1 | 4.3 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
1.1 | 16.2 | GO:0017049 | GTP-Rho binding(GO:0017049) |
1.1 | 4.3 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
1.1 | 9.6 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
1.1 | 4.3 | GO:0034235 | GPI anchor binding(GO:0034235) |
1.1 | 16.9 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
1.1 | 3.2 | GO:0004967 | glucagon receptor activity(GO:0004967) |
1.1 | 10.5 | GO:0034869 | 2-oxoglutaryl-CoA thioesterase activity(GO:0034843) 2,4,4-trimethyl-3-oxopentanoyl-CoA thioesterase activity(GO:0034869) 3-isopropylbut-3-enoyl-CoA thioesterase activity(GO:0034946) glutaryl-CoA hydrolase activity(GO:0044466) |
1.1 | 27.3 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
1.0 | 18.8 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
1.0 | 3.1 | GO:0031748 | D1 dopamine receptor binding(GO:0031748) |
1.0 | 11.4 | GO:0034185 | apolipoprotein binding(GO:0034185) |
1.0 | 16.5 | GO:0016645 | oxidoreductase activity, acting on the CH-NH group of donors(GO:0016645) |
1.0 | 14.4 | GO:0047617 | palmitoyl-CoA hydrolase activity(GO:0016290) acyl-CoA hydrolase activity(GO:0047617) |
1.0 | 5.1 | GO:0017040 | ceramidase activity(GO:0017040) |
1.0 | 5.1 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
1.0 | 5.1 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
1.0 | 2.0 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
1.0 | 6.1 | GO:0016679 | oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) |
1.0 | 3.1 | GO:0004525 | ribonuclease III activity(GO:0004525) double-stranded RNA-specific ribonuclease activity(GO:0032296) |
1.0 | 6.1 | GO:0001013 | RNA polymerase I regulatory region DNA binding(GO:0001013) |
1.0 | 1.0 | GO:0050253 | retinyl-palmitate esterase activity(GO:0050253) |
1.0 | 19.3 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
1.0 | 2.0 | GO:0003691 | double-stranded telomeric DNA binding(GO:0003691) |
1.0 | 4.0 | GO:0019158 | fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
1.0 | 169.4 | GO:0061630 | ubiquitin protein ligase activity(GO:0061630) |
1.0 | 18.0 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
1.0 | 1.0 | GO:0034739 | histone deacetylase activity (H4-K16 specific)(GO:0034739) |
1.0 | 3.0 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
1.0 | 3.0 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
1.0 | 25.8 | GO:0015485 | cholesterol binding(GO:0015485) |
1.0 | 6.9 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
1.0 | 4.0 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
1.0 | 8.9 | GO:0010181 | FMN binding(GO:0010181) |
1.0 | 26.6 | GO:0050699 | WW domain binding(GO:0050699) |
1.0 | 3.9 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
1.0 | 2.9 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
1.0 | 3.9 | GO:0035174 | histone serine kinase activity(GO:0035174) |
1.0 | 2.0 | GO:0051920 | peroxiredoxin activity(GO:0051920) |
1.0 | 11.7 | GO:0017091 | AU-rich element binding(GO:0017091) |
1.0 | 1.9 | GO:0019961 | interferon binding(GO:0019961) |
1.0 | 4.9 | GO:0015181 | arginine transmembrane transporter activity(GO:0015181) L-lysine transmembrane transporter activity(GO:0015189) |
1.0 | 11.6 | GO:0004407 | histone deacetylase activity(GO:0004407) protein deacetylase activity(GO:0033558) |
1.0 | 10.6 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
1.0 | 11.5 | GO:0008327 | methyl-CpG binding(GO:0008327) |
1.0 | 5.8 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
1.0 | 2.9 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
0.9 | 4.7 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.9 | 1.9 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.9 | 4.7 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.9 | 7.5 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
0.9 | 9.4 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
0.9 | 2.8 | GO:0061731 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.9 | 1.9 | GO:0008898 | S-adenosylmethionine-homocysteine S-methyltransferase activity(GO:0008898) |
0.9 | 5.6 | GO:0031996 | thioesterase binding(GO:0031996) |
0.9 | 2.8 | GO:0015238 | drug transmembrane transporter activity(GO:0015238) |
0.9 | 7.4 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.9 | 13.9 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.9 | 10.2 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.9 | 7.4 | GO:0042171 | lysophosphatidic acid acyltransferase activity(GO:0042171) |
0.9 | 0.9 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
0.9 | 2.7 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
0.9 | 2.7 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
0.9 | 4.5 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
0.9 | 9.9 | GO:0001618 | virus receptor activity(GO:0001618) |
0.9 | 8.1 | GO:0044548 | S100 protein binding(GO:0044548) |
0.9 | 22.5 | GO:0070063 | RNA polymerase binding(GO:0070063) |
0.9 | 2.7 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.9 | 2.7 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.9 | 5.4 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.9 | 8.0 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.9 | 7.1 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
0.9 | 4.4 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.9 | 6.2 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.9 | 0.9 | GO:0030911 | TPR domain binding(GO:0030911) |
0.9 | 1.8 | GO:0032190 | acrosin binding(GO:0032190) |
0.9 | 0.9 | GO:0008934 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.9 | 4.4 | GO:0070403 | NAD+ binding(GO:0070403) |
0.9 | 1.8 | GO:0032453 | histone demethylase activity (H3-K4 specific)(GO:0032453) |
0.9 | 0.9 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.9 | 7.0 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.9 | 15.7 | GO:0001103 | RNA polymerase II repressing transcription factor binding(GO:0001103) |
0.9 | 2.6 | GO:0015288 | porin activity(GO:0015288) |
0.9 | 3.5 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) |
0.9 | 5.2 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.9 | 1.7 | GO:0004052 | arachidonate 12-lipoxygenase activity(GO:0004052) |
0.9 | 2.6 | GO:0016840 | carbon-nitrogen lyase activity(GO:0016840) amidine-lyase activity(GO:0016842) |
0.9 | 0.9 | GO:0032137 | guanine/thymine mispair binding(GO:0032137) |
0.9 | 1.7 | GO:0035256 | G-protein coupled glutamate receptor binding(GO:0035256) |
0.9 | 4.3 | GO:0022821 | potassium ion antiporter activity(GO:0022821) |
0.9 | 96.2 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.8 | 2.5 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
0.8 | 0.8 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
0.8 | 2.5 | GO:0004771 | sterol esterase activity(GO:0004771) |
0.8 | 2.5 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.8 | 4.1 | GO:0050308 | sugar-phosphatase activity(GO:0050308) |
0.8 | 1.6 | GO:1990715 | mRNA CDS binding(GO:1990715) |
0.8 | 3.3 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.8 | 12.3 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.8 | 6.6 | GO:0030955 | potassium ion binding(GO:0030955) |
0.8 | 5.7 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.8 | 3.3 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.8 | 8.9 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.8 | 16.2 | GO:0016676 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors(GO:0016675) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.8 | 2.4 | GO:0031432 | titin binding(GO:0031432) |
0.8 | 14.5 | GO:0016836 | hydro-lyase activity(GO:0016836) |
0.8 | 4.8 | GO:0001846 | opsonin binding(GO:0001846) |
0.8 | 4.0 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.8 | 7.2 | GO:0018450 | pinocarveol dehydrogenase activity(GO:0018446) chloral hydrate dehydrogenase activity(GO:0018447) hydroxymethylmethylsilanediol oxidase activity(GO:0018448) 1-phenylethanol dehydrogenase activity(GO:0018449) myrtenol dehydrogenase activity(GO:0018450) cis-1,2-dihydroxy-1,2-dihydro-8-carboxynaphthalene dehydrogenase activity(GO:0034522) 3-hydroxy-4-methyloctanoyl-CoA dehydrogenase activity(GO:0034582) 2-hydroxy-4-isopropenylcyclohexane-1-carboxyl-CoA dehydrogenase activity(GO:0034778) cis-9,10-dihydroanthracene-9,10-diol dehydrogenase activity(GO:0034817) citronellol dehydrogenase activity(GO:0034821) naphthyl-2-hydroxymethyl-succinyl-CoA dehydrogenase activity(GO:0034847) 2,4,4-trimethyl-1-pentanol dehydrogenase activity(GO:0034863) 2,4,4-trimethyl-3-hydroxypentanoyl-CoA dehydrogenase activity(GO:0034868) 1-hydroxy-4,4-dimethylpentan-3-one dehydrogenase activity(GO:0034871) endosulfan diol dehydrogenase activity(GO:0034891) endosulfan hydroxyether dehydrogenase activity(GO:0034901) 3-hydroxy-2-methylhexanoyl-CoA dehydrogenase activity(GO:0034918) 3-hydroxy-2,6-dimethyl-5-methylene-heptanoyl-CoA dehydrogenase activity(GO:0034944) versicolorin reductase activity(GO:0042469) ketoreductase activity(GO:0045703) |
0.8 | 10.4 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.8 | 3.2 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.8 | 15.9 | GO:0036442 | hydrogen-exporting ATPase activity(GO:0036442) |
0.8 | 16.6 | GO:0004521 | endoribonuclease activity(GO:0004521) |
0.8 | 0.8 | GO:0031726 | CCR1 chemokine receptor binding(GO:0031726) |
0.8 | 14.2 | GO:0008137 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
0.8 | 2.4 | GO:0043199 | sulfate binding(GO:0043199) |
0.8 | 25.1 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.8 | 14.1 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.8 | 1.6 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
0.8 | 0.8 | GO:0005338 | nucleotide-sugar transmembrane transporter activity(GO:0005338) |
0.8 | 12.4 | GO:0070566 | adenylyltransferase activity(GO:0070566) |
0.8 | 3.1 | GO:0031013 | troponin I binding(GO:0031013) |
0.8 | 13.9 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.8 | 2.3 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
0.8 | 0.8 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.8 | 26.5 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.8 | 75.5 | GO:0005506 | iron ion binding(GO:0005506) |
0.8 | 12.1 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.8 | 6.0 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
0.8 | 4.5 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
0.8 | 0.8 | GO:0015665 | alcohol transmembrane transporter activity(GO:0015665) |
0.8 | 9.8 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.7 | 2.2 | GO:0035663 | Toll-like receptor 2 binding(GO:0035663) |
0.7 | 3.7 | GO:0008097 | 5S rRNA binding(GO:0008097) |
0.7 | 0.7 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.7 | 5.9 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.7 | 15.4 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.7 | 3.7 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.7 | 0.7 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
0.7 | 3.7 | GO:0005499 | vitamin D binding(GO:0005499) |
0.7 | 2.2 | GO:0055102 | lipase inhibitor activity(GO:0055102) |
0.7 | 2.2 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.7 | 2.9 | GO:0008656 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) |
0.7 | 7.2 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.7 | 2.2 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.7 | 2.1 | GO:0061665 | SUMO ligase activity(GO:0061665) |
0.7 | 3.6 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.7 | 5.0 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.7 | 7.1 | GO:0016799 | hydrolase activity, hydrolyzing N-glycosyl compounds(GO:0016799) |
0.7 | 2.1 | GO:0017116 | single-stranded DNA-dependent ATP-dependent DNA helicase activity(GO:0017116) |
0.7 | 4.2 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.7 | 2.1 | GO:0046978 | TAP1 binding(GO:0046978) TAP2 binding(GO:0046979) |
0.7 | 10.6 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.7 | 2.1 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
0.7 | 3.5 | GO:0098505 | G-rich strand telomeric DNA binding(GO:0098505) |
0.7 | 4.9 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
0.7 | 0.7 | GO:0070568 | guanylyltransferase activity(GO:0070568) |
0.7 | 0.7 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
0.7 | 4.2 | GO:0001848 | complement binding(GO:0001848) |
0.7 | 2.1 | GO:0004942 | anaphylatoxin receptor activity(GO:0004942) |
0.7 | 3.5 | GO:0004769 | steroid delta-isomerase activity(GO:0004769) |
0.7 | 3.5 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
0.7 | 0.7 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
0.7 | 4.2 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.7 | 35.3 | GO:0042626 | ATPase activity, coupled to transmembrane movement of substances(GO:0042626) |
0.7 | 21.4 | GO:0018024 | histone-lysine N-methyltransferase activity(GO:0018024) |
0.7 | 3.5 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.7 | 3.5 | GO:0004556 | alpha-amylase activity(GO:0004556) |
0.7 | 1.4 | GO:0008310 | single-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008310) |
0.7 | 0.7 | GO:0016743 | carboxyl- or carbamoyltransferase activity(GO:0016743) |
0.7 | 7.6 | GO:0031593 | polyubiquitin binding(GO:0031593) |
0.7 | 45.4 | GO:0008565 | protein transporter activity(GO:0008565) |
0.7 | 0.7 | GO:0016655 | oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor(GO:0016655) |
0.7 | 3.4 | GO:0035251 | UDP-glucosyltransferase activity(GO:0035251) |
0.7 | 2.7 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.7 | 0.7 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.7 | 6.1 | GO:0015643 | toxic substance binding(GO:0015643) |
0.7 | 7.4 | GO:0005372 | water transmembrane transporter activity(GO:0005372) |
0.7 | 5.4 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.7 | 1.3 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.7 | 2.7 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
0.7 | 2.0 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.7 | 2.0 | GO:0048531 | beta-1,3-galactosyltransferase activity(GO:0048531) |
0.7 | 0.7 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
0.7 | 2.0 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.7 | 2.7 | GO:0050815 | phosphoserine binding(GO:0050815) |
0.7 | 2.0 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.7 | 11.3 | GO:0043236 | laminin binding(GO:0043236) |
0.7 | 5.9 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
0.7 | 11.2 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.7 | 1.3 | GO:0031418 | L-ascorbic acid binding(GO:0031418) |
0.7 | 5.2 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.7 | 14.3 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.7 | 46.2 | GO:0036459 | thiol-dependent ubiquitinyl hydrolase activity(GO:0036459) ubiquitinyl hydrolase activity(GO:0101005) |
0.7 | 78.0 | GO:0008168 | methyltransferase activity(GO:0008168) |
0.6 | 49.3 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.6 | 0.6 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
0.6 | 1.9 | GO:0015651 | quaternary ammonium group transmembrane transporter activity(GO:0015651) |
0.6 | 1.9 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.6 | 42.4 | GO:0005178 | integrin binding(GO:0005178) |
0.6 | 19.9 | GO:0005507 | copper ion binding(GO:0005507) |
0.6 | 1.9 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.6 | 3.2 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.6 | 1.9 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.6 | 2.5 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
0.6 | 3.2 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.6 | 0.6 | GO:0019862 | IgA binding(GO:0019862) |
0.6 | 5.0 | GO:0031369 | translation initiation factor binding(GO:0031369) |
0.6 | 3.1 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.6 | 5.6 | GO:0019843 | rRNA binding(GO:0019843) |
0.6 | 1.2 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.6 | 14.8 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
0.6 | 3.7 | GO:0050700 | CARD domain binding(GO:0050700) |
0.6 | 0.6 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
0.6 | 1.8 | GO:0030983 | mismatched DNA binding(GO:0030983) |
0.6 | 4.3 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.6 | 2.4 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
0.6 | 3.0 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.6 | 4.2 | GO:0070888 | E-box binding(GO:0070888) |
0.6 | 1.2 | GO:0015143 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.6 | 4.8 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.6 | 11.5 | GO:0045502 | dynein binding(GO:0045502) |
0.6 | 1.2 | GO:0031433 | telethonin binding(GO:0031433) |
0.6 | 8.4 | GO:0016706 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors(GO:0016706) |
0.6 | 0.6 | GO:0016662 | oxidoreductase activity, acting on other nitrogenous compounds as donors, cytochrome as acceptor(GO:0016662) |
0.6 | 3.6 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
0.6 | 15.0 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) |
0.6 | 6.6 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.6 | 26.3 | GO:0042826 | histone deacetylase binding(GO:0042826) |
0.6 | 2.4 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.6 | 1.8 | GO:0043531 | ADP binding(GO:0043531) |
0.6 | 19.0 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
0.6 | 0.6 | GO:0030145 | manganese ion binding(GO:0030145) |
0.6 | 1.2 | GO:0043842 | Kdo transferase activity(GO:0043842) |
0.6 | 1.8 | GO:1990446 | U1 snRNP binding(GO:1990446) |
0.6 | 1.8 | GO:0031491 | nucleosome binding(GO:0031491) |
0.6 | 1.7 | GO:0004536 | deoxyribonuclease activity(GO:0004536) |
0.6 | 0.6 | GO:0019237 | centromeric DNA binding(GO:0019237) |
0.6 | 5.8 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.6 | 1.7 | GO:0031800 | type 3 metabotropic glutamate receptor binding(GO:0031800) |
0.6 | 5.2 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.6 | 2.9 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.6 | 2.3 | GO:0102344 | 3-hydroxy-behenoyl-CoA dehydratase activity(GO:0102344) 3-hydroxy-lignoceroyl-CoA dehydratase activity(GO:0102345) |
0.6 | 6.3 | GO:0004312 | fatty acid synthase activity(GO:0004312) |
0.6 | 1.2 | GO:0004784 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.6 | 0.6 | GO:0004069 | L-aspartate:2-oxoglutarate aminotransferase activity(GO:0004069) |
0.6 | 2.3 | GO:0090079 | translation regulator activity, nucleic acid binding(GO:0090079) |
0.6 | 2.9 | GO:0034046 | poly(G) binding(GO:0034046) |
0.6 | 1.7 | GO:0016215 | acyl-CoA desaturase activity(GO:0016215) |
0.6 | 0.6 | GO:0008504 | monoamine transmembrane transporter activity(GO:0008504) |
0.6 | 2.3 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.6 | 59.0 | GO:0003713 | transcription coactivator activity(GO:0003713) |
0.6 | 10.2 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
0.6 | 1.7 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) |
0.6 | 0.6 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.6 | 8.4 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
0.6 | 1.7 | GO:0019002 | GMP binding(GO:0019002) |
0.6 | 2.8 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.6 | 9.4 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
0.6 | 2.2 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.6 | 3.9 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.6 | 5.5 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
0.6 | 5.0 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.5 | 2.2 | GO:0005280 | hydrogen:amino acid symporter activity(GO:0005280) |
0.5 | 3.8 | GO:0015125 | bile acid transmembrane transporter activity(GO:0015125) |
0.5 | 1.6 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.5 | 1.1 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
0.5 | 1.1 | GO:0010861 | thyroid hormone receptor activator activity(GO:0010861) |
0.5 | 4.3 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.5 | 2.7 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.5 | 4.8 | GO:0003689 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.5 | 1.1 | GO:0019959 | interleukin-8 binding(GO:0019959) |
0.5 | 32.6 | GO:0004519 | endonuclease activity(GO:0004519) |
0.5 | 1.1 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.5 | 1.6 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
0.5 | 0.5 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
0.5 | 1.6 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.5 | 2.1 | GO:0051766 | inositol trisphosphate kinase activity(GO:0051766) |
0.5 | 3.7 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
0.5 | 0.5 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.5 | 14.2 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.5 | 5.3 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.5 | 20.4 | GO:0002161 | aminoacyl-tRNA editing activity(GO:0002161) |
0.5 | 0.5 | GO:1990254 | keratin filament binding(GO:1990254) |
0.5 | 3.7 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.5 | 9.4 | GO:0030552 | cAMP binding(GO:0030552) |
0.5 | 2.1 | GO:0035325 | Toll-like receptor binding(GO:0035325) |
0.5 | 3.1 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.5 | 17.6 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.5 | 16.5 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.5 | 0.5 | GO:0051022 | Rho GDP-dissociation inhibitor binding(GO:0051022) |
0.5 | 1.5 | GO:0034511 | U3 snoRNA binding(GO:0034511) |
0.5 | 20.9 | GO:0004896 | cytokine receptor activity(GO:0004896) |
0.5 | 2.0 | GO:0008329 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
0.5 | 2.5 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.5 | 10.1 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.5 | 20.2 | GO:0016811 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides(GO:0016811) |
0.5 | 1.5 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.5 | 17.7 | GO:0005496 | steroid binding(GO:0005496) |
0.5 | 0.5 | GO:0042301 | phosphate ion binding(GO:0042301) |
0.5 | 19.1 | GO:0001158 | enhancer sequence-specific DNA binding(GO:0001158) |
0.5 | 1.5 | GO:0015114 | phosphate ion transmembrane transporter activity(GO:0015114) |
0.5 | 0.5 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
0.5 | 3.5 | GO:0019200 | carbohydrate kinase activity(GO:0019200) |
0.5 | 0.5 | GO:0051373 | FATZ binding(GO:0051373) |
0.5 | 2.0 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.5 | 0.5 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.5 | 1.5 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
0.5 | 73.4 | GO:0004842 | ubiquitin-protein transferase activity(GO:0004842) |
0.5 | 0.5 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.5 | 14.3 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.5 | 3.4 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.5 | 3.4 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
0.5 | 12.1 | GO:0033549 | MAP kinase phosphatase activity(GO:0033549) |
0.5 | 0.5 | GO:0032557 | pyrimidine ribonucleotide binding(GO:0032557) |
0.5 | 1.4 | GO:0008147 | structural constituent of bone(GO:0008147) |
0.5 | 1.4 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
0.5 | 0.5 | GO:0061733 | peptide-lysine-N-acetyltransferase activity(GO:0061733) |
0.5 | 1.4 | GO:0031690 | adrenergic receptor binding(GO:0031690) |
0.5 | 7.1 | GO:0005527 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.5 | 0.9 | GO:0005326 | neurotransmitter transporter activity(GO:0005326) |
0.5 | 0.9 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.5 | 2.8 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.5 | 7.5 | GO:0000049 | tRNA binding(GO:0000049) |
0.5 | 0.5 | GO:0008408 | 3'-5' exonuclease activity(GO:0008408) |
0.5 | 2.3 | GO:0016866 | intramolecular transferase activity(GO:0016866) |
0.5 | 1.4 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
0.5 | 6.0 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.5 | 5.1 | GO:0030515 | snoRNA binding(GO:0030515) |
0.5 | 0.9 | GO:0003916 | DNA topoisomerase activity(GO:0003916) |
0.5 | 1.4 | GO:0002046 | opsin binding(GO:0002046) |
0.5 | 1.4 | GO:0004945 | angiotensin type II receptor activity(GO:0004945) |
0.5 | 0.9 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.5 | 1.4 | GO:0008422 | beta-glucosidase activity(GO:0008422) |
0.5 | 0.5 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
0.5 | 14.2 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.5 | 0.9 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.5 | 1.8 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.5 | 1.4 | GO:0004365 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
0.4 | 8.1 | GO:0004812 | aminoacyl-tRNA ligase activity(GO:0004812) |
0.4 | 40.8 | GO:0000287 | magnesium ion binding(GO:0000287) |
0.4 | 1.3 | GO:0004114 | 3',5'-cyclic-nucleotide phosphodiesterase activity(GO:0004114) |
0.4 | 1.3 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.4 | 5.8 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.4 | 15.9 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.4 | 0.4 | GO:0042281 | dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase activity(GO:0042281) |
0.4 | 8.8 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
0.4 | 0.4 | GO:0070840 | dynein complex binding(GO:0070840) |
0.4 | 6.2 | GO:0008483 | transaminase activity(GO:0008483) |
0.4 | 58.9 | GO:0003924 | GTPase activity(GO:0003924) |
0.4 | 0.4 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
0.4 | 2.6 | GO:0002039 | p53 binding(GO:0002039) |
0.4 | 0.9 | GO:0003964 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
0.4 | 1.3 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
0.4 | 0.4 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
0.4 | 0.8 | GO:0004534 | 5'-3' exoribonuclease activity(GO:0004534) |
0.4 | 1.7 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.4 | 0.8 | GO:0001032 | RNA polymerase III type 1 promoter DNA binding(GO:0001030) RNA polymerase III type 2 promoter DNA binding(GO:0001031) RNA polymerase III type 3 promoter DNA binding(GO:0001032) 5S rDNA binding(GO:0080084) |
0.4 | 18.4 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
0.4 | 4.6 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
0.4 | 4.6 | GO:0016790 | thiolester hydrolase activity(GO:0016790) |
0.4 | 0.4 | GO:0004518 | nuclease activity(GO:0004518) |
0.4 | 0.8 | GO:0004977 | melanocortin receptor activity(GO:0004977) |
0.4 | 1.3 | GO:0097153 | cysteine-type endopeptidase activity involved in apoptotic process(GO:0097153) |
0.4 | 2.1 | GO:0050780 | dopamine receptor binding(GO:0050780) |
0.4 | 1.7 | GO:0035671 | enone reductase activity(GO:0035671) |
0.4 | 7.4 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.4 | 0.8 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.4 | 1.2 | GO:0042731 | PH domain binding(GO:0042731) |
0.4 | 8.1 | GO:0043130 | ubiquitin binding(GO:0043130) |
0.4 | 1.2 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.4 | 0.8 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
0.4 | 1.2 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.4 | 0.8 | GO:0000182 | rDNA binding(GO:0000182) |
0.4 | 0.4 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.4 | 4.8 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.4 | 14.7 | GO:0004702 | receptor signaling protein serine/threonine kinase activity(GO:0004702) |
0.4 | 2.0 | GO:0051400 | BH domain binding(GO:0051400) |
0.4 | 9.0 | GO:0035064 | methylated histone binding(GO:0035064) |
0.4 | 1.2 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.4 | 3.5 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.4 | 207.2 | GO:0044822 | poly(A) RNA binding(GO:0044822) |
0.4 | 0.8 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
0.4 | 1.2 | GO:1990189 | peptide-serine-N-acetyltransferase activity(GO:1990189) peptide-glutamate-N-acetyltransferase activity(GO:1990190) |
0.4 | 1.5 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.4 | 3.1 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.4 | 0.8 | GO:0019107 | myristoyltransferase activity(GO:0019107) |
0.4 | 2.7 | GO:0016918 | retinal binding(GO:0016918) |
0.4 | 2.7 | GO:0030331 | estrogen receptor binding(GO:0030331) |
0.4 | 3.0 | GO:0019865 | immunoglobulin binding(GO:0019865) |
0.4 | 1.5 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.4 | 0.8 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.4 | 63.1 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.4 | 0.8 | GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding(GO:0001162) |
0.4 | 0.7 | GO:0017153 | sodium:dicarboxylate symporter activity(GO:0017153) |
0.4 | 0.7 | GO:0034452 | dynactin binding(GO:0034452) |
0.4 | 1.1 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.4 | 1.5 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.4 | 43.7 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.4 | 1.5 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
0.4 | 2.2 | GO:0004540 | ribonuclease activity(GO:0004540) |
0.4 | 4.1 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
0.4 | 2.6 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
0.4 | 3.7 | GO:0003724 | RNA helicase activity(GO:0003724) ATP-dependent RNA helicase activity(GO:0004004) RNA-dependent ATPase activity(GO:0008186) |
0.4 | 1.8 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) |
0.4 | 17.2 | GO:0000030 | mannosyltransferase activity(GO:0000030) |
0.4 | 0.7 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
0.4 | 6.9 | GO:0004298 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.4 | 1.8 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.4 | 0.7 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
0.4 | 42.3 | GO:0005525 | GTP binding(GO:0005525) |
0.4 | 1.5 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.4 | 1.5 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
0.4 | 5.8 | GO:0051213 | dioxygenase activity(GO:0051213) |
0.4 | 9.3 | GO:0008234 | cysteine-type peptidase activity(GO:0008234) |
0.4 | 1.4 | GO:0015368 | calcium:cation antiporter activity(GO:0015368) |
0.4 | 0.7 | GO:0071253 | connexin binding(GO:0071253) |
0.4 | 3.2 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.4 | 6.0 | GO:0004889 | acetylcholine-activated cation-selective channel activity(GO:0004889) |
0.4 | 0.4 | GO:0046848 | hydroxyapatite binding(GO:0046848) |
0.4 | 4.2 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.4 | 0.7 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.4 | 51.7 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.3 | 2.8 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.3 | 0.3 | GO:0004112 | cyclic-nucleotide phosphodiesterase activity(GO:0004112) |
0.3 | 1.0 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.3 | 5.9 | GO:0043021 | ribonucleoprotein complex binding(GO:0043021) |
0.3 | 2.1 | GO:0046332 | SMAD binding(GO:0046332) |
0.3 | 3.7 | GO:0015078 | hydrogen ion transmembrane transporter activity(GO:0015078) |
0.3 | 0.3 | GO:0019956 | chemokine binding(GO:0019956) |
0.3 | 21.1 | GO:0019902 | phosphatase binding(GO:0019902) |
0.3 | 13.4 | GO:0008146 | sulfotransferase activity(GO:0008146) |
0.3 | 14.3 | GO:0016887 | ATPase activity(GO:0016887) |
0.3 | 1.0 | GO:0001595 | angiotensin receptor activity(GO:0001595) |
0.3 | 1.0 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.3 | 1.3 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.3 | 2.6 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.3 | 1.0 | GO:0003696 | satellite DNA binding(GO:0003696) |
0.3 | 69.3 | GO:0005198 | structural molecule activity(GO:0005198) |
0.3 | 0.9 | GO:0090484 | drug transporter activity(GO:0090484) |
0.3 | 0.9 | GO:0097617 | annealing activity(GO:0097617) |
0.3 | 0.9 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
0.3 | 3.6 | GO:0016209 | antioxidant activity(GO:0016209) |
0.3 | 0.9 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
0.3 | 1.5 | GO:0008308 | voltage-gated anion channel activity(GO:0008308) |
0.3 | 21.0 | GO:0008514 | organic anion transmembrane transporter activity(GO:0008514) |
0.3 | 0.6 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
0.3 | 0.9 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.3 | 1.2 | GO:0005113 | patched binding(GO:0005113) |
0.3 | 3.2 | GO:0005355 | glucose transmembrane transporter activity(GO:0005355) |
0.3 | 1.7 | GO:0035254 | glutamate receptor binding(GO:0035254) |
0.3 | 9.0 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.3 | 2.0 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.3 | 1.1 | GO:0008410 | CoA-transferase activity(GO:0008410) |
0.3 | 1.1 | GO:0005351 | sugar:proton symporter activity(GO:0005351) |
0.3 | 0.3 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
0.3 | 38.0 | GO:0003723 | RNA binding(GO:0003723) |
0.3 | 3.0 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.3 | 3.0 | GO:0004364 | glutathione transferase activity(GO:0004364) |
0.3 | 0.3 | GO:0015197 | peptide transporter activity(GO:0015197) |
0.3 | 0.8 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
0.3 | 6.9 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.3 | 1.3 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.3 | 3.1 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
0.3 | 0.8 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.3 | 7.0 | GO:0005518 | collagen binding(GO:0005518) |
0.3 | 2.8 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.3 | 19.8 | GO:0003774 | motor activity(GO:0003774) |
0.3 | 3.3 | GO:0016763 | transferase activity, transferring pentosyl groups(GO:0016763) |
0.2 | 7.1 | GO:0016407 | acetyltransferase activity(GO:0016407) |
0.2 | 2.4 | GO:0003756 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.2 | 12.6 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
0.2 | 0.5 | GO:0016822 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
0.2 | 2.4 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.2 | 5.2 | GO:0005109 | frizzled binding(GO:0005109) |
0.2 | 0.7 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.2 | 0.5 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
0.2 | 1.4 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.2 | 3.8 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.2 | 2.8 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
0.2 | 2.6 | GO:0022829 | wide pore channel activity(GO:0022829) |
0.2 | 0.7 | GO:0031014 | troponin T binding(GO:0031014) |
0.2 | 0.2 | GO:0052872 | tocotrienol omega-hydroxylase activity(GO:0052872) |
0.2 | 0.5 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
0.2 | 3.9 | GO:0015929 | hexosaminidase activity(GO:0015929) |
0.2 | 0.2 | GO:0001962 | alpha-1,3-galactosyltransferase activity(GO:0001962) |
0.2 | 0.7 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
0.2 | 3.4 | GO:0016765 | transferase activity, transferring alkyl or aryl (other than methyl) groups(GO:0016765) |
0.2 | 0.7 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.2 | 6.8 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.2 | 1.5 | GO:0008376 | acetylgalactosaminyltransferase activity(GO:0008376) |
0.2 | 4.2 | GO:0043621 | protein self-association(GO:0043621) |
0.2 | 1.3 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.2 | 0.2 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.2 | 3.6 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.2 | 1.2 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.2 | 1.9 | GO:0035257 | nuclear hormone receptor binding(GO:0035257) |
0.2 | 1.4 | GO:0055106 | ubiquitin-protein transferase regulator activity(GO:0055106) |
0.2 | 1.0 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
0.2 | 9.9 | GO:0051020 | GTPase binding(GO:0051020) |
0.2 | 28.3 | GO:0003682 | chromatin binding(GO:0003682) |
0.2 | 0.6 | GO:0070182 | DNA polymerase binding(GO:0070182) |
0.2 | 1.2 | GO:0004303 | estradiol 17-beta-dehydrogenase activity(GO:0004303) |
0.2 | 2.5 | GO:0017022 | myosin binding(GO:0017022) |
0.2 | 0.6 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
0.2 | 0.4 | GO:0015928 | fucosidase activity(GO:0015928) |
0.2 | 0.7 | GO:0019787 | ubiquitin-like protein transferase activity(GO:0019787) |
0.2 | 0.5 | GO:0004936 | alpha-adrenergic receptor activity(GO:0004936) |
0.2 | 0.4 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
0.2 | 1.1 | GO:0048038 | quinone binding(GO:0048038) |
0.2 | 0.3 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.2 | 1.9 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
0.2 | 13.9 | GO:0004857 | enzyme inhibitor activity(GO:0004857) |
0.2 | 2.7 | GO:0019208 | phosphatase regulator activity(GO:0019208) |
0.2 | 0.7 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.2 | 0.2 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
0.2 | 0.3 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.2 | 4.0 | GO:0016628 | oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor(GO:0016628) |
0.2 | 0.3 | GO:0038100 | nodal binding(GO:0038100) |
0.2 | 20.0 | GO:0005125 | cytokine activity(GO:0005125) |
0.2 | 2.7 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.2 | 0.5 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.2 | 1.7 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.2 | 0.2 | GO:0008061 | chitin binding(GO:0008061) |
0.1 | 1.0 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.1 | 1.9 | GO:0030276 | clathrin binding(GO:0030276) |
0.1 | 4.0 | GO:0042393 | histone binding(GO:0042393) |
0.1 | 10.7 | GO:0008134 | transcription factor binding(GO:0008134) |
0.1 | 2.2 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.1 | 1.1 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.1 | 12.3 | GO:0005550 | pheromone binding(GO:0005550) |
0.1 | 1.2 | GO:0004386 | helicase activity(GO:0004386) |
0.1 | 1.2 | GO:0004993 | G-protein coupled serotonin receptor activity(GO:0004993) serotonin receptor activity(GO:0099589) |
0.1 | 0.5 | GO:0004954 | prostanoid receptor activity(GO:0004954) |
0.1 | 5.2 | GO:0008527 | taste receptor activity(GO:0008527) |
0.1 | 16.5 | GO:0004674 | protein serine/threonine kinase activity(GO:0004674) |
0.1 | 0.3 | GO:0016776 | phosphotransferase activity, phosphate group as acceptor(GO:0016776) |
0.1 | 5.9 | GO:0003714 | transcription corepressor activity(GO:0003714) |
0.1 | 1.3 | GO:0005112 | Notch binding(GO:0005112) |
0.1 | 0.4 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.1 | 1.1 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.1 | 0.1 | GO:0086008 | voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization(GO:0086008) |
0.1 | 0.7 | GO:0016638 | oxidoreductase activity, acting on the CH-NH2 group of donors(GO:0016638) |
0.1 | 0.1 | GO:0042379 | chemokine receptor binding(GO:0042379) |
0.1 | 0.3 | GO:0035240 | dopamine binding(GO:0035240) |
0.1 | 0.2 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.1 | 0.2 | GO:0051119 | sugar transmembrane transporter activity(GO:0051119) |
0.1 | 0.8 | GO:0015036 | disulfide oxidoreductase activity(GO:0015036) |
0.1 | 0.6 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
0.1 | 0.2 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.1 | 1.9 | GO:0015020 | glucuronosyltransferase activity(GO:0015020) |
0.1 | 2.6 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.1 | 0.5 | GO:0050660 | flavin adenine dinucleotide binding(GO:0050660) |
0.1 | 0.4 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.1 | 0.1 | GO:0015927 | trehalase activity(GO:0015927) |
0.1 | 0.8 | GO:0051287 | NAD binding(GO:0051287) |
0.1 | 0.5 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.1 | 8.9 | GO:0001883 | purine nucleoside binding(GO:0001883) |
0.1 | 0.3 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.1 | 9.6 | GO:0046982 | protein heterodimerization activity(GO:0046982) |
0.1 | 1.0 | GO:0008375 | acetylglucosaminyltransferase activity(GO:0008375) |
0.1 | 0.3 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.1 | 4.8 | GO:0016773 | phosphotransferase activity, alcohol group as acceptor(GO:0016773) |
0.1 | 0.1 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.1 | 1.5 | GO:0000149 | SNARE binding(GO:0000149) |
0.0 | 0.0 | GO:0005522 | profilin binding(GO:0005522) |
0.0 | 0.1 | GO:0034062 | RNA polymerase activity(GO:0034062) |
0.0 | 45.0 | GO:0004984 | olfactory receptor activity(GO:0004984) |
0.0 | 0.6 | GO:0016503 | pheromone receptor activity(GO:0016503) |
0.0 | 0.8 | GO:0016757 | transferase activity, transferring glycosyl groups(GO:0016757) |
0.0 | 0.7 | GO:0016798 | hydrolase activity, acting on glycosyl bonds(GO:0016798) |
0.0 | 0.2 | GO:0031386 | protein tag(GO:0031386) |
0.0 | 0.0 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
0.0 | 0.0 | GO:0023023 | MHC protein complex binding(GO:0023023) |
0.0 | 0.1 | GO:0048495 | Roundabout binding(GO:0048495) |
0.0 | 2.6 | GO:0030246 | carbohydrate binding(GO:0030246) |
0.0 | 0.0 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
0.0 | 0.0 | GO:0042287 | MHC protein binding(GO:0042287) |
0.0 | 0.1 | GO:0005549 | odorant binding(GO:0005549) |
0.0 | 0.0 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
0.0 | 0.0 | GO:0004935 | adrenergic receptor activity(GO:0004935) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.9 | 32.0 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
2.9 | 113.2 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
2.7 | 21.8 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
2.7 | 101.8 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
2.6 | 81.9 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
2.2 | 15.7 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
2.0 | 31.2 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
2.0 | 56.6 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
1.8 | 25.6 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
1.8 | 33.5 | PID IGF1 PATHWAY | IGF1 pathway |
1.7 | 1.7 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
1.7 | 45.3 | PID AURORA A PATHWAY | Aurora A signaling |
1.7 | 33.6 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
1.7 | 10.0 | PID IL5 PATHWAY | IL5-mediated signaling events |
1.6 | 43.5 | PID BCR 5PATHWAY | BCR signaling pathway |
1.5 | 44.7 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
1.5 | 13.9 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
1.5 | 32.3 | PID IL1 PATHWAY | IL1-mediated signaling events |
1.5 | 34.9 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
1.5 | 46.4 | PID ILK PATHWAY | Integrin-linked kinase signaling |
1.5 | 10.3 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
1.4 | 34.7 | PID TNF PATHWAY | TNF receptor signaling pathway |
1.4 | 5.7 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
1.4 | 41.0 | PID AURORA B PATHWAY | Aurora B signaling |
1.4 | 1.4 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
1.4 | 23.9 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
1.4 | 26.2 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
1.4 | 35.8 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
1.4 | 20.6 | PID EPO PATHWAY | EPO signaling pathway |
1.4 | 36.9 | PID RHOA PATHWAY | RhoA signaling pathway |
1.4 | 21.8 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
1.4 | 4.1 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
1.3 | 26.6 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
1.3 | 27.8 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
1.3 | 47.3 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
1.3 | 8.9 | PID S1P S1P1 PATHWAY | S1P1 pathway |
1.3 | 41.6 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
1.3 | 8.8 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
1.2 | 13.6 | PID IFNG PATHWAY | IFN-gamma pathway |
1.2 | 39.9 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
1.2 | 2.4 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
1.2 | 4.8 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
1.2 | 2.3 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
1.1 | 32.0 | PID RAC1 PATHWAY | RAC1 signaling pathway |
1.1 | 9.1 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
1.1 | 4.5 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
1.1 | 12.3 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
1.1 | 1.1 | PID MYC PATHWAY | C-MYC pathway |
1.1 | 36.5 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
1.1 | 14.3 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
1.1 | 2.2 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
1.1 | 19.7 | PID ARF6 PATHWAY | Arf6 signaling events |
1.1 | 35.3 | PID P53 REGULATION PATHWAY | p53 pathway |
1.1 | 13.8 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
1.1 | 5.3 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
1.0 | 13.6 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
1.0 | 1.0 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
1.0 | 38.1 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
1.0 | 4.1 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
1.0 | 21.4 | PID CONE PATHWAY | Visual signal transduction: Cones |
1.0 | 12.0 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
1.0 | 2.0 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
1.0 | 20.5 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
1.0 | 2.9 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
1.0 | 7.7 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
1.0 | 1.0 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
1.0 | 24.9 | PID LKB1 PATHWAY | LKB1 signaling events |
0.9 | 7.6 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.9 | 3.8 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.9 | 0.9 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.9 | 7.4 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.9 | 29.4 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.9 | 4.6 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.9 | 7.2 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.9 | 8.1 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.9 | 23.3 | PID PLK1 PATHWAY | PLK1 signaling events |
0.9 | 2.7 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.9 | 5.2 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.8 | 10.0 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.8 | 8.2 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.8 | 11.3 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.8 | 3.2 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.8 | 1.6 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.8 | 12.6 | PID BARD1 PATHWAY | BARD1 signaling events |
0.8 | 4.7 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.8 | 54.3 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.8 | 31.6 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.8 | 12.1 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.8 | 14.4 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.8 | 6.0 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.7 | 5.9 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.7 | 4.4 | ST GAQ PATHWAY | G alpha q Pathway |
0.7 | 4.4 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.7 | 6.9 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.7 | 9.5 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.7 | 14.9 | PID E2F PATHWAY | E2F transcription factor network |
0.7 | 0.7 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.6 | 20.0 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.6 | 15.4 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.6 | 1.3 | ST GA13 PATHWAY | G alpha 13 Pathway |
0.6 | 4.4 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.6 | 30.2 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.6 | 2.5 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.6 | 0.6 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.6 | 6.2 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.6 | 7.9 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.5 | 8.2 | PID ARF 3PATHWAY | Arf1 pathway |
0.5 | 2.7 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.5 | 16.1 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.5 | 3.2 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.5 | 1.0 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.5 | 9.8 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.5 | 3.6 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
0.5 | 7.2 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.5 | 0.5 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.5 | 2.0 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.5 | 10.0 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.5 | 15.0 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.5 | 6.7 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.5 | 2.3 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.5 | 5.0 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.4 | 8.5 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.4 | 8.8 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.4 | 6.9 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.4 | 9.2 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.4 | 1.3 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.4 | 1.2 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.4 | 4.0 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.4 | 2.3 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.4 | 70.0 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.4 | 4.3 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.4 | 2.1 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.3 | 1.7 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.3 | 3.8 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.3 | 3.3 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.3 | 1.3 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.3 | 1.2 | PID FOXO PATHWAY | FoxO family signaling |
0.3 | 1.2 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.3 | 2.1 | PID ATM PATHWAY | ATM pathway |
0.3 | 5.6 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
0.3 | 1.5 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.3 | 0.3 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.3 | 0.3 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.3 | 2.1 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.3 | 3.8 | ST FAS SIGNALING PATHWAY | Fas Signaling Pathway |
0.3 | 36.5 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.2 | 0.5 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.2 | 4.3 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.2 | 0.6 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.2 | 1.5 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.2 | 0.8 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.2 | 0.8 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.2 | 1.4 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.2 | 0.2 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.2 | 0.8 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.2 | 0.2 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
0.2 | 24.1 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.2 | 2.1 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.2 | 0.4 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.2 | 0.5 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.1 | 0.3 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.1 | 1.3 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.1 | 3.4 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.1 | 0.6 | PID ALK1 PATHWAY | ALK1 signaling events |
0.1 | 1.1 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.1 | 1.5 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.1 | 0.8 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.1 | 0.5 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.1 | 1.7 | PID P73PATHWAY | p73 transcription factor network |
0.1 | 0.9 | PID NOTCH PATHWAY | Notch signaling pathway |
0.1 | 0.1 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.0 | 0.1 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.0 | 0.1 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.0 | 0.2 | PID MTOR 4PATHWAY | mTOR signaling pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.5 | 45.3 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
4.2 | 42.5 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
3.7 | 29.8 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
3.6 | 57.3 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
3.5 | 3.5 | REACTOME REGULATION OF APOPTOSIS | Genes involved in Regulation of Apoptosis |
3.4 | 6.8 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
3.2 | 9.7 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
3.1 | 6.2 | REACTOME ENERGY DEPENDENT REGULATION OF MTOR BY LKB1 AMPK | Genes involved in Energy dependent regulation of mTOR by LKB1-AMPK |
3.0 | 36.4 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
2.7 | 46.2 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
2.7 | 71.9 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
2.6 | 23.7 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
2.6 | 43.9 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
2.6 | 64.3 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
2.5 | 45.1 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
2.5 | 19.9 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
2.4 | 21.9 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
2.3 | 25.2 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
2.2 | 2.2 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
2.2 | 4.4 | REACTOME PKB MEDIATED EVENTS | Genes involved in PKB-mediated events |
2.1 | 25.6 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
2.0 | 28.2 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
1.9 | 25.2 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
1.9 | 44.3 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
1.9 | 18.9 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
1.9 | 26.0 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
1.8 | 42.2 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
1.8 | 5.4 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
1.8 | 33.4 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
1.8 | 77.0 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
1.8 | 35.0 | REACTOME G1 PHASE | Genes involved in G1 Phase |
1.7 | 8.7 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
1.7 | 15.5 | REACTOME LIPOPROTEIN METABOLISM | Genes involved in Lipoprotein metabolism |
1.7 | 39.5 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
1.7 | 1.7 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
1.7 | 6.6 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
1.6 | 3.2 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
1.6 | 11.2 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
1.6 | 17.6 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
1.6 | 22.3 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
1.6 | 31.8 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
1.6 | 39.3 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
1.6 | 3.1 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
1.6 | 6.2 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
1.5 | 46.4 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
1.5 | 4.6 | REACTOME UNFOLDED PROTEIN RESPONSE | Genes involved in Unfolded Protein Response |
1.5 | 6.1 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
1.5 | 18.0 | REACTOME SIGNALING BY NOTCH4 | Genes involved in Signaling by NOTCH4 |
1.5 | 4.5 | REACTOME G BETA GAMMA SIGNALLING THROUGH PI3KGAMMA | Genes involved in G beta:gamma signalling through PI3Kgamma |
1.5 | 29.8 | REACTOME G BETA GAMMA SIGNALLING THROUGH PLC BETA | Genes involved in G beta:gamma signalling through PLC beta |
1.5 | 10.3 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
1.5 | 48.2 | REACTOME MRNA 3 END PROCESSING | Genes involved in mRNA 3'-end processing |
1.4 | 62.7 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
1.4 | 18.3 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
1.4 | 11.2 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
1.4 | 18.2 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
1.3 | 6.7 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
1.3 | 12.1 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
1.3 | 2.7 | REACTOME INFLUENZA LIFE CYCLE | Genes involved in Influenza Life Cycle |
1.3 | 1.3 | REACTOME GLUCAGON SIGNALING IN METABOLIC REGULATION | Genes involved in Glucagon signaling in metabolic regulation |
1.3 | 10.6 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
1.3 | 22.6 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
1.3 | 21.1 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
1.3 | 89.4 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
1.3 | 32.4 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
1.3 | 6.5 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
1.3 | 5.2 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
1.3 | 15.5 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
1.3 | 14.1 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
1.3 | 20.6 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
1.3 | 9.0 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
1.3 | 16.6 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
1.3 | 15.3 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
1.3 | 57.4 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
1.3 | 20.1 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
1.2 | 17.4 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
1.2 | 12.4 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
1.2 | 2.5 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
1.2 | 19.2 | REACTOME PIP3 ACTIVATES AKT SIGNALING | Genes involved in PIP3 activates AKT signaling |
1.2 | 7.2 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
1.2 | 61.2 | REACTOME GLYCEROPHOSPHOLIPID BIOSYNTHESIS | Genes involved in Glycerophospholipid biosynthesis |
1.2 | 10.6 | REACTOME ACTIVATION OF CHAPERONES BY ATF6 ALPHA | Genes involved in Activation of Chaperones by ATF6-alpha |
1.2 | 10.6 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
1.2 | 10.6 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
1.2 | 16.4 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
1.2 | 5.9 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
1.2 | 60.7 | REACTOME LATE PHASE OF HIV LIFE CYCLE | Genes involved in Late Phase of HIV Life Cycle |
1.2 | 9.2 | REACTOME PROCESSING OF CAPPED INTRONLESS PRE MRNA | Genes involved in Processing of Capped Intronless Pre-mRNA |
1.1 | 42.0 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
1.1 | 84.8 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
1.1 | 12.4 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
1.1 | 64.3 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
1.1 | 50.7 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
1.1 | 3.3 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
1.1 | 12.0 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
1.1 | 6.5 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
1.1 | 15.2 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
1.1 | 4.3 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
1.1 | 15.0 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
1.1 | 9.6 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
1.1 | 14.8 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
1.1 | 4.2 | REACTOME DOWNSTREAM SIGNAL TRANSDUCTION | Genes involved in Downstream signal transduction |
1.0 | 13.5 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
1.0 | 9.0 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
1.0 | 16.8 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
1.0 | 7.9 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
1.0 | 34.2 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
1.0 | 9.8 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
1.0 | 14.6 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
1.0 | 22.2 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
1.0 | 4.8 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
1.0 | 13.5 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
1.0 | 1.0 | REACTOME DESTABILIZATION OF MRNA BY KSRP | Genes involved in Destabilization of mRNA by KSRP |
1.0 | 12.4 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.9 | 4.7 | REACTOME TRANSCRIPTIONAL ACTIVITY OF SMAD2 SMAD3 SMAD4 HETEROTRIMER | Genes involved in Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer |
0.9 | 25.4 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.9 | 19.4 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.9 | 12.0 | REACTOME MRNA SPLICING MINOR PATHWAY | Genes involved in mRNA Splicing - Minor Pathway |
0.9 | 23.0 | REACTOME APOPTOTIC EXECUTION PHASE | Genes involved in Apoptotic execution phase |
0.9 | 21.9 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.9 | 14.5 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.9 | 1.8 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.9 | 13.1 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.9 | 10.4 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.9 | 4.3 | REACTOME RNA POL I TRANSCRIPTION | Genes involved in RNA Polymerase I Transcription |
0.9 | 9.4 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.8 | 3.3 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.8 | 9.0 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.8 | 5.7 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.8 | 1.6 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
0.8 | 6.4 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.8 | 107.0 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.8 | 6.3 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.8 | 3.9 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.8 | 7.1 | REACTOME PROLONGED ERK ACTIVATION EVENTS | Genes involved in Prolonged ERK activation events |
0.8 | 10.9 | REACTOME APC CDC20 MEDIATED DEGRADATION OF NEK2A | Genes involved in APC-Cdc20 mediated degradation of Nek2A |
0.8 | 45.0 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.8 | 10.8 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.8 | 9.3 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.8 | 13.1 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.8 | 3.1 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.8 | 20.6 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.8 | 7.6 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.8 | 0.8 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.8 | 7.6 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.7 | 6.7 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.7 | 3.7 | REACTOME TRAF6 MEDIATED INDUCTION OF TAK1 COMPLEX | Genes involved in TRAF6 mediated induction of TAK1 complex |
0.7 | 6.0 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.7 | 1.5 | REACTOME P75NTR RECRUITS SIGNALLING COMPLEXES | Genes involved in p75NTR recruits signalling complexes |
0.7 | 4.4 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.7 | 20.0 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
0.7 | 9.2 | REACTOME ACTIVATION OF THE MRNA UPON BINDING OF THE CAP BINDING COMPLEX AND EIFS AND SUBSEQUENT BINDING TO 43S | Genes involved in Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S |
0.7 | 8.4 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.7 | 8.3 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.7 | 4.1 | REACTOME ER PHAGOSOME PATHWAY | Genes involved in ER-Phagosome pathway |
0.7 | 5.5 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.7 | 6.8 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.7 | 4.7 | REACTOME PROTEIN FOLDING | Genes involved in Protein folding |
0.7 | 3.4 | REACTOME LIPID DIGESTION MOBILIZATION AND TRANSPORT | Genes involved in Lipid digestion, mobilization, and transport |
0.7 | 8.7 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.7 | 4.7 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.7 | 1.3 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.7 | 4.0 | REACTOME SIGNALING BY THE B CELL RECEPTOR BCR | Genes involved in Signaling by the B Cell Receptor (BCR) |
0.7 | 8.6 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
0.7 | 14.4 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.7 | 4.6 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.7 | 0.7 | REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION | Genes involved in Cyclin E associated events during G1/S transition |
0.6 | 0.6 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.6 | 18.0 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.6 | 10.8 | REACTOME EXTENSION OF TELOMERES | Genes involved in Extension of Telomeres |
0.6 | 13.6 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.6 | 21.0 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.6 | 3.7 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.6 | 3.1 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.6 | 5.5 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.6 | 67.8 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.6 | 2.9 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.6 | 4.7 | REACTOME ANTIGEN PROCESSING CROSS PRESENTATION | Genes involved in Antigen processing-Cross presentation |
0.6 | 2.9 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.6 | 19.7 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
0.6 | 4.6 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.6 | 1.7 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
0.6 | 12.5 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.6 | 3.3 | REACTOME PURINE METABOLISM | Genes involved in Purine metabolism |
0.6 | 2.8 | REACTOME MRNA PROCESSING | Genes involved in mRNA Processing |
0.6 | 8.3 | REACTOME METABOLISM OF NUCLEOTIDES | Genes involved in Metabolism of nucleotides |
0.5 | 6.6 | REACTOME KERATAN SULFATE KERATIN METABOLISM | Genes involved in Keratan sulfate/keratin metabolism |
0.5 | 15.0 | REACTOME SPHINGOLIPID METABOLISM | Genes involved in Sphingolipid metabolism |
0.5 | 0.5 | REACTOME TRANS GOLGI NETWORK VESICLE BUDDING | Genes involved in trans-Golgi Network Vesicle Budding |
0.5 | 8.9 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.5 | 5.7 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.5 | 2.6 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.5 | 5.2 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.5 | 8.8 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.5 | 5.7 | REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
0.5 | 12.3 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.5 | 19.4 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.5 | 0.5 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.5 | 42.3 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.5 | 4.4 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.5 | 10.2 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
0.5 | 0.5 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.5 | 4.8 | REACTOME METABOLISM OF MRNA | Genes involved in Metabolism of mRNA |
0.5 | 27.4 | REACTOME RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS | Genes involved in Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. |
0.5 | 0.5 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
0.5 | 1.4 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.5 | 0.5 | REACTOME PLATELET ACTIVATION SIGNALING AND AGGREGATION | Genes involved in Platelet activation, signaling and aggregation |
0.5 | 4.1 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.4 | 6.2 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.4 | 1.3 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.4 | 10.0 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.4 | 7.3 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.4 | 1.7 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.4 | 0.4 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.4 | 3.2 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.4 | 4.3 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.4 | 0.8 | REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
0.4 | 2.7 | REACTOME CDT1 ASSOCIATION WITH THE CDC6 ORC ORIGIN COMPLEX | Genes involved in CDT1 association with the CDC6:ORC:origin complex |
0.4 | 3.1 | REACTOME DOWNSTREAM SIGNALING EVENTS OF B CELL RECEPTOR BCR | Genes involved in Downstream Signaling Events Of B Cell Receptor (BCR) |
0.4 | 4.9 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.4 | 4.8 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.4 | 0.7 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.4 | 15.4 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.4 | 4.3 | REACTOME CLASS A1 RHODOPSIN LIKE RECEPTORS | Genes involved in Class A/1 (Rhodopsin-like receptors) |
0.3 | 3.7 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.3 | 4.0 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.3 | 7.8 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.3 | 6.6 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.3 | 10.3 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.3 | 0.3 | REACTOME NEF MEDIATES DOWN MODULATION OF CELL SURFACE RECEPTORS BY RECRUITING THEM TO CLATHRIN ADAPTERS | Genes involved in Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters |
0.3 | 5.4 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.3 | 10.2 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.3 | 1.2 | REACTOME INWARDLY RECTIFYING K CHANNELS | Genes involved in Inwardly rectifying K+ channels |
0.3 | 7.0 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.3 | 0.5 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.3 | 0.3 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
0.3 | 0.5 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
0.3 | 1.5 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
0.3 | 3.5 | REACTOME ACTIVATED TLR4 SIGNALLING | Genes involved in Activated TLR4 signalling |
0.2 | 0.7 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.2 | 0.2 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.2 | 0.7 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
0.2 | 2.3 | REACTOME INTERFERON SIGNALING | Genes involved in Interferon Signaling |
0.2 | 13.4 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.2 | 1.9 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.2 | 1.8 | REACTOME FATTY ACID TRIACYLGLYCEROL AND KETONE BODY METABOLISM | Genes involved in Fatty acid, triacylglycerol, and ketone body metabolism |
0.2 | 15.2 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.2 | 5.8 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.2 | 0.6 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.2 | 16.2 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.2 | 13.0 | REACTOME G ALPHA Q SIGNALLING EVENTS | Genes involved in G alpha (q) signalling events |
0.2 | 2.9 | REACTOME TRNA AMINOACYLATION | Genes involved in tRNA Aminoacylation |
0.2 | 3.1 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.2 | 4.2 | REACTOME METABOLISM OF PROTEINS | Genes involved in Metabolism of proteins |
0.2 | 1.8 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.2 | 0.3 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.2 | 0.8 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
0.1 | 2.9 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.1 | 0.7 | REACTOME TOLL RECEPTOR CASCADES | Genes involved in Toll Receptor Cascades |
0.1 | 0.9 | REACTOME GLUCOSE METABOLISM | Genes involved in Glucose metabolism |
0.1 | 0.9 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.1 | 0.2 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
0.1 | 0.1 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
0.1 | 0.5 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.1 | 0.3 | REACTOME INTEGRATION OF ENERGY METABOLISM | Genes involved in Integration of energy metabolism |
0.1 | 1.4 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.0 | 0.1 | REACTOME TRANSCRIPTION COUPLED NER TC NER | Genes involved in Transcription-coupled NER (TC-NER) |
0.0 | 0.2 | REACTOME DEFENSINS | Genes involved in Defensins |
0.0 | 0.6 | REACTOME BIOLOGICAL OXIDATIONS | Genes involved in Biological oxidations |
0.0 | 0.7 | REACTOME CHROMOSOME MAINTENANCE | Genes involved in Chromosome Maintenance |
0.0 | 0.5 | REACTOME GENERIC TRANSCRIPTION PATHWAY | Genes involved in Generic Transcription Pathway |
0.0 | 0.1 | REACTOME GASTRIN CREB SIGNALLING PATHWAY VIA PKC AND MAPK | Genes involved in Gastrin-CREB signalling pathway via PKC and MAPK |